Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chloride channel activity (GO:0005254),-0.5735416034070968,-2.103583409511768,0.0,0.009485959997393966,0.006,21/59,13.78%,SLC26A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GABRB1;GLRA1;GABRG2;TTYH2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metalloendopeptidase activity (GO:0004222),0.6558377637915038,1.994550429363942,0.0,0.015422178333857825,0.015,19/76,9.07%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;PMPCB;ECE2;EEF1AKMT4-ECE2
prerank,anion channel activity (GO:0005253),-0.5331664061734235,-1.9579163742670758,0.0,0.043872564987947095,0.064,22/61,13.78%,SLC26A7;LRRC8C;CLIC4;GABRG3;ANO1;LRRC8D;ANO4;CLCN3;GABRA2;GABRB3;GABRB1;GLRA1;GABRG2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metallopeptidase activity (GO:0008237),0.601341418177549,1.9173494837602687,0.0,0.04445216107994314,0.084,21/113,9.07%,PAPPA;ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;DPEP1;PMPCB;ECE2;EEF1AKMT4-ECE2
prerank,retinoid binding (GO:0005501),0.7629513783249321,1.88142958478383,0.0,0.0589671524529858,0.153,5/22,5.73%,RBP4;CYP26B1;NR2F2;RBP1;ALDH1A2
prerank,glutamate receptor activity (GO:0008066),-0.6629006605325344,-1.8663895435098201,0.002577319587628866,0.1245032249657958,0.235,10/19,10.33%,GRM7;GRID2;GRM3;GRIA4;GRIK1;GRIK2;GRM5;GRIA2;GRID1;GRM8
prerank,platelet-derived growth factor binding (GO:0048407),0.8390540187289689,1.8519180089135283,0.0,0.07869846885071566,0.261,5/11,3.47%,COL1A2;COL1A1;COL5A1;PDGFRA;PDGFRB
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6906357146451965,-1.8474345992901382,0.0024752475247524753,0.12183529871652878,0.295,7/16,14.03%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR;SLC12A5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.7006374817541751,-1.8421895008558633,0.002638522427440633,0.08715225747605707,0.321,6/16,5.53%,PTPRB;PTPRG;PTPRE;PTPRK;PTPRD;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.7006374817541751,-1.8421895008558633,0.002638522427440633,0.08715225747605707,0.321,6/16,5.53%,PTPRB;PTPRG;PTPRE;PTPRK;PTPRD;PTPRT
prerank,protease binding (GO:0002020),0.5805463951628933,1.8108256028088454,0.0012165450121654502,0.12700617451412324,0.454,37/99,14.71%,CCBE1;COL1A2;COL1A1;TIMP3;SERPINE1;BCL2;ITGA3;CFLAR;ATP9A;STIM1;INSL3;RFFL;LDLR;BFAR;CST3;DERL1;BDKRB2;POLG;TIMP2;DERL3;CD28;SLC2A13;RNF139;ITGB3;ITGAV;PRKN;LONP2;COL3A1;SELENOS;ADAMTSL4;RIPK2;TRIP4;NOL3;PTEN;ADRM1;AMFR;RIOK3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5952954673921615,-1.8026142556085458,0.0,0.11738875496775035,0.452,14/29,9.70%,GRID2;GRIA4;GABRG3;GRIK1;GRIK2;GABRA2;GABRB3;GABRB1;GABRG2;GLRA2;GABRB2;GRIA2;GRID1;GABRA3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7831250748223905,1.7973973088323576,0.003284072249589491,0.13048372453058138,0.527,5/15,8.86%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH1L1;ALDH2
prerank,ligand-gated anion channel activity (GO:0099095),-0.6572398751729813,-1.7968451203232552,0.013192612137203167,0.10923675809498991,0.474,13/17,21.39%,GABRG3;GABRA2;GABRB3;GABRB1;GLRA1;GABRG2;GLRA2;GABRB2;GABRA3;CFTR;GABRG1;GABRA4;GLRA3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.797161027328209,1.7741564432417738,0.005042016806722689,0.15966490510346923,0.643,5/13,8.86%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH1L1;ALDH2
prerank,ligand-gated channel activity (GO:0022834),-0.5667814446070283,-1.7615209792269937,0.0,0.14439739107144148,0.598,10/29,9.18%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,retinoic acid binding (GO:0001972),0.7984275432903812,1.7614267885662156,0.005,0.16816978286111142,0.699,2/12,1.86%,CYP26B1;NR2F2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7232495770568999,-1.751814875928006,0.011494252873563218,0.14442374096032315,0.638,4/11,11.79%,PPP1R1A;PPP1R14C;PPP1R14B;PPP1R14A
prerank,ligand-gated ion channel activity (GO:0015276),-0.5625760228750541,-1.7463760020490973,0.0,0.13883995996185716,0.656,10/30,9.18%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.5864474506490938,1.7335996548753165,0.00517464424320828,0.21913605031246344,0.832,21/60,10.67%,EPHA3;NRP1;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;ROR1;AXL;MUSK;NTRK3;EGFR;EPHB2;IGF2R;RYK;EPHB3
prerank,amino acid binding (GO:0016597),-0.5451771023423867,-1.7331247665810223,0.009584664536741214,0.14634069537646316,0.71,9/31,7.24%,GRM7;NOS3;GLRA1;GLRA2;DDAH1;NOS1;GRIN2B;DDAH2;GRIN3A
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.6358993207105221,-1.729204536590365,0.005277044854881266,0.14128607726887746,0.719,8/17,8.31%,GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRIN2B;GRIN3A;GRIA2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.7369378146414386,1.7213844586097102,0.0048543689320388345,0.23060692543921524,0.882,6/18,5.78%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.6734303562415025,-1.7090831873878294,0.007389162561576354,0.15922861424197018,0.786,4/14,5.35%,KCNJ2;KCNJ3;KCND3;KCNQ1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6589032715075173,-1.7074555088436405,0.01,0.1515382109583686,0.791,6/15,12.92%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6887381503628933,-1.706591203135162,0.01015228426395939,0.14332692683562448,0.793,7/12,9.70%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,insulin-like growth factor receptor binding (GO:0005159),0.7940682767485461,1.701528139028317,0.008710801393728223,0.2666304949377665,0.928,4/12,3.26%,IGF1;IGF2;PIK3R1;GNAS
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7518014078759321,1.69383694761123,0.011686143572621035,0.2682249447476841,0.946,2/14,0.14%,SLC7A11;SLC1A3
prerank,anion transmembrane transporter activity (GO:0008509),-0.6909204078362103,-1.6927648221648202,0.015765765765765764,0.15512334583973664,0.841,4/12,4.14%,ABCG2;SLCO2B1;SLC22A6;SLC39A8
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.7011396568975339,1.690880553456531,0.0128,0.2566641262983216,0.958,6/18,10.38%,ALDH1A1;AKR1B1;ALDH1A2;ALDH18A1;ALDH2;AKR1B10
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.8059772002790422,1.69038631172602,0.00338409475465313,0.23910856324342591,0.958,6/12,5.78%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,phospholipase activator activity (GO:0016004),0.7992208163916532,1.6891743091191809,0.00819672131147541,0.22697817759595457,0.961,3/10,6.32%,PDPK1;ARHGAP6;SRC
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7241577131218645,1.671103140469481,0.01938610662358643,0.24392656458153675,0.98,4/17,2.67%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,ephrin receptor activity (GO:0005003),0.7241577131218645,1.671103140469481,0.01938610662358643,0.24392656458153675,0.98,4/17,2.67%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,lipase activator activity (GO:0060229),0.8004566746341009,1.669720699813355,0.010221465076660987,0.23430623226831707,0.981,3/10,6.32%,PDPK1;ARHGAP6;SRC
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5944986480668828,-1.6667848549573543,0.018229166666666668,0.18570084189342773,0.894,8/19,9.70%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GRID1;GABRA3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5322614015678341,-1.6638833476067658,0.01488095238095238,0.1808573162661034,0.904,8/28,9.70%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GRID1;GABRA3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.784662864461975,1.6563321500137815,0.010889292196007259,0.2577365902358035,0.989,3/11,4.36%,ITPR1;TRPA1;RASA3
prerank,diacylglycerol kinase activity (GO:0004143),-0.6840121456934947,-1.6429817980603858,0.01978021978021978,0.20341455469411687,0.937,7/11,19.78%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,GABA-A receptor activity (GO:0004890),-0.577861383785421,-1.641352187003822,0.02203856749311295,0.19672074185071772,0.945,7/18,9.70%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6534230999889259,-1.6376331309653966,0.018223234624145785,0.19338422994687246,0.954,5/12,13.78%,SLC6A6;SLC38A5;SLC36A4;SLC3A2;SLC1A4
prerank,endopeptidase inhibitor activity (GO:0004866),0.5429841789849725,1.63471564761176,0.002430133657351154,0.3082621292849934,0.995,16/82,7.04%,COL4A3;TIMP3;AHSG;SERPINE1;SERPING1;RECK;FETUB;CAST;SERPIND1;TFPI;WFDC3;SERPINF1;SERPINH1;CST3;CRB2;TIMP2
prerank,BMP binding (GO:0036122),0.7772647421474979,1.6324877643639248,0.03220338983050847,0.3006244790625115,0.996,2/11,5.78%,GREM2;ENG
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6549178110088063,-1.6265936733562323,0.01912568306010929,0.20307171972681975,0.966,7/13,19.43%,SH3BP4;CCDC88A;GDI1;ARHGDIA;ARHGDIB;GPSM2;ITGB1BP1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6853445541498475,-1.624018696953486,0.014354066985645933,0.1983652572371707,0.968,3/11,5.35%,KCNJ3;KCND3;KCNQ1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7282562987627742,1.6177621881043458,0.024752475247524754,0.3339272731218735,0.998,6/13,15.79%,BMP6;CDH5;SRC;BMP2;BMP5;BMP4
prerank,GABA receptor activity (GO:0016917),-0.5489143711564856,-1.6130367923308593,0.022922636103151862,0.20878597954264125,0.977,7/21,9.70%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6677535957216556,-1.607340829726202,0.02320185614849188,0.21074337090364192,0.984,6/11,17.72%,ATP8A1;ATP8B1;ATP11C;ATP11A;ATP10A;ABCB4
prerank,anion:anion antiporter activity (GO:0015301),-0.5874569257803937,-1.6073286577945851,0.033734939759036145,0.20293806087017371,0.984,5/17,13.72%,SLC26A7;SLC26A2;SLC26A6;SLC25A4;SLC25A11
prerank,calcium:sodium antiporter activity (GO:0005432),0.7786784540264243,1.606517996305506,0.019642857142857142,0.3548678733240891,0.999,5/10,5.98%,SLC24A3;SLC8A1;SLC8A3;SLC24A1;SLC24A5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6069963406617722,-1.603747859902161,0.029339853300733496,0.20106847351619,0.985,8/15,12.61%,HS3ST1;HS3ST3A1;NDST3;HS3ST4;HS6ST3;HS3ST5;HS6ST2;HS3ST2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.6758276453514764,-1.602044850786277,0.03818615751789976,0.19597502701512626,0.986,5/10,18.24%,DPP10;FAP;PRCP;DPP6;DPP4
prerank,metallocarboxypeptidase activity (GO:0004181),0.639210732136293,1.5954843226658284,0.026113671274961597,0.3769361822187015,1.0,6/26,8.18%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;PEPD
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.6174179020468418,-1.5918580562092464,0.03140096618357488,0.20351336677742307,0.991,5/14,13.72%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,acid-thiol ligase activity (GO:0016878),0.7259555869645542,1.5877101874461996,0.03171953255425709,0.3883123067073237,1.0,7/13,15.66%,SLC27A5;ACSL1;ACSS3;AASDH;ACSF3;ACSS2;AACS
prerank,translation elongation factor activity (GO:0003746),-0.610594233256934,-1.5850323280761756,0.032036613272311214,0.2084233710717731,0.994,7/14,13.75%,EEF2;GTPBP1;EIF5A;EIF5AL1;GFM2;EEF1A1;EEF1B2
prerank,cation:chloride symporter activity (GO:0015377),-0.6792448130429795,-1.5839828779417342,0.030878859857482184,0.20346643103785264,0.995,5/10,17.84%,SLC12A2;SLC12A7;SLC12A6;SLC12A5;SLC12A8
prerank,phospholipid transfer activity (GO:0120014),-0.5576781641255969,-1.5830315112893367,0.014084507042253521,0.198558389945451,0.995,7/21,8.73%,PITPNC1;CERT1;PLTP;PITPNA;TNFAIP8L3;PLEKHA3;OSBPL2
prerank,CoA-ligase activity (GO:0016405),0.7061113749024706,1.5815778175974229,0.03436988543371522,0.39319576390100414,1.0,6/14,15.66%,SLC27A5;ACSL1;ACSS3;ACSF3;ACSS2;AACS
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5362485215500225,1.5769590674334246,0.016905071521456438,0.3940887356815216,1.0,20/60,10.67%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;ROR1;ACVR1;AXL;MUSK;NTRK3;EGFR;EPHB2;RYK;EPHB3
prerank,BMP receptor binding (GO:0070700),0.7282661983103467,1.5765390332422797,0.028333333333333332,0.3816665142286663,1.0,6/12,15.79%,BMP6;CDH5;SRC;BMP2;BMP5;BMP4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6382829403467372,-1.5750028546737869,0.035623409669211195,0.20579650714934483,0.997,8/12,12.98%,PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE8B;PDE7A;PDE4C
prerank,poly(U) RNA binding (GO:0008266),0.6604372134752063,1.5715741974386996,0.025437201907790145,0.3855544583464456,1.0,3/20,1.17%,RBMS1;ATXN1;RBMS3
prerank,transforming growth factor beta binding (GO:0050431),0.6426821622570125,1.562392544401126,0.03490136570561457,0.4028514897326548,1.0,7/23,6.83%,LTBP1;TGFBR3;TGFBR1;TWSG1;ACVR1;ENG;LTBP3
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5519314405255781,-1.561140775346607,0.03804347826086957,0.22369926379568703,0.999,7/19,12.57%,EFNA5;AFAP1L2;NRG3;GRM5;DGKQ;ERBB3;PAK2
prerank,mannose binding (GO:0005537),0.7262758483848829,1.5528214992702503,0.043782837127845885,0.4240952721333351,1.0,3/12,5.86%,LMAN2L;LMAN1;COLEC11
prerank,E-box binding (GO:0070888),0.5997396207107126,1.549865943126977,0.025936599423631124,0.42110484737338993,1.0,6/34,6.20%,TCF4;MITF;ZEB1;ASCL1;NEUROD1;ATOH8
prerank,semaphorin receptor activity (GO:0017154),0.7202166765876965,1.5483106901223223,0.05714285714285714,0.4139246687573926,1.0,2/11,0.20%,NRP1;PLXNA2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6620621689101864,-1.5463379658814715,0.03416856492027335,0.24152966896142347,1.0,4/10,3.90%,SLCO2A1;SLCO1C1;SLCO2B1;SLC22A6
prerank,5'-nucleotidase activity (GO:0008253),-0.6186530776035205,-1.5450342056748163,0.034912718204488775,0.23711695277269582,1.0,5/13,18.76%,NT5E;NT5C2;NT5C1A;NT5C;ACP3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6087083452182973,-1.543089929223348,0.027989821882951654,0.23418463743566356,1.0,9/13,21.39%,GABRG3;GABRA2;GLRA1;GABRG2;GLRA2;GABRA3;GABRG1;GABRA4;GLRA3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6583444864326373,-1.5410516829320722,0.03409090909090909,0.2311898712185376,1.0,5/10,22.45%,ANO1;CLCN3;CLCN5;ANO6;CLCN4
prerank,alpha-actinin binding (GO:0051393),0.6226543003682061,1.5404280929098542,0.04580152671755725,0.4271783306662003,1.0,6/24,6.40%,PDLIM5;DAG1;PDLIM2;PALLD;SYNPO2;CACNA1C
prerank,poly-pyrimidine tract binding (GO:0008187),0.6327989774767006,1.5389305578755017,0.02607361963190184,0.41966468807309576,1.0,3/23,1.17%,RBMS1;ATXN1;RBMS3
prerank,transcription coactivator binding (GO:0001223),0.6278092107882174,1.5291186436617539,0.03316749585406302,0.4403384709245614,1.0,4/20,3.09%,RORA;SMAD3;AR;THRB
prerank,receptor ligand activity (GO:0048018),0.45669035778050737,1.5289455422615037,0.0010570824524312897,0.42897683963303096,1.0,28/245,6.96%,IGF1;GREM2;EPHA7;BMP6;IGF2;GDNF;AREG;TGFA;SEMA3D;IL34;IL17D;EPGN;WNT8B;INHBE;WNT4;GAS6;SEMA5A;WNT6;CSF1;APOA1;NTF3;ENDOU;VIP;FAM3B;TSLP;CCL4;WNT5B;IL12B
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6159646274192767,-1.5228694940918837,0.047505938242280284,0.25615056355462895,1.0,8/11,29.35%,SGMS1;SGMS2;PTDSS1;PIGO;SAMD8;GNPTAB;AASDHPPT;PIGN
prerank,acylglycerol lipase activity (GO:0047372),-0.6292209545981517,-1.5216597304233697,0.05251141552511415,0.25184066968691055,1.0,3/11,4.97%,MGLL;ABHD2;LIPE
prerank,muscle alpha-actinin binding (GO:0051371),0.6783288515856705,1.5190010397599407,0.052901023890784986,0.4511822729591006,1.0,4/15,4.76%,PDLIM5;PDLIM2;PALLD;SYNPO2
prerank,endopeptidase regulator activity (GO:0061135),0.552470808000486,1.5172403484026513,0.028187919463087248,0.4454287977602465,1.0,13/40,16.26%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;RENBP;APH1B;ITIH2;ADRM1;NLRC4;PROS1
prerank,NAD binding (GO:0051287),0.5922094143911553,1.5104867120905692,0.05007587253414264,0.4564284396601304,1.0,5/26,8.86%,ALDH1A1;CRYL1;SIRT2;NNT;ALDH2
prerank,wide pore channel activity (GO:0022829),0.6140835470656436,1.5085249490055141,0.04954954954954955,0.4518012329971921,1.0,4/23,6.85%,GJA1;GJB6;GJB2;PANX1
prerank,endopeptidase activity (GO:0004175),0.4395006454198041,1.5008267365214458,0.0021008403361344537,0.4660133018949335,1.0,44/257,13.16%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;SFRP1;USP11;RHBDL3;CTSH;CTSF;USP47;MMEL1;USP20;ADAMTS9;SPRTN;PRSS48;USP35;USP24;PMPCB;USP48;MASP1;ECE2;EEF1AKMT4-ECE2;APEH;CASP7;CAPN7;CLPP;F2;USP30;ADAMTSL4;USP9X;CTSZ;USP38;USP9Y;CTSL;USP10
prerank,neuropeptide receptor activity (GO:0008188),-0.47374099690126786,-1.5005985364203676,0.051829268292682924,0.2841835515885942,1.0,18/29,39.99%,SORCS2;HCRTR2;NPY1R;SORCS1;GPR37;NPSR1;SORCS3;NPY5R;NMUR2;TACR1;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,organic cation transmembrane transporter activity (GO:0015101),0.64898116071061,1.499010823770298,0.060810810810810814,0.4611463392906489,1.0,3/16,7.71%,SLC44A1;SLC22A2;SLC22A4
prerank,calcium-release channel activity (GO:0015278),0.6482413738545469,1.4987129258710639,0.05387205387205387,0.45153169186027586,1.0,3/17,4.36%,ITPR1;TRPA1;RASA3
prerank,gap junction channel activity (GO:0005243),0.619385113420765,1.4968921665483346,0.05521472392638037,0.44710205371019446,1.0,4/22,6.85%,GJA1;GJB6;GJB2;PANX1
prerank,insulin-like growth factor binding (GO:0005520),0.6422172408857686,1.4965821408876512,0.05641025641025641,0.43830935226341444,1.0,8/15,12.98%,IGFBP2;IGFBP4;IGFBP5;IGF2R;ITGB3;ITGAV;IGFBP3;INSR
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5667044627089708,-1.4952511701393187,0.0525,0.28172223242260375,1.0,7/16,21.52%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.5667044627089708,-1.4952511701393187,0.0525,0.28172223242260375,1.0,7/16,21.52%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,monocarboxylic acid binding (GO:0033293),0.6292468367094355,1.4946083472508451,0.06578947368421052,0.4351988171382883,1.0,4/18,15.33%,CYP26B1;NR2F2;NAPEPLD;RXRA
prerank,inward rectifier potassium channel activity (GO:0005242),-0.5045243705138575,-1.4920078193782274,0.05099150141643059,0.28178571170036415,1.0,12/24,26.49%,KCNJ2;KCNJ3;ABCC9;KCNN2;KCNJ15;KCNJ10;KCNJ8;KCNJ6;ABCC8;KCNJ13;KCNJ16;KCNN1
prerank,nuclear export signal receptor activity (GO:0005049),0.7014992521176071,1.491205211969569,0.0913978494623656,0.43592223440003763,1.0,5/11,14.09%,RANBP17;NUP42;XPO7;CSE1L;NUP214
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5197329262478004,1.4907809901636206,0.03183023872679045,0.4282107595243669,1.0,8/53,6.45%,SLC7A11;SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC22A2;SLC7A13;SLC38A6
prerank,ion channel activity (GO:0005216),-0.39005698884085505,-1.4906952402418672,0.01020408163265306,0.278418081336555,1.0,18/80,9.18%,TRPM3;PIEZO2;GRID2;GRIA4;PIEZO1;GRIK1;GRIK2;GRIN2A;ABCC9;MCUB;GABRB1;TRPC1;UNC80;GRIN2B;GRIN3A;TRPM7;GRIA2;GRID1
prerank,amino acid:sodium symporter activity (GO:0005283),0.7054052146367051,1.4834001644021995,0.06428571428571428,0.4413646001757946,1.0,2/11,3.85%,SLC1A3;SLC6A13
prerank,nucleotidase activity (GO:0008252),-0.5709281009217966,-1.4810937486716107,0.04884318766066838,0.29035615321810415,1.0,6/15,21.67%,NT5E;NT5C2;NT5C1A;NT5C;ACP3;BPNT2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6544083238293543,1.4774231569546246,0.07166666666666667,0.4509074954843852,1.0,2/15,1.08%,SLC1A3;SLC1A5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.702947169640221,1.4762820416118023,0.07368421052631578,0.44589983714374676,1.0,3/11,15.15%,SLC25A24;SLC35B3;LRRC8A
prerank,phosphatidylglycerol binding (GO:1901611),-0.5998950556425511,-1.4704795577437684,0.05223880597014925,0.3045882467913219,1.0,3/13,3.42%,PITPNC1;PLTP;PITPNA
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43801784640750563,1.4617598782478645,0.004434589800443459,0.4832910158229475,1.0,50/188,17.97%,TCF7L2;ZBTB20;TBL1XR1;SMAD3;PBX1;AR;SOX5;RUNX1;ARID5B;PRDM5;NKX2-1;ARID4A;YAP1;IRF1;CREB3L2;KLF15;TCF7;BCOR;NFE2L2;CEBPA;RNF10;NR1D1;NCOR1;FOXC2;NONO;MZF1;GLIS2;FOXA1;TFAM;CEBPB;REST;PER3;GLI1;ZNF513;GATA6;ETS1;TCF12;TAF9;HDAC4;FOXK2;NR1H3;RXRA;PSPC1;CREB3L1;ATF5;SP1;AHRR;FOXO3;CARM1;SOX11
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6420331999612382,1.458248053705964,0.07255520504731862,0.48551302162144994,1.0,8/15,20.74%,SETD1A;WDR82;KMT2A;SETD4;WDR5;SETD1B;RBBP5;CXXC1
prerank,carboxypeptidase activity (GO:0004180),0.5504990631429248,1.4561702622126216,0.06618705035971223,0.48320076394691436,1.0,9/35,12.64%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;NAALADL1;PEPD;CPA2;CTSZ
prerank,protein kinase C binding (GO:0005080),0.5345680098746823,1.454874518903225,0.046413502109704644,0.47824952602116666,1.0,9/43,9.62%,NELL1;PDLIM5;PRKCSH;DACT1;GRK5;TOP2B;PARD6G;PARD6B;ITGAV
prerank,insulin-like growth factor I binding (GO:0031994),0.6465986761924142,1.4527608522164612,0.07205623901581722,0.47646414115655483,1.0,7/13,12.98%,IGFBP2;IGFBP4;IGFBP5;ITGB3;ITGAV;IGFBP3;INSR
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5792454455127155,-1.4517657469582654,0.0728643216080402,0.33786472827452696,1.0,8/13,13.54%,KCNQ1;PRKAR1A;GSK3A;PRKAR2B;CSK;PRKAR2A;PRKAR1B;RYR2
prerank,rRNA binding (GO:0019843),-0.42390398636724724,-1.4511761026216436,0.03146853146853147,0.3322457489087237,1.0,16/42,21.42%,RPS14;RPS13;RPS3;RPL11;RPS9;CAVIN1;RPS5;MRPS18A;PPAN;RPL5;FASTKD2;RPLP0;MRPS7;RPL23;RPF2;RRS1
prerank,phospholipase binding (GO:0043274),0.653712013874809,1.447549429715854,0.10430463576158941,0.4835150089599867,1.0,4/13,9.87%,PDPK1;ARHGAP6;SRC;PRKN
prerank,nuclease activity (GO:0004518),0.5046898860606557,1.4465773723354658,0.0521978021978022,0.47834892120270883,1.0,10/52,10.65%,ENPP1;REXO5;SND1;OGG1;REXO4;RNASE12;RNASEL;PARN;RNASE7;DNASE1L1
prerank,cadherin binding (GO:0045296),-0.3088318801130457,-1.4420104866124748,0.0,0.3436103009840329,1.0,74/315,11.18%,PKP4;DOCK9;PTPRB;COBLL1;MRTFB;STXBP6;MPP7;FNBP1L;PTPRJ;CTNND2;ESYT2;BAIAP2L1;CDH2;ITGA6;NOTCH3;PROM1;F11R;CDH1;ANK3;KDR;BSG;TJP2;EPN2;CTNNA3;TJP1;CEMIP2;STK38;HSPA8;RPL34;IQGAP1;TRPC4;CBL;CDH12;SPTBN1;RDX;CDH6;PAICS;EEF2;UBAP2;PTPRT;CDH8;DIAPH3;TES;TMOD3;LRRFIP1;CDH9;HSP90AB1;EHD4;CDH13;EPS8L2;ANLN;TAGLN2;CLIC1;HNRNPK;FMNL2;WASF2;PACSIN2;PFKP;TRIM25;SNX1;PCBP1;LASP1;CDH10;ABCF3;ALDOA;CLINT1;SH3GLB2;SCRIB;JUP;RPL29;GLOD4;RANGAP1;BZW2;RPL6
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.43138221608257377,-1.440813088057568,0.06535947712418301,0.3398527591374031,1.0,15/37,25.88%,WARS1;WARS2;LARS1;TARS3;YARS2;YARS1;QARS1;TARS2;KARS1;FARS2;NARS2;MARS2;AARS2;TARS1;VARS2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6564882926543301,1.437352793209442,0.08121827411167512,0.49839339648917197,1.0,5/14,7.04%,COL4A3;TIMP3;RECK;FETUB;TIMP2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.61489691721949,-1.4358644961444864,0.07788944723618091,0.343754187169713,1.0,7/10,25.72%,GABRG3;GABRA2;GABRG2;GABRA3;GABRG1;GABRA4;GABRA5
prerank,nucleotide diphosphatase activity (GO:0004551),0.6367694818109818,1.435344463946202,0.10256410256410256,0.49639485865719035,1.0,3/14,6.87%,CILP;ENPP1;NUDT13
prerank,"DNA binding, bending (GO:0008301)",-0.5616097231776029,-1.4326883087900386,0.08788598574821853,0.3443710894424296,1.0,6/14,20.30%,LEF1;FOXD1;HHEX;TOP2A;HMGB2;HMGA2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5325794677101849,1.4320618081232632,0.0625,0.4983529144903829,1.0,7/38,6.16%,SERPINE1;SERPING1;SERPIND1;TFPI;WFDC3;SERPINF1;SERPINH1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.44379991424640186,-1.4292168092108593,0.050314465408805034,0.3447068509053003,1.0,9/32,22.37%,KCNB2;KCNQ5;KCNQ1;KCNC2;KCNQ3;KCNA2;KCNS3;KCNC1;KCNC4
prerank,growth factor receptor binding (GO:0070851),0.46465582764095936,1.4290749155009372,0.04257907542579075,0.500047212718531,1.0,19/95,11.78%,ESM1;PDGFD;AREG;TGFA;IL6R;KL;EPGN;PDGFRA;PDGFRB;FRS2;TSLP;SRC;PIBF1;IL12B;ITGB3;FGF2;TRIP6;HBEGF;EGF
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.46154083313824434,-1.4290406630879875,0.06267806267806268,0.33895367776402374,1.0,10/27,15.37%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC22A6;SLC39A8;SLC25A30;SLC26A6;SLC25A11;XPR1
prerank,leak channel activity (GO:0022840),0.6150213912981195,1.4271620321878917,0.10383386581469649,0.4979605927099498,1.0,4/18,6.85%,KCNK2;NALCN;KCNK7;PANX1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.45634800725535996,-1.42498835800727,0.044444444444444446,0.34105770648525013,1.0,16/31,28.65%,SLC12A2;SLC12A7;KCNK5;ABCC9;SLC12A6;KCNK10;KCNA2;SLC12A5;SLC12A8;HCN1;TMEM38B;KCNC4;ABCC8;KCNK4;SLC12A9;AQP1
prerank,actin binding (GO:0003779),0.4346226030947247,1.4217265364556495,0.014590347923681257,0.5058474493505366,1.0,31/170,10.44%,PLEKHH2;PHACTR1;MTSS1;PDLIM5;MICAL3;NCALD;CALD1;GSN;SYNE2;DAG1;TLN2;TPM1;PDLIM2;PARVA;SHROOM2;MACF1;VASH2;MYH10;PHACTR2;SYNPO2;IQGAP2;LIMA1;SMTN;LRRK2;VCL;MYL4;CAPZB;ACTN4;PRKN;SYNPO2L;TNNT3
prerank,metalloexopeptidase activity (GO:0008235),0.502417407210307,1.4145514013857086,0.06477732793522267,0.5214538141279539,1.0,8/51,8.18%,CPXM2;CPQ;AEBP1;VASH2;CPXM1;AGBL2;DPEP1;PEPD
prerank,hormone activity (GO:0005179),0.4903253372607057,1.4078245528980518,0.08850726552179657,0.5354027881276612,1.0,3/54,8.52%,IGF1;VIP;NPFF
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.6595380049785577,1.403342126558676,0.11245674740484429,0.5417907303774223,1.0,3/12,15.15%,SLC25A24;SLC35B3;LRRC8A
prerank,actinin binding (GO:0042805),0.5720818219304222,1.3936167117192368,0.1015625,0.5645858329177517,1.0,6/21,10.11%,PDLIM5;DAG1;SYNPO2;CSRP2;CACNA1C;CSRP3
prerank,poly-purine tract binding (GO:0070717),0.5551425229342255,1.3926677981535027,0.08708708708708708,0.55963067631315,1.0,6/27,10.83%,RBMS1;ATXN1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.46315213294965435,-1.3919141775850563,0.09230769230769231,0.40669009100896164,1.0,12/26,28.34%,PPP1R1A;PPP1R14C;PTN;PPP1R14B;PPP1R14A;MGAT5;PPME1;LMTK2;CABIN1;PPP1R11;PPP1R1B;SET
prerank,lipoprotein particle receptor binding (GO:0070325),0.5433819929207551,1.3899804002796168,0.09090909090909091,0.5599260140400311,1.0,5/27,9.05%,LRP1;HSPG2;APOE;APOA1;PICALM
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5912009250610623,1.3862963259126502,0.11574074074074074,0.5637032977765237,1.0,4/18,5.78%,TGFBR3;SMAD3;TGFBR1;ENG
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.401505357689171,-1.38339264700675,0.04743083003952569,0.41758321361409284,1.0,10/48,7.75%,TRPM3;PIEZO2;SLC12A2;SLC12A7;PIEZO1;ABCC9;TRPC1;SLC12A6;UNC80;TRPM7
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.470631847239723,1.3785165704102846,0.07901554404145078,0.5811340253232824,1.0,13/60,14.36%,LRRK1;PPM1H;PPM1E;CTDSPL;PPP3CA;LRRK2;MTMR3;RPAP2;CTDSP2;PPP1R3C;PHLPP2;PTEN;PPP1R3D
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.599324432348678,1.3772532539427793,0.12398042414355628,0.5694714948690403,1.0,1/16,0.21%,ATP6V0A4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.599324432348678,1.3772532539427793,0.12398042414355628,0.5694714948690403,1.0,1/16,0.21%,ATP6V0A4
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5113343812811479,1.3769302985841059,0.10644677661169415,0.5628856358447365,1.0,16/34,21.17%,IGF2;PARP16;CKS1B;MAP2K1;ALS2;STK4;SPRY2;CCNK;DDX3X;STRADA;CCNT2;RICTOR;TAOK1;ETAA1;MLST8;CCNT1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.47535667052294783,-1.3748857170142794,0.09944751381215469,0.4306230590483636,1.0,12/21,14.91%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,cell adhesion mediator activity (GO:0098631),-0.4657841854556332,-1.3719293988278316,0.09510086455331412,0.4305809424226921,1.0,9/24,10.43%,ESAM;BSG;CNTN4;NTNG1;CNTN6;SIRPA;LRRC4C;ROBO4;EMB
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6168903835556536,1.3708792926539703,0.13095238095238096,0.5746852672031451,1.0,4/14,8.49%,PYCR1;MTHFR;PYCR3;ALDH1L1
prerank,fatty acid synthase activity (GO:0004312),-0.5868685950297357,-1.3699221768630703,0.11160714285714286,0.42809219472110194,1.0,2/10,5.16%,ELOVL7;ELOVL5
prerank,LRR domain binding (GO:0030275),0.6181359906867141,1.3697282384430163,0.132996632996633,0.5708764715980975,1.0,3/14,12.73%,ROBO1;PMF1;PAWR
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4540767309858696,1.3682144559673848,0.07235142118863049,0.5681746385723138,1.0,16/72,12.71%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;ADAP2;TULP3;SNX18;COMMD1;PICALM;GSDME;SYTL2;SNX21
prerank,P-type ion transporter activity (GO:0015662),-0.5496499158042724,-1.3645063995131883,0.12857142857142856,0.43356860019834803,1.0,5/12,12.10%,ATP2C1;ATP2A3;ATP2B2;ATP2B4;ATP7A
prerank,growth factor activity (GO:0008083),0.4606397339359472,1.3630193309770389,0.07272727272727272,0.5773678013738023,1.0,16/74,13.76%,IGF2;GDNF;AREG;TGFA;EPGN;CSF1;NTF3;ENDOU;IL12B;CSPG5;FGF2;HBEGF;EGF;F2;MDK;NRTN
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.450438041073262,-1.3625006345226485,0.09971509971509972,0.43109241644406804,1.0,10/26,15.46%,SLC6A6;ABCG2;SLC16A6;SLC5A6;SLC16A9;SLC16A1;SLC16A4;SLC26A6;SLC16A13;MPC1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5587760789036028,-1.361250732852665,0.12529550827423167,0.4274154668056551,1.0,4/12,16.77%,ENTPD1;ENTPD2;ENTPD6;ENTPD3
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.41594506569549367,-1.3611817082913298,0.076158940397351,0.4211011673843129,1.0,18/35,27.99%,TAF1B;RRN3;TAF1;BAZ2A;TBP;FOXP1;TAF1C;UBTF;H3-3A;AGO1;NPM1;GTF2B;TAF4;RUVBL2;SMARCA4;PIH1D1;FOS;TBPL1
prerank,store-operated calcium channel activity (GO:0015279),-0.596292855563016,-1.3608846466820048,0.11210762331838565,0.4157363550350405,1.0,4/10,5.84%,TRPC3;TRPC4;TRPC5;TRPC1
prerank,GDP binding (GO:0019003),-0.3594699643181867,-1.3569026707894187,0.06072874493927125,0.4185679848850088,1.0,16/63,14.00%,RAP1A;RIT2;RAB27A;KRAS;RAB21;RAP1B;RAB5B;RAB12;RAB8B;ARL3;RAB27B;RASL12;DIRAS2;RALB;RIT1;RAB4A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.46130766015796365,-1.3568089931538145,0.10422535211267606,0.4126908140170582,1.0,12/23,14.91%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,poly(A) binding (GO:0008143),0.5582854883898534,1.355042330639962,0.14683153013910355,0.5953050435581299,1.0,5/21,10.83%,RBMS1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,peptidase inhibitor activity (GO:0030414),0.5144747822655129,1.354174606634965,0.1145975443383356,0.5908110398586868,1.0,10/33,12.78%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;TIMP2;RENBP;ITIH2
prerank,heme binding (GO:0020037),0.46293999070014014,1.351951608270099,0.09693877551020408,0.5905568515639065,1.0,16/65,13.29%,PTGIS;CYP26B1;CYB5B;CYP1B1;TDO2;FLVCR2;SRC;HEBP1;CYP27A1;NR1D1;CYB5A;SDHC;PGRMC2;SLC48A1;NOX4;CYB5R4
prerank,steroid hydroxylase activity (GO:0008395),0.579345505031005,1.3513556256820152,0.15171288743882544,0.5853623864659859,1.0,5/16,17.41%,CYP7B1;CYP1B1;CYP27A1;CYP2R1;CYP1A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6365227829254674,1.3493344902911988,0.15282392026578073,0.5852423176035251,1.0,3/12,4.16%,SULF2;SULF1;GALNS
prerank,copper ion binding (GO:0005507),0.4957113586339056,1.3489444767049827,0.12044817927170869,0.5795975297905733,1.0,4/42,5.06%,PAM;MOXD1;MT3;HEPH
prerank,protein heterodimerization activity (GO:0046982),0.4057791174535062,1.347988831767983,0.05420353982300885,0.5754380739377579,1.0,39/178,13.74%,TCF4;BMP6;ADRA1B;ARNT2;BCL2;ATP1A2;TPM1;ITGA3;IRAK2;ZHX2;NEUROD1;MIGA2;EPAS1;ADRA2C;BDKRB2;BUD23;ATP1B2;IL12B;AGTR1;TOP2B;TLR6;IRAK3;ARNT;ZBTB1;EXT1;KATNB1;MICU2;KRT10;BHLHE41;ADRA2A;KATNA1;YWHAE;RRAGD;MTTP;NR4A1;TUBB2B;TPM2;TRMT112;P4HB
prerank,glycine binding (GO:0016594),-0.5501929903645288,-1.3466218799284806,0.11655011655011654,0.42893478402501795,1.0,6/11,21.39%,GLRA1;GLRA2;GRIN2B;GRIN3A;GRIN1;GLRA3
prerank,pseudouridine synthase activity (GO:0009982),0.611244779450187,1.344613239684091,0.14353312302839116,0.5790326956257529,1.0,6/13,19.11%,PUS3;RPUSD4;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,CoA hydrolase activity (GO:0016289),0.5870178962437888,1.3445168333432416,0.14751286449399656,0.5727917311915444,1.0,4/16,5.18%,ACOT11;ACOT6;ACOT2;NUDT7
prerank,cyclic nucleotide binding (GO:0030551),-0.4606032217813249,-1.344147877914269,0.12362637362637363,0.4281875499527885,1.0,4/21,4.93%,PDE5A;PDE4D;PDE4B;PDE2A
prerank,cytokine receptor activity (GO:0004896),0.4424838099939268,1.336783759396435,0.08948004836759371,0.5892481706148108,1.0,14/83,10.38%,GHR;IL31RA;IL6R;LEPR;OSMR;GFRA2;XCR1;ACKR2;CCR9;IL12B;IL13RA1;IL15RA;CNTFR;GFRA4
prerank,tRNA methyltransferase activity (GO:0008175),0.5777946551895481,1.3354525832516386,0.15525876460767946,0.5867904582477087,1.0,6/16,15.04%,TRMT44;BCDIN3D;TRMT13;TRMT9B;THUMPD3;THUMPD2
prerank,FAD binding (GO:0071949),0.5244461096974237,1.3324562871911065,0.15814696485623003,0.5891784881381106,1.0,5/24,8.84%,MICAL3;MTHFR;DDO;SQOR;AIFM1
prerank,glutathione transferase activity (GO:0004364),0.5317706914304422,1.3321787660278273,0.13841368584758942,0.5835553285682331,1.0,6/23,13.34%,PTGES;GSTM4;GSTM2;MGST1;GSTT1;GSTK1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.39337374957856386,-1.3304827933272254,0.096875,0.4531522140421743,1.0,17/37,25.23%,SLCO2A1;SLCO1C1;SLC22A8;SLCO2B1;SLC22A6;COX4I1;UQCRH;COX6A1;COX5B;SLCO4A1;COX5A;COX8A;UQCR10;UQCR11;SLCO1B1;UQCRQ;UQCRFS1
prerank,DNA-binding transcription factor binding (GO:0140297),0.4010636979999236,1.3283300841897627,0.04381161007667032,0.5887160829434674,1.0,30/189,11.74%,TCF7L2;LDB2;FHL2;RUNX1T1;SMAD3;AR;BCL2;DACT1;PRRX1;PRDM5;YAP1;ASCL1;TLE1;CRTC3;NEUROD1;TBX3;SKI;NFE2L2;SIK1;RERE;MTA2;RBPJ;MTA3;NCOR1;NEK6;IFI27;CXXC5;RBL2;TEAD3;BHLHE41
prerank,potassium channel activity (GO:0005267),-0.33787667406837685,-1.3252680574598168,0.03488372093023256,0.45930563501080346,1.0,18/89,9.21%,KCNB2;KCNK5;KCNQ5;KCND2;GRIK1;GRIK2;KCND3;KCNMA1;ABCC9;KCNN2;KCNK13;KCNQ1;KCNH7;KCNH5;KCNC2;KCNMB2;KCNK10;KCNQ3
prerank,calcium channel inhibitor activity (GO:0019855),0.621519983053605,1.325093298553736,0.16817359855334538,0.5928992002430741,1.0,1/11,0.27%,ITPR1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5258460856122673,-1.314480119567053,0.15331807780320367,0.4783359423010215,1.0,2/12,1.59%,PIEZO2;PIEZO1
prerank,protein tyrosine kinase activity (GO:0004713),0.4145520816408365,1.3141662356479986,0.07057416267942583,0.6190039029295483,1.0,23/108,10.81%,EPHA3;EPHA7;DDR2;LYN;FGFR1;EPHA4;EPHA8;FGFR2;FGFR4;PDGFRA;KIT;PDGFRB;ROR1;AXL;MUSK;SRC;NTRK3;EGFR;EPHB2;RYK;BAZ1B;EPHB3;TTBK1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6225024003541731,1.3140869141400124,0.20462633451957296,0.6128375255807772,1.0,5/10,16.71%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4698522173368401,1.3120778534541733,0.13674033149171272,0.6126289088443642,1.0,11/47,9.93%,SLC7A11;SLC7A2;SLC1A5;SLC6A13;SLC22A2;PDPN;SLC7A13;SLC38A6;SLC22A4;SLC43A1;SLC38A9
prerank,fibroblast growth factor binding (GO:0017134),0.5444221751943131,1.3114849746848707,0.15806451612903225,0.6081084958951117,1.0,9/21,15.81%,FGFR1;KL;FGFR2;FGFR4;GLG1;ITGB3;ITGAV;CXCL13;FIBP
prerank,transcription cis-regulatory region binding (GO:0000976),0.3762959085371743,1.3109849569610232,0.01954732510288066,0.6035787006391545,1.0,89/406,18.08%,TCF7L2;ZBTB20;RORA;TRPS1;TBL1XR1;TEAD1;SMAD3;PBX1;AR;SOX5;RUNX1;GLI3;AEBP1;ARID5B;PRDM5;NKX2-1;ARID4A;YAP1;ASCL1;MLXIP;MXI1;IRF1;MSC;RFX5;ETV6;CREB3L2;KLF15;TCF7;EPAS1;ZBTB8B;CUX2;BCOR;NR5A1;NFE2L2;CEBPA;SREBF1;RNF10;NR1D1;BBX;DR1;OSR1;NCOR1;FOXC2;NONO;ARNT;MZF1;ACTN4;ZBTB4;CREB3;GLIS2;FOXA1;RBL2;TFAM;ZNF177;ZBTB8A;POLRMT;CEBPB;NFE2;REST;PER3;STAT6;GLI1;ZNF513;GATA6;ETS1;TCF12;HOXC8;ZNF25;TAF9;HDAC4;FOXK2;TWIST2;NR1H3;RXRA;TFCP2;MTF1;PSPC1;ZBTB17;TFDP1;CREB3L1;ATF5;LONP1;SP1;AHRR;FOXO3;IRF2;CARM1;SOX11;NFIL3
prerank,lipid phosphatase activity (GO:0042577),0.5980576875160938,1.3062959965402279,0.15358931552587646,0.6119559883890898,1.0,3/14,3.11%,PLPP3;EPHX2;PLPP7
prerank,potassium channel regulator activity (GO:0015459),-0.3572369406390785,-1.3059609532991847,0.07906976744186046,0.4922738940647599,1.0,10/49,11.13%,DPP10;KCNIP4;KCNAB1;NEDD4L;ABCC9;KCNMB2;SGK1;WNK2;ADRB2;DPP6
prerank,voltage-gated calcium channel activity (GO:0005245),0.4798812016253548,1.3025328667489746,0.13798219584569732,0.6170650131505512,1.0,5/37,11.52%,CACNA2D3;CACNB1;CACNA1C;ITGAV;CACNA1G
prerank,O-methyltransferase activity (GO:0008171),0.6365712250754116,1.2996481216682034,0.19680851063829788,0.61979365468508,1.0,5/10,15.77%,COMT;FTSJ3;LRTOMT;BCDIN3D;CMTR2
prerank,bHLH transcription factor binding (GO:0043425),0.5491784802026645,1.2995402536021488,0.1859706362153344,0.6141481265687748,1.0,3/19,3.29%,FHL2;SMAD3;ASCL1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5176639172790926,-1.2987494596597062,0.1554524361948956,0.503161529467032,1.0,5/13,8.37%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,ligand-gated calcium channel activity (GO:0099604),0.559643500853318,1.2984309808049979,0.16583747927031509,0.6115736097266813,1.0,3/19,4.36%,ITPR1;TRPA1;RASA3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6120728092977884,1.2963827511132318,0.2130281690140845,0.6119403969076038,1.0,5/11,16.71%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,calcium channel activity (GO:0005262),0.4238233637829596,1.295771975102562,0.10844892812105927,0.608044180082068,1.0,13/84,10.40%,CACNA2D3;SLC24A3;SLC24A1;MCU;CACNB1;SLC24A5;CACNA1C;PANX1;CUL5;ORAI2;TRPM4;ITGAV;ANXA6
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5050055679276572,1.2931623148457574,0.17551622418879056,0.6097052365811929,1.0,11/27,23.17%,POLR2D;POLR3A;POLR2C;POLRMT;PRIMPOL;POLR2L;MED21;POLR1F;POLR1H;POLR1D;POLR1C
prerank,neuropeptide binding (GO:0042923),-0.46975999171976224,-1.29167180447471,0.14058355437665782,0.5144285384301021,1.0,14/18,52.36%,SORL1;GPR37;NMUR2;SSTR2;MC4R;SSTR1;OPRD1;NMUR1;OPRM1;GPR149;SSTR3;MCHR1;SSTR4;OPRL1
prerank,receptor tyrosine kinase binding (GO:0030971),0.44708140616458814,1.288864747448521,0.13157894736842105,0.616329504671977,1.0,7/56,4.91%,ANGPT1;CBLB;PIK3R1;DOCK4;GAS6;ANGPT2;FRS2
prerank,protein kinase activator activity (GO:0030295),0.444482429383615,1.2882173450530934,0.1393548387096774,0.6125656245591571,1.0,25/60,21.04%,IGF2;PRKAG2;GAS6;MT3;GPRC5D;PARP16;MAP2K1;ALS2;STK4;SPRY2;STK11;FGF13;DDX3X;RGCC;WNK1;STRADA;DUSP19;MARK2;GPRC5A;AGAP2;RICTOR;TAOK1;ETAA1;MADD;MLST8
prerank,kinase inhibitor activity (GO:0019210),0.4804352115973463,1.2860901040016857,0.16815476190476192,0.61302137270147,1.0,7/33,12.77%,RHOH;AHSG;PARVA;ITPRIP;DNAJC3;TAOK3;DUSP19
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4809186896068717,-1.2846987468415412,0.16243654822335024,0.5250114013942276,1.0,9/17,17.72%,PITPNC1;ATP8B1;PLTP;PITPNA;ABCG1;PCTP;ATP10A;PITPNB;ABCB4
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5237569980594784,-1.2810314897935735,0.17937219730941703,0.5280617794751812,1.0,5/12,8.37%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.589825683837144,1.27913104141651,0.21025641025641026,0.6277814767676736,1.0,2/12,4.91%,PIK3R1;FRS2
prerank,pyridoxal phosphate binding (GO:0030170),0.5455873980512864,1.279125272494246,0.1987281399046105,0.6222499730872733,1.0,5/20,16.58%,ABAT;ACCS;PDXK;PYGM;PYGB
prerank,ligand-gated cation channel activity (GO:0099094),-0.33109759971707786,-1.277571499755839,0.054187192118226604,0.530013193041892,1.0,12/75,8.31%,KCNJ2;GRIA4;PTK2B;GRIK1;GRIK2;KCNJ3;GRIN2A;P2RX7;KCNN2;GRIN2B;GRIN3A;GRIA2
prerank,sulfotransferase activity (GO:0008146),0.4833738146769303,1.277473370132846,0.16572237960339944,0.6215822237655494,1.0,5/33,4.77%,UST;GAL3ST3;GAL3ST2;TPST1;HS6ST1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.45238656356059936,-1.2770466234579283,0.1484593837535014,0.5246848429422756,1.0,5/20,10.45%,DLG2;TJP2;MAGI3;AK6;MPP1
prerank,mRNA 3'-UTR binding (GO:0003730),0.4216558449493967,1.2765531915410142,0.12935323383084577,0.618930276161714,1.0,13/79,12.96%,CELF2;RBMS1;RBMS3;CSDC2;IGF2BP2;CPEB1;ZFP36L1;CPEB3;RBMS2;PARN;SERBP1;LARP1;UTP23
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.40844883405433086,1.2729027977129157,0.12298136645962733,0.6235424445927069,1.0,22/91,16.06%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;SH3PXD2B;ADAP2;TULP3;SNX18;COMMD1;PICALM;WIPI1;GSDME;SYTL2;SNX21;PIRT;GSDMD;PARD3;LAPTM4B
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5989743354351528,1.2718322497484698,0.2158273381294964,0.6211051650353681,1.0,2/11,10.38%,AKR1B1;AKR1B10
prerank,pre-mRNA binding (GO:0036002),0.4986135181175288,1.2706368432025252,0.16542473919523099,0.6191858528567176,1.0,11/28,23.18%,CELF2;U2AF1L4;RBM22;HNRNPA1;ERI1;RNPC3;RBM41;HNRNPU;RBM4;PRPF8;ZRSR2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6022734952771703,1.2703624908425752,0.22296173044925124,0.6147144587002599,1.0,6/10,21.82%,KAT2B;HEXIM2;INCA1;CDKN2C;CDKN1B;HEXIM1
prerank,ubiquitin protein ligase activity (GO:0061630),0.3763697797891903,1.2691514800003036,0.07135250266240682,0.6130089090968281,1.0,63/228,19.41%,MYCBP2;RNF220;PDZRN3;HECW2;SH3RF3;CBLB;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;SMURF2;RFFL;CDC42;BFAR;ZNRF3;DTX4;KCMF1;TRIP12;UBE4B;RNF10;RNF145;RNF185;UBR4;RNF139;UBOX5;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;RNF217;RNFT1;MUL1;RC3H2;RNF19A;AMFR;RNF2;UBE2D1;HLTF;UBR5;ASB1;HACE1;RNF13;HUWE1;NHLRC3;MSL2;RNF138;UBE3B;DTX3;UBR3;RNF135;UBE3A;RNF34;RC3H1;TRIM21;TRIM41;TRIM26;TRIM32;RNF11
prerank,histone demethylase activity (GO:0032452),0.4911624477094926,1.2678545092871447,0.17134416543574593,0.6116089546732064,1.0,13/27,23.24%,FBXL19;KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;JARID2;KDM5A;KDM4C;KDM3A
prerank,ATPase binding (GO:0051117),0.4299732469231735,1.2656167225007338,0.1608300907911803,0.612670944774131,1.0,16/71,12.23%,ATP6V0A4;AR;ABCA1;TMTC4;ANK1;PPP3CA;SRC;DERL1;ATP1B2;SLC2A13;EGFR;ATP6V1E1;CLPP;TOR1AIP1;SELENOS;PTPN3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.41525805780716685,1.2641901582012511,0.15517241379310345,0.611731656235534,1.0,28/78,21.29%,CASP12;CFLAR;SFRP1;USP11;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;CASP7;USP30;USP9X;CTSZ;USP38;USP9Y;CTSL;USP10;CASP9;CASP1;CAPN15;PIGK;USP37;USP46;USP49;UCHL1;PDIA3
prerank,kinase activator activity (GO:0019209),0.4927423949761378,1.263166951044617,0.19742489270386265,0.6095930575484039,1.0,12/30,16.74%,PRKAG2;MT3;GPRC5D;STK11;FGF13;RGCC;WNK1;STRADA;DUSP19;MARK2;GPRC5A;AGAP2
prerank,channel activity (GO:0015267),0.45611331721642906,1.262964160948625,0.18258426966292135,0.6053985176825497,1.0,8/41,12.55%,TRPA1;BCL2;PDPN;PANX1;AQP6;P2RX5;TMEM120B;KCNK3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6069040320625512,1.259762215071014,0.22702702702702704,0.6093200421176721,1.0,3/10,11.65%,DSE;RENBP;GALM
prerank,tau-protein kinase activity (GO:0050321),0.532574349908318,1.2593001884045756,0.20754716981132076,0.605729448056728,1.0,6/20,15.21%,ROCK2;MARK1;BRSK1;TTBK1;MARK2;DYRK1A
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3549509978343509,1.2563932869891627,0.01805416248746239,0.6088358490770783,1.0,156/731,17.63%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PKNOX2;SMAD3;PBX1;ZEB2;ARNT2;AR;SOX5;ZKSCAN2;MITF;NKX6-1;GLIS3;RUNX1;NR2F2;GLI2;PRRX1;SALL1;KCNIP3;SP7;ZIC1;GLI3;IKZF2;MAF;ZEB1;RUNX2;PRDM5;NKX2-1;THRB;FOXP2;ASCL1;NFIB;DNMT3A;MLXIP;RARB;JDP2;SIX5;ZIC4;NFIX;MXI1;IRF1;MEOX2;IKZF4;ZIC2;MSC;RFX5;NEUROD4;CREB3L2;ZNF83;NEUROD1;RARG;KLF15;BCL6;TBX3;SP4;TCF7;HLF;SKI;ATOH8;HES7;BATF;ZNF23;ZNF483;NR5A1;NFE2L2;CEBPA;ZBTB38;ZNF697;SREBF1;ZBTB24;NR1D1;MED8;RBPJ;CHD2;HIVEP2;TCF7L1;FOXC2;STAT5B;ARNT;MZF1;SMAD1;HOXC5;GTF2IRD1;ZBTB4;GMEB1;NSD1;ZBTB1;CREB3L4;CREB3;STAT2;PAX1;GLIS2;FOXA1;ZSCAN21;NR1D2;ZKSCAN3;KLF9;SP5;TEAD3;NKX2-8;CEBPB;ZBTB37;NFE2;BHLHE41;REST;ZFP30;STAT6;GLI1;NR4A1;NPAS2;ZNF182;MYCN;GATA6;HIVEP1;EBF1;STAT4;ETS1;TCF12;ZNF383;ZNF148;HDAC4;FOXK2;HOXD1;ZNF219;NR1H3;HOXC4;RXRA;TFCP2;MYBL1;MYT1;MTF1;ZNF585B;ZNF585A;ZBTB17;MXD4;MAFA;CREB3L1;ZNF423;FOXJ3;EBF4;PLAG1;ZSCAN20;FOXO6;NEUROD6;SP1;CREB5;ZFAT;ZSCAN29;FOXO3;IRF2;ZIC5
prerank,carboxylic acid binding (GO:0031406),-0.3763832312485962,-1.2563185589417623,0.14035087719298245,0.5706180906359197,1.0,15/38,25.04%,GRM7;NOS3;GLRA1;GLRA2;NOS1;GRIN2B;GRIN3A;GLUD1;MAG;GCLC;RTN4R;GRIN1;GLRA3;EPDR1;SHMT1
prerank,pentosyltransferase activity (GO:0016763),0.46763419123991773,1.2561571251081076,0.20874471086036672,0.6047983396671713,1.0,12/36,19.45%,ART4;PARP11;LARGE1;LARGE2;PARP16;SIRT2;PARP14;TNKS2;UPP2;LACC1;PPAT;SIRT5
prerank,SH3 domain binding (GO:0017124),-0.33811632629939387,-1.252551832715899,0.10648148148148148,0.5736720024930003,1.0,14/62,10.19%,AFAP1L1;SHANK3;SGIP1;ELMO1;AFAP1L2;ENAH;ADAM12;ADAM15;CBL;ARHGAP27;PTPN12;WASF2;SHANK1;SKAP1
prerank,MHC class II protein complex binding (GO:0023026),-0.5279869545263236,-1.252185835579888,0.18937644341801385,0.5677742306773514,1.0,4/11,11.86%,HSPA8;ATP1B1;HSP90AB1;CD81
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.35288732903233344,1.250462854175043,0.023069207622868605,0.6152611751860827,1.0,154/732,17.63%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PKNOX2;SMAD3;PBX1;ZEB2;ARNT2;AR;SOX5;ZKSCAN2;MITF;NKX6-1;GLIS3;RUNX1;NR2F2;GLI2;PRRX1;SALL1;KCNIP3;SP7;ZIC1;GLI3;IKZF2;MAF;ZEB1;RUNX2;PRDM5;NKX2-1;THRB;FOXP2;ASCL1;NFIB;DNMT3A;MLXIP;RARB;JDP2;SIX5;ZIC4;NFIX;MXI1;IRF1;MEOX2;IKZF4;ZIC2;MSC;RFX5;NEUROD4;ZNF83;NEUROD1;RARG;KLF15;BCL6;TBX3;SP4;TCF7;HLF;SKI;ATOH8;HES7;BATF;ZNF23;ZNF483;NR5A1;NFE2L2;CEBPA;ZBTB38;ZNF697;SREBF1;ZBTB24;NR1D1;MED8;RBPJ;CHD2;HIVEP2;TCF7L1;FOXC2;STAT5B;ARNT;MZF1;SMAD1;HOXC5;GTF2IRD1;ZBTB4;GMEB1;NSD1;ZBTB1;CREB3L4;CREB3;STAT2;PAX1;GLIS2;FOXA1;ZSCAN21;NR1D2;ZKSCAN3;KLF9;SP5;TEAD3;NKX2-8;CEBPB;ZBTB37;NFE2;BHLHE41;REST;ZFP30;STAT6;GLI1;NR4A1;NPAS2;ZNF182;MYCN;GATA6;HIVEP1;EBF1;STAT4;ETS1;TCF12;ZNF383;ZNF148;HDAC4;FOXK2;HOXD1;ZNF219;NR1H3;HOXC4;RXRA;TFCP2;MYBL1;MYT1;MTF1;ZNF585B;ZNF585A;ZBTB17;MXD4;MAFA;ZNF423;FOXJ3;EBF4;PLAG1;ZSCAN20;FOXO6;NEUROD6;SP1;CREB5;ZFAT;ZSCAN29;FOXO3;IRF2;ZIC5
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.37116590515988485,1.2501071854990078,0.0851063829787234,0.6115201875937651,1.0,64/232,19.90%,MYCBP2;RNF220;PDZRN3;HECW2;SH3RF3;CBLB;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;SMURF2;RFFL;CDC42;BFAR;ZNRF3;DTX4;KCMF1;TRIP12;RNF10;RNF145;RNF185;UBR4;RNF139;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;UFL1;RNF217;RNFT1;MUL1;RC3H2;RNF19A;AMFR;RNF2;UBE2D1;HLTF;UBR5;ASB1;HACE1;RNF13;HUWE1;NHLRC3;MSL2;RNF138;UBE3B;DTX3;UBR3;RNF135;UBE3A;RNF34;RC3H1;TRIM21;TRIM41;TRIM26;TRIM32;RNF11;ARIH2;NSMCE2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5661439367301895,1.2466743762149484,0.2153846153846154,0.6162067431337016,1.0,2/14,7.31%,DHRS3;ADH1A
prerank,magnesium ion binding (GO:0000287),0.38726463772788,1.2432826942383817,0.12300683371298406,0.620393104014907,1.0,42/135,22.09%,EYA2;ADCY2;MARK1;EPHX2;CIB4;MVK;MAP3K20;LRRK2;PDXK;ADPRH;SIK1;BRSK1;DXO;IRAK3;MAST2;OXSR1;STK4;NEK6;IDH2;CLYBL;STK11;TDP2;RAP2A;MARK2;PSPH;CERK;FOXK2;NLRC4;GNAI1;ENDOV;DYRK3;RP2;RHEB;PPA1;EXD2;FAN1;OPA1;PGM1;NUDT5;PPA2;NUDT12;PAPOLA
prerank,calcium activated cation channel activity (GO:0005227),-0.45901196409104505,-1.242274143365407,0.1940700808625337,0.5863299774271556,1.0,7/17,16.84%,ANO1;KCNMA1;KCNN2;KCNMB2;TMEM63C;TMEM63B;ANO6
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4809740602179999,1.2404251634289765,0.21323529411764705,0.623183281664448,1.0,10/27,23.17%,POLR2D;POLR3A;POLR2C;POLRMT;POLR2L;MED21;POLR1F;POLR1H;POLR1D;POLR1C
prerank,outward rectifier potassium channel activity (GO:0015271),0.5765866885794046,1.2382063568110864,0.2552083333333333,0.6249778970641015,1.0,2/11,2.36%,KCNK2;KCNT2
prerank,transcription coregulator binding (GO:0001221),0.43140803269039263,1.2352245051080588,0.1958904109589041,0.6282269703645026,1.0,10/50,10.04%,RORA;SMAD3;AR;THRB;CHD6;USP11;NR1D1;NEK6;PHF1;FAM89B
prerank,gated channel activity (GO:0022836),-0.47398824619163143,-1.234413526601706,0.20601851851851852,0.6002213612885924,1.0,2/14,1.59%,PIEZO2;PIEZO1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3478698012783011,1.2339374526712055,0.01905717151454363,0.6273562033181727,1.0,171/831,17.63%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;TRPS1;ZFHX4;TEAD1;PKNOX2;SMAD3;PBX1;ZEB2;ARNT2;AR;SOX5;ZKSCAN2;MITF;NKX6-1;GLIS3;RUNX1;NR2F2;GLI2;PRRX1;SALL1;KCNIP3;SP7;ZIC1;GLI3;IKZF2;MAF;ZEB1;AEBP1;RUNX2;PRDM5;NKX2-1;THRB;FOXP2;ASCL1;NFIB;DNMT3A;MLXIP;RARB;JDP2;SIX5;ZIC4;NFIX;MXI1;IRF1;MEOX2;IKZF4;ZIC2;MSC;RFX5;NEUROD4;ETV6;ZNF83;NEUROD1;RARG;KLF15;BCL6;TBX3;SP4;TCF7;EPAS1;HLF;ZBTB8B;CUX2;SKI;ATOH8;HES7;BATF;ZNF23;ZNF483;NR5A1;NFE2L2;CEBPA;ZBTB38;ZNF697;SREBF1;ZBTB24;NR1D1;BBX;MED8;RBPJ;OSR1;CHD2;HIVEP2;TCF7L1;FOXC2;STAT5B;ARNT;MZF1;SMAD1;HOXC5;GTF2IRD1;ACTN4;ZBTB4;GMEB1;NSD1;ZBTB1;CREB3L4;CREB3;STAT2;PAX1;GLIS2;FOXA1;ZSCAN21;NR1D2;ZKSCAN3;RBL2;ZNF177;ZBTB8A;KLF9;SP5;TEAD3;NKX2-8;CEBPB;ZBTB37;NFE2;BHLHE41;REST;ZFP30;STAT6;GLI1;NR4A1;NPAS2;ZNF182;MYCN;GATA6;HIVEP1;EBF1;STAT4;ETS1;TCF12;HOXC8;ZNF383;ZNF25;ZNF148;HDAC4;FOXK2;HOXD1;ZNF219;TWIST2;NR1H3;HOXC4;RXRA;TFCP2;MYBL1;MYT1;MTF1;ZNF585B;ZNF585A;ZBTB17;TFDP1;MXD4;MAFA;ZNF423;FOXJ3;EBF4;ATF5;PLAG1;ZSCAN20;FOXO6;NEUROD6;SP1;CREB5;ZFAT;ZSCAN29;FOXO3;IRF2;ZIC5
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.49582036555537595,-1.2322645180113763,0.20185614849187936,0.5990056636285415,1.0,5/12,13.79%,PIK3R6;PIK3R3;IPMK;PIK3C2B;PIK3CA
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5007336345775624,-1.2319462163898864,0.23317307692307693,0.5930341923370784,1.0,3/11,7.47%,KCNMA1;KCNN2;KCNMB2
prerank,MAP-kinase scaffold activity (GO:0005078),0.5847481915912309,1.2307975687673067,0.24436741767764297,0.6312377792634398,1.0,6/11,16.57%,KSR1;SH3RF1;MAP2K1;DUSP19;AKAP13;MAPK8IP3
prerank,GTPase regulator activity (GO:0030695),0.3707365255343072,1.2304259395148769,0.12169312169312169,0.6276820055355237,1.0,35/212,9.35%,ALDH1A1;NRP1;ASAP1;RIN2;ERRFI1;RABGAP1L;RHOH;TBC1D4;DLC1;SYDE2;ARHGAP28;USP6NL;ARHGEF10L;ARHGAP18;NPRL3;ASAP3;ARHGAP29;RAPGEF2;IQGAP2;ARHGAP19;SMAP2;ARHGAP32;ARHGAP10;ARFGAP3;LRRK2;ACAP2;ADPRH;ARHGAP35;ALS2;SYDE1;ARRB1;ARHGAP9;ARL2;RUNDC3A;TBC1D2B
prerank,myosin V binding (GO:0031489),-0.46596961147309013,-1.228609340428382,0.2246376811594203,0.5944046422524323,1.0,8/15,24.74%,RAB6A;RAB3C;RAB11A;RAB27B;RAB6B;RAB3A;RAB14;RAB39B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5096575975391697,1.2284736972484127,0.22839506172839505,0.6282593698988173,1.0,4/22,7.09%,RBMS3;CPEB1;ZFP36L1;CPEB3
prerank,voltage-gated potassium channel activity (GO:0005249),-0.31337099992289624,-1.2256696924256292,0.1366120218579235,0.5959686117807168,1.0,12/80,5.92%,KCNB2;KCNJ2;KCNQ5;KCND2;KCNJ3;KCND3;KCNMA1;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2
prerank,protein serine/threonine kinase activity (GO:0004674),0.3565247635337791,1.2245823166679957,0.07216494845360824,0.6342266288110284,1.0,74/334,16.62%,STK17B;DAPK2;PDPK1;NRK;ROCK2;CDK14;CAMK1D;CDK8;DAPK1;GRK3;GRK5;BMPR1A;DMPK;MARK1;MYLK;TGFBR1;IRAK2;ACVR1;MAPK4;CDK16;SBK3;PRKAA2;MAP3K20;CASK;NUAK1;LRRK2;AKT3;ULK2;SIK1;EIF2AK3;MAP2K1;BRSK1;ARAF;IRAK3;MAST2;OXSR1;MAP4K4;STK4;EGFR;MAP3K8;CAMK2B;NEK6;VRK3;CCNK;STK11;TAOK3;BRAF;TTBK1;IKBKE;TBK1;MAP4K5;ACVR1B;WNK1;TLK1;MAP3K13;MAP3K15;RIPK2;PIK3R4;MOK;CDK12;MARK2;STK16;PLK2;CLK4;RIOK3;DYRK1A;TRIO;PIKFYVE;CLK3;MAPKAPK2;DYRK1B;AKT1;ATM;CDK10
prerank,cation transmembrane transporter activity (GO:0008324),0.4347797410350134,1.2245800140785044,0.19650067294751009,0.6297602441010915,1.0,7/48,6.45%,SLC7A2;SLC1A5;SLC41A1;SLC6A9;SLC22A2;SFXN2;SLC38A6
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5650046284077218,1.2238185224412867,0.26512455516014233,0.6273292993508287,1.0,5/12,16.82%,TENT5A;TENT5D;TENT4A;TENT4B;PAPOLG
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34522181747535613,1.2213010902803694,0.04536290322580645,0.6294932521639737,1.0,99/597,14.60%,TCF7L2;TCF4;ZBTB20;TBL1XR1;TEAD1;PKNOX2;SMAD3;PBX1;ARNT2;AR;SOX5;RUNX1;GLI2;ZIC1;GLI3;MAF;ARID5B;RUNX2;PRDM5;NKX2-1;THRB;ARID4A;YAP1;ASCL1;NFIB;RARB;JDP2;ZIC4;NFIX;LBX2;IRF1;MEOX2;TSPYL2;MSC;RFX5;CREB3L2;NEUROD1;RARG;KLF15;BCL6;TBX3;TCF7;HLF;CUX2;BCOR;HES7;BATF;ZNF23;ZW10;NR5A1;NFE2L2;MBD2;CEBPA;SREBF1;RNF10;NR1D1;BBX;OSR1;NCOR1;TCF7L1;FOXC2;KDM5B;NONO;ARNT;MZF1;GMEB1;CREB3L4;CREB3;PAX1;GLIS2;FOXA1;NR1D2;TFAM;ZNF177;CENPC;NKX2-8;CEBPB;ZBTB37;NFE2;MCM2;BHLHE41;SPDEF;REST;PER3;GLI1;NR4A1;MBD4;ZNF513;NPAS2;MYCN;GATA6;HIVEP1;ETS1;TCF12;HOXC8;TAF9;HDAC4;FOXK2;HOXD1
prerank,DNA binding (GO:0003677),0.344984383324782,1.219051119249445,0.03610832497492478,0.6308828383980614,1.0,142/694,16.67%,TCF7L2;TCF4;POLR2D;RBMS1;RORA;TEAD1;SMAD3;PBX1;ZEB2;C1D;BCL2;NR2F2;GLI2;SP7;ARID5B;PRDM5;NKX2-1;THRB;ARID4A;FOXP2;NFIB;DNMT3A;PDS5B;RARB;NUPR1;ZIC4;IRF1;RLF;MEOX2;OGG1;APLP2;ZIC2;RFX5;NEUROD1;RARG;LIG4;RAD51B;BCL6;DENND4A;TBX3;SP4;EPAS1;HLF;COLEC11;CUX2;INO80;GTF3C1;HES7;SMARCA1;BATF;SHOC1;CUL4B;DMC1;NR5A1;NFE2L2;SPRTN;POLG;CEBPA;DCLRE1C;DDX60;SREBF1;TSHZ2;REXO4;SNAPC1;RBPJ;TET1;POLL;SAFB2;CHD2;HIVEP2;LIN9;EGFR;TCF7L1;FOXC2;KDM5B;MLH1;AIFM1;NHEJ1;ARNT;HNRNPA1;ZBTB4;SPATA24;PHF1;SMC6;CXXC5;FOXA1;ZKSCAN3;MBD1;DNASE1L1;TFAM;DDX3X;DNASE2;CENPC;TDP2;POLRMT;NKX2-8;CEBPB;NFE2;MCM2;SPDEF;DCLRE1A;RAD18;CCDC25;GLI1;NR4A1;CAMTA1;MBD4;ZNF513;NPAS2;MYCN;RC3H2;YAF2;HMCES;ETS1;ZNF148;TAF9;HDAC4;FOXK2;RAD51D;ZNF219;SNAPC4;NR1H3;FUBP3;SAP30L;POGK;RBM6;SMARCB1;CAMTA2;RXRA;TFCP2;TSHZ1;RBM5;MTF1;HUWE1;HDGFL3;RTF2;MAFA;TIMELESS;RNF138;ZNF423;FOXJ3;ZBP1
prerank,semaphorin receptor binding (GO:0030215),-0.4073770474442088,-1.218335182668578,0.2028985507246377,0.6080135513714249,1.0,8/23,12.36%,SEMA6D;SEMA6A;SEMA7A;RIT2;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,RNA cap binding (GO:0000339),-0.45684560235978555,-1.2177839568342024,0.20681265206812652,0.6026935616822509,1.0,7/16,20.67%,EIF4E;CYFIP2;EIF4A1;SNUPN;EIF4E2;EIF3D;DCPS
prerank,FMN binding (GO:0010181),-0.517227764115901,-1.217505967176029,0.23950617283950618,0.596952482631701,1.0,8/11,37.94%,NOS3;NOS1;MTRR;NOS2;PPCDC;HAO1;NDOR1;DUS2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.46682267573208003,-1.2172133305455142,0.20506329113924052,0.591346168507755,1.0,7/14,24.46%,OTUD7B;MINDY2;MINDY1;YOD1;USP15;DESI2;USP7
prerank,solute:anion antiporter activity (GO:0140323),0.5443356649284542,1.2141076323145692,0.25601374570446733,0.6394673896255617,1.0,1/14,0.09%,SLC7A11
prerank,cGMP binding (GO:0030553),-0.5058385697945706,-1.2127242639865694,0.25,0.5961301782046491,1.0,2/11,4.93%,PDE5A;PDE2A
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3443911559358297,-1.2077555131830324,0.1746031746031746,0.6022596477512107,1.0,11/51,9.20%,SLCO2A1;SLCO1C1;SLC7A5;SLC22A8;SLCO2B1;CLCN3;SLC5A6;SLC22A6;MFSD2A;SLC35E4;SLC25A30
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5109400325612494,-1.2061871315695238,0.25116279069767444,0.5997669346805896,1.0,3/10,10.31%,MECOM;PRDM16;SUV39H1
prerank,calcium ion binding (GO:0005509),0.3508947687832293,1.2040831372135337,0.10995850622406639,0.661678718127078,1.0,46/323,10.76%,ITPR1;FBN1;PAM;ENPP1;CLEC3B;CDH11;SLC8A1;SPARC;ADGRV1;GSN;PLSCR2;LRP1;GJB2;MAN1C1;PPP3CA;CIB4;ASPH;FBLN1;MCTP2;STIM1;RAPGEF2;SLC25A24;PLA2G4A;SMOC2;BAIAP3;SCUBE1;COLEC11;CDH5;TNNC1;DCHS1;CABCOCO1;RCN1;SYT9;FKBP9;NAALADL1;PLSCR4;MASP1;ANXA3;TRPM4;MICU2;S100A11;ANXA6;SLIT3;SLIT1;BRAF;PCDHB8
prerank,R-SMAD binding (GO:0070412),0.5041202050062863,1.2040607560421952,0.2589703588143526,0.6572814716770963,1.0,3/18,2.84%,SMAD3;LDLRAD4;PMEPA1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.47633095178350765,1.2039192693392455,0.23736600306278713,0.6532659393333105,1.0,6/25,13.24%,ART4;PARP11;PARP16;SIRT2;PARP14;TNKS2
prerank,lipase activity (GO:0016298),-0.3480929959585718,-1.2037105163118296,0.18439716312056736,0.6000716659065738,1.0,15/43,26.75%,MGLL;ABHD2;LIPE;PLA1A;PNPLA8;PNPLA3;PNPLA2;ABHD6;PITPNM3;DAGLB;LYPLA1;LIPH;LIPA;LIPC;FAAH
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5797000741946283,1.201287341523023,0.30244755244755245,0.655950603887014,1.0,5/10,21.43%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,cytokine activity (GO:0005125),0.38073536974113736,1.2009324720016759,0.17048054919908467,0.6525738257201545,1.0,19/131,11.30%,BMP6;IL34;IL17D;WNT8B;INHBE;WNT4;CCL19;WNT6;CSF1;CXCL16;FAM3B;TSLP;CCL4;WNT5B;IL12B;BMP2;FGF2;BMP15;IFNK
prerank,ATP binding (GO:0005524),0.35424520518115943,1.2008012960872327,0.13283740701381508,0.6486088353065012,1.0,44/266,12.98%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;ABCA1;ATP1A2;BMPR1A;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO1B;MYO18A;MYH10;ACVR1;MVK;LIG4;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;IRAK3;MAST2;OXSR1;MAP4K4;CLPX;STK4;NEK6;STK11;ABCB9;P2RX5;ABCE1;PEX6;MAP4K5;ACVR1B;WNK1;TLK1;MTREX;INSR
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4924361308141359,-1.1996771078893034,0.2549019607843137,0.604622154833895,1.0,10/11,50.79%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,cytokine receptor binding (GO:0005126),0.39937555515349266,1.1985105984030069,0.18437118437118438,0.6502099485162818,1.0,11/83,7.39%,TGFBR3;SMAD3;IL34;IL6R;OSMR;CCL19;CSF1;TSLP;PIBF1;IL12B;IL13RA1
prerank,protein tyrosine kinase binding (GO:1990782),0.39837993233565955,1.1980047086805472,0.21717171717171718,0.6472896781904628,1.0,10/71,6.63%,ANGPT1;CBLB;DOCK4;NEDD9;EPHA4;GAS6;ANGPT2;ACVR1;CDH5;CD247
prerank,chemokine binding (GO:0019956),0.4643359934150424,1.197301100045761,0.24041297935103245,0.6448753143002364,1.0,8/30,13.14%,XCR1;ACKR2;CCR9;PDPN;ITGB3;ITGAV;FGF2;CXCR6
prerank,dynactin binding (GO:0034452),-0.4930537529394692,-1.194994470689232,0.26004728132387706,0.6105282428822725,1.0,6/12,28.04%,BICD1;PAFAH1B1;BICDL1;BICD2;GSK3B;SPTBN5
prerank,GTPase activator activity (GO:0005096),0.34821090966917767,1.189028716029208,0.12783505154639174,0.6622813732012565,1.0,52/313,9.39%,ALDH1A1;NRP1;ASAP1;MYCBP2;RIN2;ERRFI1;RABGAP1L;TBC1D4;FARP1;RAPGEF4;DLC1;SYDE2;DOCK4;DOCK10;ARHGAP28;USP6NL;RCBTB2;ARHGEF10L;DOCK11;IQSEC2;DENND2A;ARHGAP18;NPRL3;ASAP3;ARHGAP29;FGD1;RAPGEF2;FGD4;IQGAP2;ARHGAP19;SMAP2;DENND4A;ARHGAP32;ARFGEF2;ARHGAP10;ARFGAP3;LRRK2;ACAP2;ADPRH;DENND5A;ARHGEF17;DOCK5;ARHGEF18;ARHGAP35;ALS2;SYDE1;ARRB1;ARHGAP9;RGL1;ARHGEF11;TBC1D2B;RAPGEF1
prerank,disordered domain specific binding (GO:0097718),-0.40282009719079415,-1.188317801432468,0.21643835616438356,0.6207903375522255,1.0,4/23,11.06%,FN1;HSP90AB1;CALM1;CALM3
prerank,sequence-specific DNA binding (GO:0043565),0.33467523526672543,1.183609328278532,0.09475806451612903,0.672294877094801,1.0,82/590,11.84%,TCF7L2;TCF4;ZBTB20;RORA;TEAD1;PKNOX2;SMAD3;PBX1;ZEB2;ARNT2;BCL2;NR2F2;GLI2;ZIC1;GLI3;MAF;RUNX2;PRDM5;THRB;FOXP2;ASCL1;NFIB;RARB;JDP2;ZIC4;NFIX;LBX2;FBXL19;MEOX2;MSC;RFX5;NEUROD1;RARG;KLF15;BCL6;TBX3;SP4;TCF7;EPAS1;HLF;CUX2;HES7;BATF;ZNF23;NR5A1;NFE2L2;MBD2;ZBTB38;SREBF1;NR1D1;BBX;SNAPC1;RBPJ;OSR1;TET1;SAFB2;TCF7L1;FOXC2;KDM5B;ARNT;ZBTB4;GMEB1;TELO2;CREB3L4;CREB3;PAX1;GLIS2;CXXC5;FOXA1;NR1D2;ZKSCAN3;MBD1;TFAM;ZNF177;KMT2A;POLRMT;NKX2-8;CEBPB;ZBTB37;NFE2;BHLHE41;SPDEF
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.45338512642914364,-1.180880031119712,0.2718204488778055,0.6334203288455913,1.0,4/14,6.48%,MAL;NOD1;BCL2L13;ATP2A3
prerank,phosphotyrosine residue binding (GO:0001784),-0.3631184662018747,-1.1802726996624457,0.19594594594594594,0.6287096278369864,1.0,6/37,3.60%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB
prerank,death receptor activity (GO:0005035),-0.48303501570515794,-1.179856846772797,0.26681614349775784,0.623804482376702,1.0,2/11,3.05%,TNFRSF11A;TNFRSF19
prerank,sequence-specific mRNA binding (GO:1990825),-0.5110789386114101,-1.1797042800586546,0.2843601895734597,0.6182813212587138,1.0,5/10,26.78%,DHFR;TYMS;DHX9;RBM24;FMR1
prerank,metal ion binding (GO:0046872),0.33682480202300175,1.174586237696695,0.11866125760649088,0.6924649938936169,1.0,70/477,10.95%,ITPR1;FBN1;PAM;ENPP1;CLEC3B;EYA2;CDH11;ADCY2;SLC8A1;SPARC;ADGRV1;GSN;PLSCR2;LRP1;GJB2;MARK1;MAN1C1;PPP3CA;EPHX2;CIB4;HMGCLL1;ASPH;APOE;FBLN1;MCTP2;STIM1;RAPGEF2;MT3;SLC25A24;MVK;PLA2G4A;SMOC2;BAIAP3;SCUBE1;MAP3K20;COLEC11;CDH5;TNNC1;LRRK2;PDXK;ADPRH;SIK1;DCHS1;CABCOCO1;BRSK1;DXO;RCN1;IRAK3;MAST2;SYT9;FKBP9;OXSR1;NAALADL1;STK4;PLSCR4;MASP1;ANXA3;NEK6;IDH2;TRPM4;CLYBL;MICU2;STK11;S100A11;ANXA6;SLIT3;SLIT1;BRAF;PCDHB8;TDP2
prerank,alkali metal ion binding (GO:0031420),0.5336530443686802,1.1734366414709736,0.30033557046979864,0.691441925913884,1.0,3/13,6.54%,ATP1A2;PDXK;ADPRH
prerank,adenyl ribonucleotide binding (GO:0032559),0.34330492173460514,1.1714720174778566,0.16701680672268907,0.6922233405315074,1.0,47/291,12.98%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;ABCA1;RAPGEF4;ATP1A2;BMPR1A;DMPK;MPPED2;MARK1;MLKL;PRKAG2;TGFBR1;MYO1B;MYO18A;MYH10;RAPGEF2;ACVR1;MVK;LIG4;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;IRAK3;MAST2;OXSR1;MAP4K4;CLPX;STK4;NEK6;STK11;ABCB9;P2RX5;ABCE1;PEX6;MAP4K5;ACVR1B;WNK1;TLK1;MTREX;INSR
prerank,frizzled binding (GO:0005109),0.4431925306961366,1.1705878296716496,0.27089337175792505,0.6903129301641416,1.0,8/34,10.19%,WNT8B;WNT4;WNT6;SFRP1;FZD1;ZNRF3;WNT5B;RYK
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5211228089141167,1.1694658480265934,0.3083197389885807,0.6890252964976522,1.0,3/15,5.22%,XCR1;ACKR2;CCR9
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4614214980533769,1.1693218331260635,0.27786032689450224,0.6851487779825217,1.0,4/27,3.95%,SLC8A1;SLC8A3;SLC41A1;SLC9A9
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4130188955355697,1.1634772089748622,0.28055555555555556,0.6962549291700202,1.0,19/42,23.56%,CCNA2;CKS1B;KAT2B;CCNK;HEXIM2;INCA1;CCNL2;CCNL1;CNPPD1;CCNQ;CDKN2C;CCNT2;CDKN1B;CCND2;CCNT1;HEXIM1;CCNG2;CCNE2;CCNY
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2998980403708147,-1.1633162692313326,0.21495327102803738,0.6546431025560021,1.0,24/71,17.46%,PTPRB;PTPRG;PTPRJ;UBASH3B;PTPN14;PTPRE;PTPRK;PTPRD;PTPRT;PTPN12;DUSP22;ACP1;PTPN2;PTP4A2;CDC14A;PTPN22;MTMR6;DUSP11;HACD2;PTPN6;PTPRN;PTPRC;PALD1;DUSP23
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4037712550167095,1.162942077193643,0.24867724867724866,0.6933822375108064,1.0,7/55,7.33%,ITPR1;SLC24A3;SLC24A1;MCU;SLC24A5;PANX1;CUL5
prerank,adrenergic receptor binding (GO:0031690),0.5073914514970557,1.1618254610451701,0.29069767441860467,0.6923202756442631,1.0,6/16,13.46%,GNAS;NEDD4;RAPGEF2;ADRA2C;ADRA2A;DLG4
prerank,transition metal ion binding (GO:0046914),0.33330114517849874,1.1617816597071073,0.15439672801635992,0.6882669936244404,1.0,97/397,19.93%,PAPPA;PAM;MYCBP2;MOXD1;ENPP1;AGMO;ADCY2;CBLB;ADAM33;SEC24D;SMAD3;GLI2;MSRB3;ZEB1;MPPED2;SLC30A8;FBXL19;LARGE1;IKZF4;MT3;ENDOU;HPF1;HEPH;SLC11A2;SKI;LARGE2;PDXK;RBSN;B4GALT1;TIMP2;DPEP1;SIRT2;ADH1A;TRAF7;TET1;NAALADL1;KDM5B;COMMD1;BBOX1;NSD1;PRKN;PHF2;TIMM9;CXXC5;BAZ1B;MBD1;ABCE1;KDM5C;TDP2;KMT2A;CPA2;NAPEPLD;MNAT1;SEC23A;CDA;KDM7A;NFU1;RASSF1;HDAC4;RNF2;SAP30L;CXXC4;CYP2R1;RXRA;PHF8;LACC1;SHH;MYT1;MELTF;DPP3;RIOX1;COA6;AOX1;SEC24A;SORD;SMPDL3B;GLO1;ZDHHC20;PIM1;DUSP12;PRIMPOL;DHX58;RABIF;KPNB1;HHIP;CDADC1;POLR2L;RC3H1;SOD3;FDX1;SCD;RNF11;SIRT5;KDM4A;MDM4;ARIH2;TET3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.37113688878316425,-1.155034184869407,0.2389937106918239,0.6706440737409908,1.0,12/31,20.61%,UBE2G1;UBE2H;UBE2J1;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.36950127787377096,-1.15420281090148,0.22658610271903323,0.6667619799094163,1.0,6/27,10.26%,RNF144B;RNF144A;RNF125;SIAH1;SIAH3;DCUN1D4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3540176161113848,-1.1488755590373565,0.24382716049382716,0.6742102554569792,1.0,9/35,12.32%,TEC;YES1;PTK2B;BMX;CLK1;PKDCC;CSK;FES;PEAK1
prerank,sodium:proton antiporter activity (GO:0015385),-0.4829221204341885,-1.146104067325884,0.3137254901960784,0.6753895723144534,1.0,4/11,8.37%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5199935976533103,1.1453028546696218,0.31327433628318585,0.7282065333376739,1.0,3/13,9.75%,HSD3B2;ECI1;IDI1
prerank,adenylate cyclase binding (GO:0008179),0.5394637843704,1.1450826331700255,0.3177083333333333,0.7246169269436595,1.0,2/10,2.70%,ADCY2;ADCY5
prerank,TBP-class protein binding (GO:0017025),-0.4112776582817891,-1.1450128576704728,0.2532981530343008,0.6722746852657596,1.0,10/21,26.21%,ESR1;TAF1B;TAF1;HHEX;GTF2A2;RUVBL1;YEATS2;GTF2B;THRA;RUVBL2
prerank,zinc ion binding (GO:0008270),0.33243806353804956,1.1448333152153083,0.21436114044350582,0.7209734961231353,1.0,73/293,19.93%,PAPPA;PAM;MYCBP2;ENPP1;CBLB;ADAM33;SEC24D;SMAD3;GLI2;MSRB3;ZEB1;SLC30A8;FBXL19;IKZF4;MT3;HPF1;SKI;PDXK;RBSN;TIMP2;DPEP1;SIRT2;ADH1A;TRAF7;TET1;NAALADL1;KDM5B;BBOX1;NSD1;PRKN;PHF2;TIMM9;CXXC5;BAZ1B;MBD1;KDM5C;KMT2A;CPA2;NAPEPLD;MNAT1;SEC23A;CDA;KDM7A;RASSF1;HDAC4;RNF2;SAP30L;CXXC4;RXRA;PHF8;SHH;MYT1;DPP3;SEC24A;SORD;SMPDL3B;GLO1;ZDHHC20;DUSP12;PRIMPOL;DHX58;RABIF;KPNB1;HHIP;CDADC1;POLR2L;RC3H1;RNF11;SIRT5;KDM4A;MDM4;ARIH2;TET3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.45182214856801184,-1.1442384883533057,0.3262411347517731,0.6683896345038765,1.0,5/13,16.38%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,RNA methyltransferase activity (GO:0008173),0.47354091601227544,1.1413819607822713,0.3220064724919094,0.72570712715689,1.0,9/19,28.37%,FTSJ3;BCDIN3D;TRMT13;TRMT9B;METTL4;METTL3;TRMT12;TYW3;MEPCE
prerank,Notch binding (GO:0005112),-0.384947686061358,-1.1402815814546925,0.27113702623906705,0.6730834270717242,1.0,12/22,22.01%,CCN3;DNER;JAG2;NOTCH4;SNW1;GALNT11;KCTD10;DLL4;CUL3;DLL1;DTX1;MEGF10
prerank,iron ion binding (GO:0005506),0.41273091554245406,1.1397309455709108,0.2937158469945355,0.7257706660233146,1.0,19/48,19.40%,AGMO;HEPH;TET1;PHF2;CDO1;ABCE1;KDM7A;NFU1;CYP2R1;PHF8;EGLN1;MELTF;RIOX1;AOX1;ALKBH1;PHYH;FDX1;SCD;FTO
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.470432970435273,-1.1383325080353688,0.3060240963855422,0.6723070135433704,1.0,2/11,4.71%,LEF1;GATA2
prerank,potassium ion leak channel activity (GO:0022841),0.5039061611304462,1.1368410723584976,0.32838283828382836,0.7295408760086032,1.0,2/15,6.36%,KCNK2;KCNK7
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3532949854189908,1.1366100040920966,0.23958333333333334,0.7259216213515978,1.0,16/134,7.47%,SLC1A3;SLC7A2;GJA1;SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC2A10;SLC25A24;PDPN;SFXN2;SLCO3A1;SLC35A3;SLC38A6;SFXN5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4931593381413849,1.1359242305384116,0.3370967741935484,0.7235567681697053,1.0,3/16,10.23%,TDO2;ALOXE3;CDO1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4686077795226777,1.1340342929085994,0.35093167701863354,0.7243733247968054,1.0,1/22,0.21%,ATP6V0A4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.5274199085957731,1.133899028994712,0.336283185840708,0.7206549706913968,1.0,2/11,9.40%,SLC2A10;SLC5A3
prerank,SH2 domain binding (GO:0042169),0.43767378427128184,1.131865193285994,0.31547619047619047,0.7221259173648319,1.0,5/31,6.32%,DAG1;AFAP1;DLC1;SH3PXD2B;SRC
prerank,I-SMAD binding (GO:0070411),0.5160536091413548,1.1300098536197376,0.36548223350253806,0.7230330758532673,1.0,3/13,9.27%,SMAD3;TGFBR1;SMAD1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.309564342963101,-1.1266708398712268,0.23553719008264462,0.6974036546779708,1.0,26/57,27.56%,COX4I1;NDUFC1;UQCRH;COX6A1;COX5B;NDUFA6;NDUFA5;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;COX5A;NDUFS1;COX8A;NDUFS5;UQCR10;UQCR11;NDUFS7;NDUFB3;UQCRQ;UQCRFS1;CYB561D2;NDUFV2;UQCRC1;NDUFB4
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5342319070359991,1.1261733343055111,0.3586206896551724,0.728692886347222,1.0,4/11,12.91%,MAP3K20;EGFR;MAP3K13;MAP3K15
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.37988449090221316,-1.1256410464350703,0.3,0.6941616998523997,1.0,4/23,5.65%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.4279162290200642,1.1254820912487107,0.3066860465116279,0.7265063931332549,1.0,15/32,21.43%,PHYHD1;TET1;BBOX1;P4HTM;KDM7A;JMJD7;PHF8;EGLN1;RIOX1;ALKBH1;PHYH;FTO;KDM4A;TET3;KDM4C
prerank,phosphatase inhibitor activity (GO:0019212),-0.3971692664691154,-1.1233316361313181,0.2696629213483146,0.6943094374588283,1.0,12/20,34.31%,PTN;MGAT5;PPME1;LMTK2;URI1;ANP32E;STYX;CABIN1;PPP1R1B;SET;SAG;ENSA
prerank,solute:sodium symporter activity (GO:0015370),-0.3624770514021963,-1.122946410243105,0.28,0.6892494514631882,1.0,3/27,8.07%,SLC4A10;SLC5A6;SLC4A8
prerank,cardiolipin binding (GO:1901612),0.5269734974683458,1.1227523111504891,0.36804308797127466,0.7294680382827269,1.0,5/10,21.34%,GSDME;PLEKHN1;GSDMD;STOML2;OPA1
prerank,microtubule motor activity (GO:0003777),-0.31442445055230117,-1.1221211214838909,0.2342007434944238,0.6855399661982194,1.0,20/51,22.95%,STARD9;KIF26B;KIF13A;KIF6;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF18B;KIF5A;KIF4A;KIF22;KIF14;KIF1B
prerank,beta-tubulin binding (GO:0048487),0.4373781806232632,1.121380216749943,0.34087481146304677,0.7289966039490396,1.0,9/31,19.09%,GJB6;DLEC1;PDCD5;FGF13;EML4;IFT74;TAOK1;HTT;APPL1
prerank,ubiquitin-specific protease binding (GO:1990381),0.48058705060906926,1.1213784279604646,0.3624382207578254,0.7250445266119341,1.0,8/19,21.35%,DERL1;DERL3;PRKN;SELENOS;PTEN;AMFR;SUMO1;BAG6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.334757910103758,1.1186313406073534,0.27692307692307694,0.7280788324704421,1.0,32/181,15.33%,TCF7L2;LDB2;SMAD3;ARNT2;AR;DACT1;PRRX1;CDK5RAP3;NEUROD1;NCOA2;TBX3;TACC1;NFE2L2;RERE;MTA2;RBPJ;MTA3;NCOR1;ARNT;ACTN4;IFI27;NCOR2;RBL2;TEAD3;BHLHE41;TRIP4;NCOA3;TADA3;TCERG1;HDAC4;SMARCB1;RXRA
prerank,epidermal growth factor receptor binding (GO:0005154),0.4479907521390214,1.1179595018423387,0.3312883435582822,0.7259202758759422,1.0,6/25,13.79%,AREG;TGFA;EPGN;HBEGF;EGF;ARF4
prerank,protein kinase C activity (GO:0004697),-0.43562217451212026,-1.115144157640839,0.34102564102564104,0.6981864182248572,1.0,4/14,16.88%,PRKCH;PKN1;PRKCZ;PRKCE
prerank,chemorepellent activity (GO:0045499),0.4437863876053535,1.11349533601819,0.3485540334855403,0.7334485296511364,1.0,4/25,4.39%,EPHA7;SEMA3D;SEMA5A;APOA1
prerank,3'-5' DNA helicase activity (GO:0043138),0.4794052647437871,1.1131369053491456,0.3375594294770206,0.7304833474210672,1.0,4/16,11.63%,NAV2;RECQL5;ASCC3;MCM2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3372360722445118,1.1129875941889706,0.2677165354330709,0.727045550024726,1.0,27/173,12.15%,ZBTB20;TRPS1;ZEB2;MITF;KCNIP3;ZEB1;AEBP1;PRDM5;FOXP2;ASCL1;JDP2;MXI1;ETV6;BCL6;TBX3;SKI;NR1D1;MZF1;GTF2IRD1;ZBTB4;ZBTB1;ZKSCAN3;ZNF177;CEBPB;ZBTB37;BHLHE41;REST
prerank,metalloaminopeptidase activity (GO:0070006),-0.4109249779050616,-1.1102696597899435,0.33080808080808083,0.705675067533406,1.0,7/16,26.67%,XPNPEP3;MMP15;RNPEPL1;MMP16;TRHDE;LNPEP;NPEPPS
prerank,NADPH binding (GO:0070402),-0.44477023600111265,-1.1096529507048913,0.32338308457711445,0.7015722709548013,1.0,8/13,29.36%,KCNAB1;DHFR;CBR3;HMGCR;GRHPR;CBR4;MTRR;LBR
prerank,sterol binding (GO:0032934),0.38517157683207826,1.109328667972943,0.32249674902470743,0.7325582455264614,1.0,19/56,19.60%,RORA;ABCA1;INSIG2;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;GRAMD1A;VDAC1;OSBPL9;NR1H3;OSBPL5;GRAMD1C;NPC1;INSIG1;OSBP2;ERLIN1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2833701112002498,-1.1092826112326744,0.26570048309178745,0.6967746104589849,1.0,35/85,30.32%,ENPP2;MGLL;ABHD2;NDST3;PLA2G7;LIPE;PNPLA7;BCHE;PAFAH1B2;PLAAT3;PNPLA3;PLA2G4C;TARS2;PNPLA2;ABHD6;PNPLA6;DAGLB;LYPLA2;AARS2;PLA2G4F;LYPLA1;PLA2G4E;GDPD1;AOAH;ABHD4;PLAAT1;LIPA;LIPC;PLA2G4B;FAAH;PGAP1;ACHE;CA2;PON3;LPL
prerank,protein kinase regulator activity (GO:0019887),0.3522667816113701,1.1049295914636763,0.3140495867768595,0.7398703374191669,1.0,36/95,23.56%,PARVA;CCNA2;PRKAG2;MT3;ITPRIP;GPRC5D;DNAJC3;CCNK;STK11;FGF13;TAOK3;CCNL2;RGCC;CCNL1;WNK1;STRADA;DUSP19;MARK2;CNPPD1;GPRC5A;CDKN1C;AGAP2;CCNQ;CCNT2;CDKN1B;PRKAG1;ELP4;MADD;TRIB1;CCND2;CCNT1;HEXIM1;CCNG2;CCNE2;NCKAP1L;CCNY
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3589066190305015,-1.1035767445337266,0.3016759776536313,0.70650320815268,1.0,9/29,13.78%,SLC26A7;SLC26A2;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC26A6;SLC25A11;SLC1A4
prerank,ATP hydrolysis activity (GO:0140603),0.4005252745597374,1.102268733410342,0.3537117903930131,0.7428821724016943,1.0,14/41,18.00%,MYO18A;RNF213;RHOBTB3;SHOC1;CLPX;DDX3X;MYO1E;ABCD2;ABCA3;TOR1B;ABCB6;SMCHD1;DDX4;TOR3A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.44287932997682167,1.100148545821212,0.34915773353751917,0.7446312786085811,1.0,2/24,1.24%,CAMK1D;DAPK1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.45208433612992605,1.0985939556041284,0.3498452012383901,0.7409158737406325,1.0,2/21,1.14%,CDK14;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.45208433612992605,1.0985939556041284,0.3498452012383901,0.7409158737406325,1.0,2/21,1.14%,CDK14;CDK8
prerank,small GTPase binding (GO:0031267),0.3365643618895138,1.0985395766173338,0.3028953229398664,0.7372467748289945,1.0,38/169,14.66%,MYCBP2;RABGAP1L;RHOH;ABCA1;RAPGEF4;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;FGD4;IQGAP2;GOLGA4;RHOBTB3;LRRK2;STRN3;RANBP9;NDRG1;SPHK2;AFDN;ALS2;MYO1C;TRIP11;ARFIP2;PICALM;GGA2;FMNL1;BRAF;RNF152;FGD3;GOLGA5;TNFAIP1;RAB3GAP1;TSC2;WASF1;AKAP13;TBC1D20;FLNA
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4539873266562551,-1.098102814642336,0.34772182254196643,0.7142833018437683,1.0,5/12,17.02%,CISD2;CISD1;ISCU;SDHB;CIAPIN1
prerank,single-stranded RNA binding (GO:0003727),0.38991814692893845,1.0949755782299835,0.33060109289617484,0.7424611497729361,1.0,5/43,10.83%,POLR2D;A1CF;DDX60;HNRNPA1;DDX3X
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3313578903858664,-1.0947935717082335,0.2893772893772894,0.7170651725410992,1.0,12/42,10.43%,STXBP6;BAIAP2L1;ESAM;BSG;CNTN4;NTNG1;TMOD3;CNTN6;SIRPA;LRRC4C;ROBO4;EMB
prerank,single-stranded DNA binding (GO:0003697),0.3548064885515253,1.0935907062936392,0.3349282296650718,0.7422851128015366,1.0,15/93,15.02%,POLR2D;RBMS1;RAD51B;SHOC1;DMC1;SPRTN;REXO4;MLH1;HNRNPA1;SMC6;TDP2;MCM2;HMCES;RAD51D;FUBP3
prerank,N-methyltransferase activity (GO:0008170),0.4585547436045218,1.0933913754712896,0.3752012882447665,0.7391112017282597,1.0,4/20,9.50%,NNMT;HNMT;TRMO;DIMT1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31781099680605135,1.0929566432762068,0.2760041194644696,0.7364634466593599,1.0,86/346,19.41%,MYCBP2;RNF220;PDZRN3;HECW2;SH3RF3;CBLB;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;SMURF2;RFFL;RNF213;CDC42;BFAR;BCOR;ZNRF3;CUL4B;PML;DTX4;KCMF1;RNF31;TRIP12;CUL5;RNF10;RNF145;UBE2U;TRAF7;FBXL3;RNF185;UBR4;RNF139;UBA7;PRKN;ITCH;RNF181;ASB12;MIB1;RNF6;RNF38;RNF152;FBXO9;FBXO11;ERCC8;FBXO4;RSPRY1;RNF217;BTRC;RNFT1;TNFAIP1;MUL1;RC3H2;UBE2E2;RNF19A;AMFR;RNF2;UBE2D1;HLTF;UBR5;ASB1;DZIP3;HACE1;RNF13;HUWE1;UBE2R2;NHLRC3;MSL2;RNF138;UBE3B;RNF214;PJA2;DTX3;UBR3;RNF135;UBE3A;TRIM45;RNF34;RC3H1;TRIM21;TRIM41;TRIM47;TRIM26;TRIM32;RNF11
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3779139326114861,-1.0887378152498794,0.3333333333333333,0.7274125427135473,1.0,9/21,20.17%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,potassium ion antiporter activity (GO:0022821),0.48501800884719487,1.0882814737335704,0.343804537521815,0.7447102274699662,1.0,5/15,9.47%,SLC24A3;SLC9A9;SLC24A1;SLC24A5;SLC9A5
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3967560695796137,1.0850439506448117,0.3616398243045388,0.7494487052472895,1.0,17/40,26.22%,NNMT;DNMT3A;COMT;HNMT;LRTOMT;THUMPD3;TPMT;THUMPD2;METTL4;DNMT3B;PEMT;N6AMT1;DNMT1;CARNMT1;SETD3;ARMT1;RRP8
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.41150395880998386,-1.084639671734835,0.36,0.7324847099159554,1.0,5/15,16.38%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,cysteine-type peptidase activity (GO:0008234),0.36111742115744216,1.084228458233443,0.33669609079445145,0.7478393477029179,1.0,27/73,21.29%,SFRP1;USP11;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;ATG4A;OTULINL;CASP7;USP30;USP9X;CTSZ;USP38;USP9Y;CTSL;USP10;CASP9;CASP1;ATG4B;USP37;USP46;USP49;UCHL1;PDIA3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4231607672332307,1.0841339758456259,0.3688046647230321,0.7445158871552702,1.0,3/27,5.92%,ITPR1;SLC41A1;SLC11A2
prerank,chloride channel regulator activity (GO:0017081),-0.41993397221495543,-1.083922359195071,0.3643410852713178,0.728608130923864,1.0,6/14,22.46%,VAMP8;SGK1;WNK2;CFTR;STX1A;WNK4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3625492660016383,1.0831912809723232,0.34517766497461927,0.7433003173672205,1.0,8/70,9.51%,GXYLT2;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;EXT1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4656321861081919,1.0829553439377326,0.37349397590361444,0.7402777714857699,1.0,3/17,4.62%,ACOT11;ACOT6;ACOT2
prerank,ATPase activator activity (GO:0001671),0.44296593092041747,1.0828919834288842,0.37101910828025475,0.7368461743757271,1.0,4/20,16.12%,DNAJC1;ATP1B2;TOR1AIP1;TOR1AIP2
prerank,lipoprotein particle binding (GO:0071813),-0.3799049263264709,-1.0802354842043007,0.3742857142857143,0.7321884161834648,1.0,7/20,11.23%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,sialyltransferase activity (GO:0008373),-0.38509588303064446,-1.079904287682167,0.3151862464183381,0.7275133919757062,1.0,4/20,1.03%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST6GAL1
prerank,phospholipase C activity (GO:0004629),-0.3592600127520142,-1.079157427864708,0.375,0.7238613906344703,1.0,4/25,5.65%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,galactosyltransferase activity (GO:0008378),-0.45875610496352803,-1.079072693528835,0.38461538461538464,0.7186773696897792,1.0,3/11,6.40%,B4GALT4;B4GALT5;B4GALT7
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4669140417190289,1.0777864599834304,0.38803418803418804,0.7457164047416128,1.0,2/16,1.90%,SLC1A5;SLC13A3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5038273610816574,1.076126791851027,0.38137082601054484,0.7463587729102688,1.0,2/12,7.70%,B3GALT1;B3GALNT1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.40302567030828307,-1.0758584726718914,0.3367088607594937,0.721021448234753,1.0,7/16,11.23%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.33464202710105,-1.0719882767608382,0.38125,0.7257549894672833,1.0,12/34,20.61%,UBE2G1;UBE2H;UBE2J1;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4447257996651456,-1.0699190830802892,0.39598997493734334,0.7253969409771857,1.0,5/12,27.34%,TRAF5;TRAF1;TRAF2;BABAM2;TRAF6
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3168860691005012,-1.0674478297634584,0.303886925795053,0.7262558296909901,1.0,6/42,3.60%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4403671562067689,-1.0672225055480287,0.4009111617312073,0.7163179378967346,1.0,6/11,27.78%,BAG4;HSPBP1;GRPEL1;HSPH1;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.4403671562067689,-1.0672225055480287,0.4009111617312073,0.7163179378967346,1.0,6/11,27.78%,BAG4;HSPBP1;GRPEL1;HSPH1;GRPEL2;BAG2
prerank,mannosyltransferase activity (GO:0000030),0.43952830359412887,1.0666368013595515,0.3936,0.7665686619509068,1.0,2/21,1.98%,TMTC1;TMTC4
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2779448568448704,-1.0650985942930105,0.31601731601731603,0.71675744348166,1.0,25/74,22.74%,NADK2;DGKB;DGKH;HK2;PANK3;RFK;DGKK;IPMK;DGKG;ETNK1;DGKQ;FAM20C;PIK3C2B;PIK3CA;CLP1;NOL9;TKFC;NADK;DGKZ;DGKI;CHKA;PGM2L1;PIK3CG;PKM;KHK
prerank,hyaluronic acid binding (GO:0005540),0.5001655338793093,1.064409704984145,0.38461538461538464,0.7684303504531383,1.0,3/10,14.64%,CEMIP;LYVE1;CHODL
prerank,exonuclease activity (GO:0004527),0.38184417080624194,1.064211092798556,0.38440111420612816,0.7653534145122478,1.0,10/46,11.76%,ENPP1;REXO5;POLG;DCLRE1C;REXO4;DXO;EXOSC1;REXO2;ERI1;EXOSC7
prerank,glutamate receptor binding (GO:0035254),-0.39369845851583785,-1.0613201222611715,0.37948717948717947,0.7210927410430323,1.0,6/17,16.40%,SHANK3;SHANK1;NSF;HOMER1;IGSF11;HOMER3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.43120563394152994,-1.0597623518152868,0.37681159420289856,0.7199225714571487,1.0,7/12,27.99%,TAF1;TBP;H3-3A;GTF2B;RUVBL2;FOS;TBPL1
prerank,microtubule binding (GO:0008017),-0.23736036519815584,-1.0585394630234022,0.30120481927710846,0.7180142028796664,1.0,55/222,19.40%,DNM3;MTUS1;SGIP1;MAP2;REEP1;STARD9;NAV3;CCDC88A;EML5;KIF26B;MID1;KIF13A;FMN1;KIF6;RPS3;KIF2A;FNTA;ARHGEF2;KRIT1;SUN2;CDK5;SYBU;RP1;RAB11A;ARL3;PAFAH1B1;CCDC61;KIF16B;KIF20B;KIF1A;NEFH;POLB;DCTN1;KIF15;GAS2L1;TRPV4;CCDC88C;CDK5RAP2;CEP57;MAP1B;KIF21A;CAPN6;PRC1;GAS8;KIF23;IRAG2;DNM1;KIF18A;REEP2;MAST1;MTCL1;CLASP1;KNSTRN;SPAG5;KIF18B
prerank,RNA stem-loop binding (GO:0035613),0.4909175616999822,1.058425950092358,0.40176991150442476,0.7761090927116564,1.0,7/12,22.90%,MYH10;CPEB3;DDX3X;RC3H2;RC3H1;LARP6;METTL16
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33126611623092894,-1.058171230799401,0.3356401384083045,0.7138020211233449,1.0,7/33,10.26%,RNF144B;RNF144A;RNF125;SIAH1;RPS3;SIAH3;DCUN1D4
prerank,GTPase activity (GO:0003924),-0.2415193503797735,-1.0581094090721794,0.3626373626373626,0.7090100893914238,1.0,50/192,18.52%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;GBP5;EEF2;RAB6A;GNA14;GBP4;GCH1;RAB3C;RAB21;GBP7;RAP1B;RAB5B;RHOB;GTPBP10;GNB2;RAB11A;RAB8B;EFTUD2;GTPBP1;RAB27B;RASL12;ARHGDIB;ATL2;GFM2;DIRAS2;GPN3;RALB;GNG5;GNB1;RAB24;RIT1;RAB6B;EEF1A1;RAB4A;GNG11;GPN2;GNA11;GNA12;RAB3A;DNM1;NKIRAS2;GNA13;TBCC;GNAZ;RAB5C
prerank,DNA polymerase activity (GO:0034061),-0.36479543936881065,-1.0519833629947717,0.38186813186813184,0.7188863314463393,1.0,9/22,20.17%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,chloride channel inhibitor activity (GO:0019869),-0.44702893615271133,-1.0514136579896145,0.3986013986013986,0.7152784887490732,1.0,5/10,22.46%,VAMP8;WNK2;CFTR;STX1A;WNK4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4857342369348133,1.0513918072394328,0.4233576642335766,0.7898461427059894,1.0,4/13,9.55%,PDGFD;PDGFRA;PDGFRB;ITGB3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4471143704764385,-1.047583978316815,0.41379310344827586,0.7197151676401139,1.0,3/10,13.15%,OTUD4;YOD1;TNFAIP3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4436556505955477,-1.0446727568808414,0.44285714285714284,0.7218083420164663,1.0,6/10,26.83%,USP22;EP300;NAA60;BRCA2;ATF2;HAT1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.47442025771223584,1.044586454336722,0.444636678200692,0.8033752361782567,1.0,1/13,0.46%,SLC7A2
prerank,G protein-coupled receptor binding (GO:0001664),0.32660671691952603,1.043915386402771,0.411901983663944,0.8013400821741298,1.0,26/132,15.46%,GRK3;WNT8B;WNT4;GNAS;CCL19;WNT6;INSL3;SFRP1;FZD1;USP20;ZNRF3;WNT5B;AGTR1;TULP3;NPFF;ARRB1;ARHGEF11;ADM;PRKN;RYK;PTCH2;GNAO1;GPRASP2;FLNA;RSPO1;NPY
prerank,androgen receptor binding (GO:0050681),-0.3432262346315138,-1.041749460197346,0.3898809523809524,0.7240158968010945,1.0,10/25,19.31%,KDM1A;SNW1;FOXP1;PKN1;TRIM68;TMF1;EP300;ARID5A;DDX5;RNF14
prerank,ion gated channel activity (GO:0022839),-0.3501235191746172,-1.0414127047029997,0.42178770949720673,0.71996708804724,1.0,8/24,16.84%,ANO1;ANO4;TTYH2;ANO3;ANO2;TMEM63C;TMEM63B;ANO6
prerank,clathrin adaptor activity (GO:0035615),0.4522159400268151,1.0398111258978202,0.43865546218487395,0.8078729818238063,1.0,4/15,10.41%,STON1;DAB2;AP1G2;AP1M1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2991551530866687,1.0392320769326249,0.3952772073921971,0.8056069896523304,1.0,86/431,17.94%,STK17B;DAPK2;ENPP1;RHOH;DAPK1;KSR1;ABCA1;ATP1A2;RHOD;BMPR1A;DMPK;MARK1;RANBP17;MLKL;PRKAG2;RHOBTB1;TGFBR1;RRAS2;MYO1B;MYO18A;MYH10;ACVR1;MVK;LIG4;OAS2;RHOBTB3;MRAS;MAP3K20;CDC42;LRRK2;PDXK;AKT3;RHOBTB2;SIK1;BRSK1;RAB22A;IRAK3;MAST2;OXSR1;MAP4K4;CLPX;STK4;ARL2;ARFIP2;NEK6;STK11;ABCB9;RHOT1;ARL1;ANXA6;P2RX5;ABCE1;PEX6;RAP2A;RRAGD;RHOQ;MAP4K5;ACVR1B;WNK1;TLK1;MTREX;TUBB2B;INSR;RND3;MARK2;ARF4;ABCD2;HSPA9;TUBB2A;RTEL1;GNL2;NLRC4;ARF6;ARL5A;AKT1;AGAP2;PTPA;GCK;RAB32;LONP1;PIM1;RHOG;RHOU;ABCB6;PRKCI;GNAI1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4270466387264508,-1.0390155036744417,0.4244604316546763,0.7214088179926001,1.0,5/12,20.54%,CNOT6L;PAN3;PNLDC1;CNOT7;CNOT8
prerank,estrogen receptor binding (GO:0030331),-0.32716107920103865,-1.0387792983193145,0.39308176100628933,0.7174454745087819,1.0,12/32,24.61%,LEF1;ESR1;MED1;NRIP1;TAF10;PPARGC1B;STRN;ARID5A;SRARP;PPID;DCAF1;PADI2
prerank,ubiquitin binding (GO:0043130),0.3480929709189494,1.038124195229361,0.4083969465648855,0.804786679210824,1.0,14/73,10.59%,SMAD3;NEDD4;FAF2;SPRTN;RNF31;CKS1B;SIRT2;UBXN2B;RNF185;USPL1;UBXN11;PRKN;OTULINL;RAE1
prerank,double-stranded RNA binding (GO:0003725),-0.27059368477667145,-1.035809818991063,0.3349282296650718,0.7198319108736726,1.0,17/70,15.29%,STRBP;IFIH1;MBNL1;TFRC;LRRFIP1;VIM;HSP90AB1;TUBB4B;ELAVL1;EIF4A1;MSN;ADAR;SUPV3L1;SLC3A2;APTX;ADARB2;MRPL44
prerank,phosphatidylinositol binding (GO:0035091),-0.26408565298490555,-1.0351629628300183,0.33505154639175255,0.7168478770288702,1.0,20/91,14.58%,PITPNC1;ESYT2;MCF2L;EPB41;DENND1B;CCDC88A;SNX13;PITPNA;WDFY3;TNFAIP8L3;SNX27;HIP1R;ITPR3;SNX1;SCARB1;EXOC8;FES;PLEKHF2;PHF12;GAP43
prerank,microtubule minus-end binding (GO:0051011),0.4711997648551197,1.0350759950291668,0.4322916666666667,0.8082582227382723,1.0,4/13,19.18%,MACF1;HAUS7;CAMSAP1;NUMA1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.496558398769425,1.0334064544336221,0.432937181663837,0.8087838575361562,1.0,3/10,11.70%,ECHDC2;ECI1;ECHS1
prerank,C-C chemokine receptor activity (GO:0016493),0.43280426643846825,1.033046683989228,0.4182098765432099,0.8061050839560492,1.0,3/21,5.22%,XCR1;ACKR2;CCR9
prerank,phosphatase activity (GO:0016791),0.3407558184644053,1.0326132586308976,0.4258064516129032,0.8035642421340724,1.0,5/73,2.77%,CILP;PLPP3;ATP1A2;PXYLP1;EPHX2
prerank,transcription corepressor binding (GO:0001222),0.4061850263840291,1.0293289034811308,0.44395924308588064,0.8079552870924286,1.0,7/27,12.21%,RORA;USP11;NR1D1;NEK6;PHF1;FAM89B;PER3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4154509673492399,1.02900374333066,0.4174603174603175,0.805073996505811,1.0,3/22,9.05%,HSPG2;APOE;PICALM
prerank,methyl-CpG binding (GO:0008327),0.4224927380959125,1.0283914600686392,0.44773790951638065,0.8030089820804934,1.0,7/22,15.14%,MBD2;ZBTB38;TET1;ZBTB4;CXXC5;MBD1;CXXC4
prerank,double-stranded DNA binding (GO:0003690),0.2907890634850423,1.0279754366004605,0.4212121212121212,0.8004106558853881,1.0,73/531,13.93%,TCF4;ZBTB20;RBMS1;TEAD1;PKNOX2;PBX1;ARNT2;GLI2;ZIC1;GLI3;MAF;RUNX2;THRB;ASCL1;NFIB;RARB;JDP2;ZIC4;NFIX;LBX2;MEOX2;MSC;RFX5;NEUROD1;RARG;KLF15;RAD51B;BCL6;TBX3;TCF7;HLF;CUX2;HES7;BATF;ZNF23;DMC1;NR5A1;SPRTN;DDX60;SREBF1;REXO4;NR1D1;BBX;OSR1;EGFR;TCF7L1;FOXC2;KDM5B;ARNT;GMEB1;CREB3L4;CREB3;PAX1;GLIS2;FOXA1;NR1D2;MBD1;ZNF177;NKX2-8;CEBPB;ZBTB37;NFE2;BHLHE41;SPDEF;TERF2;NR4A1;CAMTA1;NPAS2;MYCN;GATA6;HIVEP1;TCF12;HOXC8
prerank,WW domain binding (GO:0050699),0.40609294957057396,1.0243364517637763,0.4376899696048632,0.8057889234931763,1.0,5/26,11.62%,PMEPA1;RAPGEF2;TCEAL8;TCEAL1;NFE2
prerank,Hsp90 protein binding (GO:0051879),-0.3167683472217628,-1.0218041504814868,0.4096774193548387,0.7446402588659414,1.0,10/33,22.78%,SLC12A2;KDR;RPS3;UNC45B;ERN1;NOD2;HIF1A;USP19;PPID;PPEF2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4339538975820264,-1.021070189733421,0.4520547945205479,0.7417325886497306,1.0,4/10,12.90%,SHANK3;SHANK1;NSF;IGSF11
prerank,serine-type peptidase activity (GO:0008236),0.32642835650504476,1.0200387550781411,0.42636579572446553,0.8127840556788105,1.0,11/96,12.01%,GZMK;MMP2;RHBDL3;ENDOU;CTSH;PRSS48;MASP1;APEH;HTRA1;CLPP;F2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4838053938766903,1.0194982280852085,0.478494623655914,0.8104571650454655,1.0,3/10,10.87%,ASH1L;NSD1;SETD5
prerank,GTPase binding (GO:0051020),0.30745925939712254,1.0157432257473586,0.45054945054945056,0.8156474765310071,1.0,43/194,15.72%,MYCBP2;RABGAP1L;RHOH;ABCA1;RAPGEF4;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;FGD4;IQGAP2;GOLGA4;RHOBTB3;GNB3;LRRK2;STRN3;RANBP9;NDRG1;SPHK2;AFDN;ALS2;MYO1C;TRIP11;ARFIP2;PICALM;GGA2;FMNL1;BRAF;RNF152;RRAGD;FGD3;GOLGA5;TNFAIP1;RAB3GAP1;TSC2;WASF1;AKAP13;TBC1D20;FLNA;RADIL;RAPGEF6;HACE1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.48452738635845666,1.013386396211759,0.4519774011299435,0.8179346229677258,1.0,2/10,6.40%,CACNB1;CACNA1C
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.409127283603672,1.0128300546358735,0.46489859594383776,0.8156077998480694,1.0,2/25,1.47%,MICAL3;CYP26B1
prerank,Hsp70 protein binding (GO:0030544),-0.31759009339128863,-1.0126164177976653,0.43167701863354035,0.7582839272916803,1.0,11/31,24.81%,RPS3;DNAJB14;SACS;ERN1;NOD2;GPR37;DNAJC8;HIKESHI;PPID;PPEF2;DNAJB1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.31138565418928926,1.0104189668965065,0.465675057208238,0.8177631384298557,1.0,41/147,16.75%,MYCBP2;RIN2;FARP1;RAPGEF4;DOCK4;DOCK10;RCBTB2;DOCK11;IQSEC2;DENND2A;FGD1;RAPGEF2;FGD4;DENND4A;ARFGEF2;DENND5A;ARHGEF17;DOCK5;ARHGEF18;ALS2;RGL1;ARHGEF11;RAPGEF1;EIF2B4;ARHGEF10;SBF2;LAMTOR2;EGF;FGD3;DENND1A;RAB3GAP1;AKAP13;SERGEF;EPS8L1;CCZ1;EIF2B3;RAPGEF6;FNIP1;ARFGEF1;RAB3IL1;DENND6A
prerank,cAMP binding (GO:0030552),-0.41069138146666706,-1.0091507314776778,0.4496487119437939,0.7624713223691462,1.0,3/11,4.93%,PDE4D;PDE4B;PDE2A
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2855451266650863,-1.0086271440461616,0.43656716417910446,0.7590546615414684,1.0,19/49,24.73%,CPNE8;ESYT2;MCTP1;DYSF;CPNE3;SYT1;PCLO;PLA2G4C;SYT6;CPNE5;SYT4;SYT15;ANXA1;PLA2G4F;PLA2G4E;SYT5;ANXA8;ESYT3;CPNE9
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3501564220074891,1.0081182876604575,0.4445983379501385,0.8197843226031825,1.0,4/49,2.77%,ATP1A2;PXYLP1;MPPED2;EPHX2
prerank,hexosaminidase activity (GO:0015929),0.4713937478076465,1.0074300729582533,0.4616695059625213,0.8179482095637929,1.0,1/12,0.61%,CEMIP
prerank,fibroblast growth factor receptor binding (GO:0005104),0.41364672025764215,1.0063552233406787,0.47913446676970634,0.8169199443175152,1.0,3/21,9.95%,KL;FRS2;FGF2
prerank,AMP binding (GO:0016208),0.46232485032480847,1.0042325965733874,0.4722222222222222,0.8184656007314106,1.0,2/11,3.48%,MPPED2;PRKAG2
prerank,exopeptidase activity (GO:0008238),-0.2802123563668738,-1.0041799613761175,0.4198473282442748,0.7652989714667716,1.0,19/50,26.67%,DPP10;FAP;PRCP;XPNPEP3;ACE2;DPP6;MME;METAP2;BLMH;GGH;CPE;DPP4;DPEP3;NUDT16;RCE1;TRHDE;LNPEP;CPB1;NPEPPS
prerank,motor activity (GO:0003774),-0.2739134597510388,-1.0035858265583817,0.4602510460251046,0.7621046611795195,1.0,20/60,22.95%,STARD9;KIF26B;KIF13A;KIF6;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF18B;KIF5A;KIF4A;KIF22;KIF14;KIF1B
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.47701408742011164,0.9997980739804664,0.48154657293497366,0.8255818877165666,1.0,1/11,0.27%,ITPR1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.29808736959390514,-0.9996807194432648,0.4371069182389937,0.7671188187156335,1.0,4/35,3.00%,PLCE1;GPCPD1;ENPP2;APEX2
prerank,titin binding (GO:0031432),0.44588399702575526,0.999046478956499,0.4816112084063047,0.8239903566170752,1.0,1/13,0.91%,ACTN2
prerank,mRNA binding (GO:0003729),0.29484503776996723,0.9959728141177158,0.4989406779661017,0.8276744704695281,1.0,45/249,17.58%,CELF2;SAMD4A;RBMS1;RBMS3;A1CF;RBFOX1;CSDC2;RBMXL2;RBFOX2;HNRNPLL;MYH10;IGF2BP2;CPEB1;SNRNP70;ZFP36L1;THOC2;ACO1;SF1;CPEB3;DXO;RBMS2;RBPMS;METTL14;HNRNPR;PARN;EIF3A;DDX3X;NUP98;EIF2S2;SERBP1;LARP1;UTP23;RC3H2;RBM4B;SRSF5;PCF11;FUBP3;SYNCRIP;RBM5;IGF2BP1;DCP1A;HNRNPC;SF3B1;CRYZ;SRRM2
prerank,manganese ion binding (GO:0030145),0.35627029104724517,0.9951954345216197,0.4667590027700831,0.8261024403092485,1.0,6/48,7.03%,ADCY2;MPPED2;LARGE1;ENDOU;LARGE2;B4GALT1
prerank,filamin binding (GO:0031005),-0.41221365093755374,-0.9932753623610584,0.46454767726161367,0.7782246877130313,1.0,1/11,0.02%,NEBL
prerank,protein phosphatase 2A binding (GO:0051721),-0.34220149017475754,-0.9920547674138189,0.46175637393767704,0.7764330121200276,1.0,9/23,20.45%,CTTNBP2NL;GRIN3A;ADCY8;STRN;PPME1;FOXO1;STRN4;SMG7;DAB2IP
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.32078129995040217,-0.9914417120974862,0.4678362573099415,0.7733057449682763,1.0,6/29,14.58%,PTPRJ;GCH1;NFATC1;SIRT1;DUSP7;DUSP8
prerank,pyrophosphatase activity (GO:0016462),0.3478226853359761,0.9908755941674172,0.472258064516129,0.8325810998072226,1.0,7/50,10.83%,CILP;ENPP1;NUDT7;DXO;DOLPP1;PLPP5;DDX3X
prerank,C-C chemokine binding (GO:0019957),0.41201721557750426,0.9903998498814099,0.4635258358662614,0.8303735074936852,1.0,3/22,5.22%,XCR1;ACKR2;CCR9
prerank,NAD+ binding (GO:0070403),0.4575130114666123,0.9887663970915865,0.4913194444444444,0.8308721719890413,1.0,2/12,7.23%,CRYL1;SIRT2
prerank,voltage-gated cation channel activity (GO:0022843),-0.2491010126953226,-0.988320935676395,0.47468354430379744,0.7759387473018,1.0,26/97,20.15%,KCNB2;PTK2B;KCNQ5;KCND2;GRIN2A;KCND3;KCNMA1;KCNQ1;KCNH7;KCNH5;KCNC2;GRIN2B;GRIN3A;CACNA2D2;KCNQ3;KCNA2;CACNA1D;CACNA2D1;KCNS3;CACHD1;CACNG3;CACNG4;CACNA1A;HCN1;CACNB3;GRIN1
prerank,peptidoglycan binding (GO:0042834),-0.4199569525919581,-0.9861513386334589,0.47058823529411764,0.7766206267509284,1.0,3/10,14.82%,NOD1;PGLYRP1;NOD2
prerank,ankyrin binding (GO:0030506),-0.35188326571877315,-0.9853518373292103,0.45194805194805193,0.7740459162962258,1.0,8/19,16.35%,CDH1;NRCAM;SPTBN1;SPTB;PLEC;CACNA1D;KCTD6;PTPRC
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.28935172323257974,0.9809823978600544,0.5176093916755603,0.8454429312016364,1.0,61/254,20.38%,TCF4;NFIA;SMAD3;AR;MITF;RUNX1;PRRX1;SP7;NFIB;MLXIP;IRF1;RLF;MEOX2;RFX5;NEUROD1;KLF15;HLF;CEBPA;RBPJ;FOXC2;MZF1;SMAD1;GMEB1;CREB3;GLIS2;FOXA1;ZSCAN21;NKX2-8;STAT6;NR4A1;SMARCD2;MYCN;ETS1;TCF12;FOXK2;HOXC4;TFCP2;MYBL1;MTF1;ZNF585B;ZNF585A;ZBTB17;TFDP1;CREB3L1;FOXJ3;ATF5;PLAG1;SP1;FOXO3;IRF2;GTF2I;SOX11;ELF1;RFXANK;POU2F3;NFAT5;ELK4;MDM4;SMAD2;ATF1;FOXC1
prerank,histone deacetylase activity (GO:0004407),0.4146064441633241,0.9794180411312429,0.49837662337662336,0.8454541736192903,1.0,10/19,28.52%,SIRT2;HDAC8;HDAC4;SUDS3;MIER3;HDAC5;HDAC6;HDAC1;MIER1;SIRT7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.33820275662480853,0.9790630068232643,0.5026455026455027,0.8428315567763709,1.0,14/55,16.55%,SLC7A2;SLC16A12;SLC13A3;SLC6A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC16A3;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,protein phosphatase binding (GO:0019903),-0.23816806097430043,-0.9768547953027538,0.48366013071895425,0.7901595428711585,1.0,31/117,17.44%,PPP1R16B;CTTNBP2NL;ITGA1;IQGAP1;MET;KIFAP3;PXN;KCNQ1;PTPRT;ERBB2;FLT4;GRIN3A;SIRPA;ATP2B4;AP3B1;ANAPC7;AKAP11;GTF2F1;JUP;SKAP1;MTMR9;ADCY8;STRN;PPP1R3B;CEACAM1;PPME1;FOXO1;STRN4;JAK3;RACK1;SMG7
prerank,glucuronosyltransferase activity (GO:0015020),0.4112980470085455,0.9767694092628585,0.48335974643423135,0.8446566402992194,1.0,5/19,15.41%,LARGE1;LARGE2;EXT1;EXT2;CHSY1
prerank,phospholipase A2 activity (GO:0004623),-0.3208273751506494,-0.9766179158305256,0.4897959183673469,0.7861420006027404,1.0,14/26,36.98%,PLA2G7;PLAAT3;PNPLA8;PNPLA3;PLA2G4C;PLA2G4F;PLA2G4E;PLAAT1;PLA2G4B;PLA2G5;PLB1;PLA2G6;PLA2G3;PLAAT5
prerank,transaminase activity (GO:0008483),0.46361561559601316,0.9758881308890757,0.5106007067137809,0.8432012500949508,1.0,1/11,2.28%,ABAT
prerank,retinoid X receptor binding (GO:0046965),0.4619371664150005,0.9749278114319289,0.48928571428571427,0.8419634711941681,1.0,3/11,9.49%,RARG;TACC1;NSD1
prerank,tubulin binding (GO:0015631),-0.21159260261973575,-0.9734092334983975,0.6,0.7891064034169334,1.0,70/295,18.70%,DNM3;MTUS1;SGIP1;TTLL7;MAP2;UNC5C;TTLL5;REEP1;STARD9;DIP2B;NAV3;RABGAP1;CCDC88A;EML5;KIF26B;MID1;DIXDC1;KIF13A;FMN1;KIF6;RPS3;KIF2A;TBCE;FNTA;ARHGEF2;KRIT1;SUN2;CDK5;PAK1;SYBU;RP1;EFHC2;RAB11A;ARL3;PAFAH1B1;AGBL4;CCDC61;ALDOA;KIF16B;KIF20B;KIF1A;NEFH;PHF6;GIT1;POLB;DCTN1;KIF15;GAS2L1;TRPV4;TPPP3;CCDC88C;CDK5RAP2;EMD;CEP57;MAP1B;KIF21A;CAPN6;PRC1;GAS8;CDK5R1;BRCA2;KIF23;IRAG2;DNM1;KIF18A;REEP2;MAST1;MTCL1;CLASP1;RAB11FIP5
prerank,triglyceride lipase activity (GO:0004806),-0.33938983672854495,-0.9726964082384403,0.49732620320855614,0.7862997231654865,1.0,7/20,30.32%,LIPE;PNPLA3;PNPLA2;DAGLB;LIPH;LIPC;LPL
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.36470680766707597,0.9702026848197942,0.47007299270072994,0.8491629948055675,1.0,12/33,21.71%,AR;RECQL5;WDR43;PAF1;NCOA3;PCF11;CDC73;ELOF1;WAC;ELP4;HNRNPU;SCAF8
prerank,N-acetyltransferase activity (GO:0008080),0.40747923160189875,0.9697390244434496,0.5222929936305732,0.8469110208495418,1.0,9/19,24.67%,KAT2B;SAT2;NAA50;NAA80;NAT2;SAT1;SMARCE1;NAT14;ESCO1
prerank,vinculin binding (GO:0017166),-0.3901902820554486,-0.9681981426205534,0.49878934624697335,0.7924320203570115,1.0,3/11,8.47%,UTRN;PXN;SORBS3
prerank,chemoattractant activity (GO:0042056),0.38776234208583493,0.965599369405992,0.5150078988941548,0.8528236036082069,1.0,5/26,16.92%,GDNF;NTF3;FGF2;BMP4;CX3CL1
prerank,nuclear receptor coactivator activity (GO:0030374),0.33914673276159457,0.9634868073364704,0.5230352303523035,0.854196569515786,1.0,21/52,22.13%,NCOA2;BRD8;ATXN7L3;TACC1;MED14;ZMIZ1;ACTN4;FGF2;PSMC3IP;HELZ2;ETS1;NCOA3;SS18;NCOA7;CARM1;MED30;NCOA6;DCAF6;ACTN1;MED12;PRKCB
prerank,methyltransferase activity (GO:0008168),0.34639486146001564,0.9624649518753037,0.5140056022408963,0.8532376862391892,1.0,13/46,21.79%,NNMT;COMT;BUD23;NSUN2;FTSJ3;LRTOMT;BCDIN3D;NSUN4;METTL4;DNMT3B;METTL3;N6AMT1;DNMT1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.20845282180816319,-0.9613219789621197,0.5844155844155844,0.8049514626360024,1.0,60/248,18.85%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;VWA8;GBP5;EEF2;RAB6A;GNA14;GBP4;KIF2A;GCH1;RAB3C;RAB21;GBP7;RAP1B;RAB5B;RHOB;GTPBP10;GNB2;RAB11A;RAB8B;EFTUD2;GTPBP1;RAB27B;RASL12;ARHGDIB;ATL2;KIF20B;GFM2;KIF1A;DIRAS2;GPN3;RALB;GNG5;GNB1;RAB24;RIT1;KIF15;CFTR;RAB6B;EEF1A1;RAB4A;GNG11;RUVBL1;GPN2;GNA11;GNA12;RAB3A;DNM1;NKIRAS2;CHD3;GNA13;TBCC;GNAZ;RAB5C;CLU;DHX9
prerank,phosphate ion binding (GO:0042301),-0.4110210501803088,-0.958900670548118,0.5118483412322274,0.8061449072785316,1.0,5/10,31.78%,PDE2A;PNP;MTHFD2;CHST14;ADSS2
prerank,ephrin receptor binding (GO:0046875),0.39278586536684296,0.9581926151197655,0.500780031201248,0.859653187996734,1.0,5/21,9.16%,LYN;EFNB2;SRC;EFNA2;EFNB1
prerank,potassium:proton antiporter activity (GO:0015386),-0.41480475489388974,-0.9566481869626544,0.5346320346320347,0.8070435034506012,1.0,3/10,8.37%,SLC9A2;SLC9A6;SLC9A7
prerank,symporter activity (GO:0015293),-0.40302210486167733,-0.9563516098042267,0.5176211453744494,0.8033022683467284,1.0,2/10,7.74%,SLC5A6;MFSD2A
prerank,tropomyosin binding (GO:0005523),0.4199066167951917,0.9555941734731858,0.5032258064516129,0.8619401320873771,1.0,3/16,2.90%,CALD1;TMOD4;TNNT1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.4017139115320926,-0.9534934314043549,0.5348314606741573,0.8052135946111897,1.0,5/10,21.47%,SIRPA;JUP;CXADR;DSG2;DSP
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4515794231500708,0.9514010589985376,0.5391459074733096,0.8679537517491789,1.0,2/10,7.03%,B3GALT1;B4GALT1
prerank,phosphatidic acid binding (GO:0070300),-0.3403704881794288,-0.9498966256380984,0.5416666666666666,0.8092182624999095,1.0,2/19,0.82%,PITPNC1;PLTP
prerank,sodium channel regulator activity (GO:0017080),-0.2897019700704558,-0.9472189248034852,0.5370370370370371,0.8108661496114888,1.0,8/37,10.51%,NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4;SGK1;GPLD1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3392022913840798,0.9467565448040988,0.5288590604026846,0.8751562827371536,1.0,6/46,11.34%,B3GALT1;OGT;LARGE1;B3GALNT1;EXT1;MGAT3
prerank,histone acetyltransferase binding (GO:0035035),0.39563537228720175,0.9422453081888357,0.5265700483091788,0.8814346688891908,1.0,5/21,13.23%,GLI3;EPAS1;SIRT2;KANSL1L;TRIP4
prerank,protein kinase binding (GO:0019901),0.26816202807068934,0.9412284236840344,0.644803229061554,0.8802310429146085,1.0,78/479,14.10%,TCF7L2;NELL1;ERRFI1;PDLIM5;RHOH;GHR;SMAD3;SASH1;PRKCSH;IL31RA;RHOD;DACT1;GRK5;KIF13B;NEDD9;EPHA4;NBEAL1;CCNA2;CEP152;PDGFRB;PRKAG2;RHOBTB1;KIF20A;CDK5RAP3;RFFL;ACVR1;MAPK4;TOM1L2;RHOBTB3;PKIA;CDH5;SKI;CDC42;CD247;RHOBTB2;NISCH;SIK1;CKS1B;ERCC6L2;IL15RA;TOP2B;IRAK3;PARD6G;OXSR1;PARD6B;DNAJC3;SPRY2;KAT2B;NEK6;SMAD1;ZBTB4;CCNK;TELO2;ITGAV;PRKN;PARN;KIZ;SPRED3;TNIP2;RGCC;UFL1;ADRA2A;WNK1;DACT2;MAP3K13;DUSP19;MAP2K6;MVP;NOX4;TRIP4;VDAC1;GATA6;LLGL1;RND3;SUFU;PTPN23;IBTK;FAM83F
prerank,protein phosphatase 1 binding (GO:0008157),-0.32938755683394416,-0.9408067216135484,0.5488126649076517,0.8216821942797577,1.0,9/21,31.31%,PPP1R16B;KCNQ1;AKAP11;PPP1R3B;PPP1R11;LILRB1;PPP1R16A;PPP1R3F;PHACTR4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3630240691405596,0.940431554280907,0.564179104477612,0.8785398592578658,1.0,5/30,7.14%,GAS6;CAST;MT3;CST3;DPEP1
prerank,GTPase inhibitor activity (GO:0005095),0.43947909903498905,0.938928449979546,0.5771230502599654,0.8782600674964463,1.0,4/13,12.87%,RHOH;IQGAP2;ARL2;GPS1
prerank,adenylyltransferase activity (GO:0070566),0.37848356504039654,0.9381383332001914,0.5380875202593193,0.8766849388496448,1.0,10/21,25.21%,OAS2;TENT4A;TENT4B;PAPOLG;NMNAT2;COASY;PAPOLA;NMNAT1;PAPOLB;ABL1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4215870089607179,0.9359850571818841,0.5515548281505729,0.877976222772377,1.0,5/14,14.94%,ACO1;EXO5;NUBPL;NFU1;ETFDH
prerank,actin monomer binding (GO:0003785),0.38468529119278216,0.9342530195089698,0.5435114503816794,0.8782860908200583,1.0,3/22,7.52%,MTSS1;LIMA1;MYL4
prerank,voltage-gated anion channel activity (GO:0008308),-0.359833603779234,-0.9335278425944896,0.5402597402597402,0.8344145878035522,1.0,3/15,9.35%,ANO1;CLCN3;CLCN5
prerank,hormone receptor binding (GO:0051427),-0.3519500658507912,-0.9303749226139159,0.5807228915662651,0.8372841878949768,1.0,3/14,13.03%,SOCS2;JAK2;TYK2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.2835856162266784,-0.9302146179980022,0.56,0.828670005471268,1.0,15/34,29.12%,NDUFC1;NDUFA6;NDUFA5;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;NDUFS1;NDUFS5;NDUFS7;NDUFB3;NDUFV2;NDUFB4;NDUFV3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.2835856162266784,-0.9302146179980022,0.56,0.828670005471268,1.0,15/34,29.12%,NDUFC1;NDUFA6;NDUFA5;NDUFA8;NDUFB7;NDUFA7;NDUFA10;NDUFA3;NDUFS1;NDUFS5;NDUFS7;NDUFB3;NDUFV2;NDUFB4;NDUFV3
prerank,endopeptidase activator activity (GO:0061133),0.4357887202977402,0.9296529134534429,0.5443686006825939,0.8850522759764706,1.0,4/10,20.11%,APH1B;ADRM1;NLRC4;PSME3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.37254638066126966,-0.9284453563508127,0.5609756097560976,0.8280748488901539,1.0,3/12,6.48%,NOD1;BCL2L13;ATP2A3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4407763134682259,0.9276151118171476,0.5221843003412969,0.886018140915401,1.0,2/10,7.14%,DPYSL3;DPEP1
prerank,proton transmembrane transporter activity (GO:0015078),-0.283182405375629,-0.9255989010630306,0.6013745704467354,0.8302107143995797,1.0,15/39,27.12%,CLCN3;COX4I1;CLCN5;UQCRH;COX6A1;COX5B;COX5A;COX8A;UQCR10;UQCR11;CLCN4;UQCRQ;ATP6V1F;UQCRFS1;UQCRC1
prerank,leucine zipper domain binding (GO:0043522),0.4382539703827451,0.9240355299844728,0.5355871886120996,0.8903939221849653,1.0,4/10,21.67%,PMF1;PAWR;AATF;DDIT3
prerank,hexosyltransferase activity (GO:0016758),0.2963078864493727,0.9226577584282433,0.6007326007326007,0.8900876582474765,1.0,9/101,7.70%,TMTC1;TMTC4;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;ALG5;B3GALNT1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.35178426406168534,-0.9193805424893787,0.5619047619047619,0.8403042302188826,1.0,3/15,10.55%,EPB41;WDFY3;SCARB1
prerank,phosphatase binding (GO:0019902),0.29349497499234156,0.9183440184705086,0.5948174322732627,0.8961106082531545,1.0,25/105,15.97%,PIK3R1;SMAD3;ANK1;CDH5;EIF2AK3;MAST2;EGFR;MTMR3;ANAPC5;VRK3;IKBKE;PPP1R3C;RCAN3;TBK1;STAT6;CD33;WNK1;SYTL2;MVP;TSC2;DLG4;SPRED1;CEP192;DZIP3;PIK3R2
prerank,histone deacetylase binding (GO:0042826),0.2964975895606271,0.9179729890006654,0.594059405940594,0.8936223557820249,1.0,23/88,17.29%,DACT1;GLI3;BCOR;BEX4;SIRT2;TOP2B;MTA2;ZMYND15;MTA3;NCOR1;BRMS1L;KAT2B;PRKN;NCOR2;BHLHE41;YWHAE;AKAP8L;HDAC4;CAMTA2;SUDS3;KPNA2;NIPBL;SP1
prerank,MAP kinase activity (GO:0004707),-0.3506116368617237,-0.9176579490856457,0.5643340857787811,0.8397196457166761,1.0,7/14,25.37%,NLK;MAPK10;MAPK8;MAPK3;MAPK1;MAPK7;MAPK11
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.38956607170064006,0.9164505036222884,0.566006600660066,0.8934268549423638,1.0,7/18,22.79%,GAS6;MT3;DPEP1;NOL3;BIRC3;BIRC2;XIAP
prerank,calcium channel regulator activity (GO:0005246),0.3362205217262946,0.9149234345676869,0.5698166431593794,0.893457098520938,1.0,2/37,4.20%,ITPR1;STIM1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3810249210695344,0.9146203328503563,0.5817901234567902,0.8908937515225546,1.0,2/18,3.63%,PDLIM5;CNN3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.319955773278433,0.9131422711818931,0.594222833562586,0.8908215700455149,1.0,16/53,23.31%,MICAL3;DPYD;MTHFR;DDO;SQOR;AIFM1;FOXRED2;NOX4;ETFDH;AOX1;CYB5R3;ETFA;SDHA;PRODH;LDHD;DLD
prerank,nucleotidyltransferase activity (GO:0016779),0.37246168767376203,0.9111590146058905,0.563011456628478,0.8918789966670223,1.0,8/19,21.61%,TUT7;TENT4A;TUT4;CRPPA;TENT4B;PAPSS2;YRDC;NUDT5
prerank,tau protein binding (GO:0048156),0.33770466487100004,0.9108512503917761,0.5831062670299727,0.8893000953261186,1.0,8/40,15.21%,ROCK2;MARK1;APOE;BRSK1;PICALM;TTBK1;MARK2;DYRK1A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.31590362455943155,-0.9106496393473069,0.5920679886685553,0.8425854817633391,1.0,11/22,38.47%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;CHRM5;HRH3;HTR2B;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.31590362455943155,-0.9106496393473069,0.5920679886685553,0.8425854817633391,1.0,11/22,38.47%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;CHRM5;HRH3;HTR2B;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.31590362455943155,-0.9106496393473069,0.5920679886685553,0.8425854817633391,1.0,11/22,38.47%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;CHRM5;HRH3;HTR2B;HTR1D
prerank,guanyl ribonucleotide binding (GO:0032561),-0.20547592382483523,-0.9091407138652997,0.7752808988764045,0.8415061124234562,1.0,37/196,14.00%,PDE5A;RAP1A;RIT2;RAB27A;KRAS;ARL4A;GBP5;PDE2A;TGM2;RAB6A;REM1;GBP4;GCH1;RAB21;GBP7;RAP1B;RAB5B;RHOB;RAB12;GTPBP10;TUBB4B;RAB8B;ARL3;NOA1;RAB27B;RASL12;GLUD1;ATL2;DIRAS2;RAB39A;RALB;ARF1;RIT1;EEF1A1;ARF3;ARF5;RAB4A
prerank,regulatory RNA binding (GO:0061980),0.33259540938426124,0.9084975356273812,0.5915492957746479,0.8909547941234375,1.0,12/38,24.63%,ZC3H7B;TUT7;PIWIL4;HNRNPA1;TUT4;ZNF346;DICER1;RC3H1;AGO4;RBM4;SOX2;AGO3
prerank,cholesterol transfer activity (GO:0120020),0.39117014966635033,0.9077002870863716,0.5807504078303426,0.8893434649702358,1.0,5/16,15.28%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.33327865617559593,-0.9073857895998959,0.582089552238806,0.8411066953330292,1.0,6/16,17.94%,MTMR2;INPP5F;MTMR9;SACM1L;MTMR6;SYNJ1
prerank,thioesterase binding (GO:0031996),0.4202415771267226,0.905453859333471,0.568695652173913,0.890645275167962,1.0,4/11,15.76%,CDC42;ADRA2A;HAUS7;ARF6
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.32508310687518926,0.9051979827555132,0.6043656207366985,0.888033455193715,1.0,17/44,20.74%,SETD7;ASH1L;KMT5B;SETD1A;NSD1;SETD5;WDR82;KMT2A;SETD4;KMT2E;SMYD3;SETDB1;WDR5;SETD1B;RBBP5;N6AMT1;CXXC1
prerank,phospholipase activity (GO:0004620),-0.23866369868528617,-0.9031528598438038,0.6625514403292181,0.8463557421144234,1.0,24/67,26.55%,PLCE1;ENPP2;MGLL;PNPLA7;PLAAT3;PNPLA8;GPLD1;PNPLA3;PLA2G4C;SMPDL3A;ABHD6;PITPNM3;PLD3;PNPLA6;LYPLA2;PLA2G4F;LYPLA1;PLA2G4E;GDPD1;LIPH;ABHD4;PLAAT1;LIPC;PLA2G4B
prerank,protein phosphatase regulator activity (GO:0019888),0.3171514202475767,0.903033114257411,0.6021361815754339,0.8892061319333753,1.0,8/53,13.57%,RCAN2;DMPK;RCAN1;RCAN3;PPP4R4;PPP2R5D;BOD1L1;IGBP1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.35284996179799566,-0.8996469065124467,0.6094986807387863,0.8495712447412206,1.0,5/15,21.15%,COX4I1;COX6A1;COX5B;COX5A;COX8A
prerank,sodium channel activity (GO:0005272),0.33511281428210843,0.8971817517175571,0.5894886363636364,0.8981373729920169,1.0,3/37,5.45%,SCN7A;SHROOM2;GRIK5
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.38570445551527954,0.8968011864593471,0.5922818791946308,0.8956028811616801,1.0,5/18,16.74%,PIK3R1;WDR91;WDR81;PIK3R2;AGAP2
prerank,chemokine receptor activity (GO:0004950),0.3671786176871212,0.8959337684250294,0.603030303030303,0.8943030094134845,1.0,3/24,5.22%,XCR1;ACKR2;CCR9
prerank,solute:proton symporter activity (GO:0015295),0.3802712060540396,0.8931374763588121,0.612141652613828,0.8967417109468914,1.0,3/16,7.48%,SLC2A10;SLC11A2;SLC2A13
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.382378038951375,-0.8928310062274055,0.6073059360730594,0.8605394619858103,1.0,5/10,28.47%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PIK3CD
prerank,syntaxin binding (GO:0019905),0.3056892258484538,0.888642142037387,0.6263157894736842,0.9026824165633677,1.0,8/61,8.05%,DAPK1;ABCA1;UNC13C;STXBP3;BAIAP3;LRRK2;STX16;SYT9
prerank,kinase binding (GO:0019900),0.2545343629866513,0.8877841898445703,0.7708757637474541,0.9013528101878548,1.0,91/434,17.59%,TCF7L2;ERRFI1;RHOH;GHR;GSN;SMAD3;SASH1;IL31RA;RHOD;KIF13B;WWC2;NBEAL1;CCNA2;SP100;CEP152;PDGFRB;PRKAG2;RHOBTB1;KIF20A;CDK5RAP3;RFFL;MAPK4;TOM1L2;RHOBTB3;SKI;CDC42;SRC;RHOBTB2;PARP16;NISCH;SIK1;CEBPA;CKS1B;ERCC6L2;IL15RA;IRAK3;OXSR1;TTC28;EGFR;DNAJC3;SPRY2;KAT2B;NEK6;SMAD1;ZBTB4;CCNK;TELO2;PRKN;PARN;KIZ;SPRED3;TRIP6;TNIP2;RGCC;UFL1;ADRA2A;WNK1;STRADA;MAP3K13;MAP2K6;MVP;TRIP4;MYCN;VDAC1;GATA6;LLGL1;DLG4;RND3;SUFU;PTPN23;IBTK;FAM83F;SPRED1;FLNA;CEP192;BAG5;TPCN2;TBL2;STX1B;CASP9;LAPTM4B;RNF138;CASP1;AGAP2;SGO1;ATF5;ZC3HC1;TNS2;RHOG;CDKN2C;FOXO3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.41075837699325063,0.8838357695275821,0.5948275862068966,0.9059056761385509,1.0,7/12,23.24%,PHF2;KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,peptidase activator activity (GO:0016504),0.35811840323107036,0.8838326597407883,0.6129032258064516,0.9028032594394463,1.0,7/22,15.66%,PCOLCE;PSME4;CLPX;APH1B;CASP8AP2;ADRM1;NLRC4
prerank,amyloid-beta binding (GO:0001540),0.2933922199088037,0.8837930817664715,0.6510745891276865,0.8997994246769239,1.0,12/79,9.05%,LRP1;HSPG2;EPHA4;APOE;APOA1;LDLR;CST3;APBB2;TLR6;APBA1;EPHB2;PICALM
prerank,voltage-gated sodium channel activity (GO:0005248),0.3624087958430661,0.8832930280461673,0.6236559139784946,0.8977046971056933,1.0,1/22,0.67%,SCN7A
prerank,ferrous iron binding (GO:0008198),-0.3042316111579989,-0.8832002213429259,0.6572237960339944,0.8767660702365172,1.0,5/21,12.12%,EGLN3;FTL;FTH1;EGLN2;ISCU
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3827775499308508,-0.8822551833164003,0.6454545454545455,0.8745877255847287,1.0,5/10,10.49%,PRKAR1A;PRKAR2B;PKIB;PRKAR2A;PRKAR1B
prerank,Wnt-activated receptor activity (GO:0042813),0.3858693305346907,0.8821630623971041,0.6003344481605352,0.8968542550919832,1.0,4/15,10.19%,FZD2;ROR1;FZD1;RYK
prerank,cation channel activity (GO:0005261),0.2869258970904566,0.8798827813419977,0.6861042183622829,0.8981396097735229,1.0,13/94,10.40%,SLC24A3;NALCN;TRPA1;CALHM5;SLC24A1;MCU;SLC24A5;KCNK7;PANX1;CUL5;KCNQ4;TRPM4;ANXA6
prerank,NADP binding (GO:0050661),-0.27363683382355686,-0.8786640893721093,0.668769716088328,0.8777993542613338,1.0,19/32,29.36%,KCNAB1;NOS3;NOS1;ME1;DHFR;SPR;CBR3;DHCR7;HSD11B1;TM7SF2;HMGCR;CAT;GRHPR;NOX1;CBR4;MTRR;CRYZL1;NOS2;LBR
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.4205883907960647,0.8771729251434781,0.6167557932263814,0.9001799342558732,1.0,1/10,3.85%,SLC6A13
prerank,hydro-lyase activity (GO:0016836),0.3290133925980344,0.8746143640033393,0.6455172413793103,0.9020178216894476,1.0,6/41,11.70%,GMDS;ECHDC2;ACO1;ENO2;ECI1;ECHS1
prerank,chemokine activity (GO:0008009),0.33721444218877233,0.8738131776188619,0.6378539493293591,0.9006364034626578,1.0,5/31,16.92%,CCL19;CXCL16;CCL4;CXCL13;CX3CL1
prerank,death domain binding (GO:0070513),-0.36902970781488487,-0.8727557546283288,0.6336405529953917,0.886039145969454,1.0,6/11,19.28%,CRADD;DAPL1;BCL2L1;MCL1;RACK1;DAP
prerank,lysophospholipase activity (GO:0004622),0.3686959376058123,0.8720982504712638,0.62402496099844,0.9009334186986137,1.0,3/20,5.75%,ASPG;PLA2G4A;LYPLAL1
prerank,chemokine receptor binding (GO:0042379),0.3311176952129146,0.871586275707519,0.6528571428571428,0.8989981668864789,1.0,6/35,16.92%,CCL19;CXCL16;CCL4;ITCH;CXCL13;CX3CL1
prerank,acetylcholine receptor activity (GO:0015464),-0.2963947411254168,-0.871134005264139,0.6759776536312849,0.8852842260868393,1.0,12/22,44.77%,CHRM3;CHRM2;CHRM1;CHRNB1;CHRM5;HRH3;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.27536426903655264,0.8695608955545848,0.6776960784313726,0.8997131821446094,1.0,32/100,19.79%,MYO10;OGT;MYO1B;SH3PXD2B;IQGAP2;PLA2G4A;OSBPL8;ADAP2;PLEKHA8;ARHGAP9;COMMD1;ARFIP2;SNX12;WIPI1;GOLPH3L;PLEKHN1;SNX21;DENND1A;PIRT;SAP30L;OSBPL5;GSDMD;PARD3;LAPTM4B;AKT1;GOLPH3;FCHSD2;ATG2B;RNF34;ZFYVE16;SESTD1;WDR45
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.41792754514125713,0.8687119954020998,0.6072664359861591,0.8984144928442472,1.0,4/11,15.35%,UBE4B;UBOX5;AMFR;UBR5
prerank,sterol transfer activity (GO:0120015),0.36791036589628423,0.8671123747289533,0.6197411003236246,0.8981568695538941,1.0,5/17,15.28%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.33006589574280004,0.8666486033646218,0.6439169139465876,0.8960627666071375,1.0,6/32,9.93%,SLC1A5;SLC6A9;SFXN2;SLC38A6;SLC43A1;SLC38A9
prerank,ribosomal small subunit binding (GO:0043024),0.3788184718293607,0.8665059027976525,0.6304347826086957,0.8933716299739939,1.0,6/17,20.78%,ERAL1;ABCE1;DDX3X;LARP1;PIM1;PTCD3
prerank,syntaxin-1 binding (GO:0017075),0.360865831411966,0.8647608773681167,0.6401225114854517,0.8936027964540347,1.0,4/22,6.25%,DAPK1;UNC13C;STXBP3;LRRK2
prerank,ribosomal large subunit binding (GO:0043023),-0.3588139999780704,-0.8643181977259661,0.6252983293556086,0.89526072465601,1.0,6/11,26.82%,MRRF;MALSU1;NPM1;CPEB2;LTN1;CPSF6
prerank,general transcription initiation factor binding (GO:0140296),-0.2928360850607878,-0.8621920615139905,0.6565096952908587,0.8949077798029267,1.0,11/25,23.22%,ESR1;TAF1B;TAF1;TBP;HHEX;GTF2A2;RUVBL1;YEATS2;THAP7;GTF2B;THRA
prerank,PDZ domain binding (GO:0030165),0.29616674370195967,0.8621487311821165,0.6915887850467289,0.8954760018664614,1.0,9/61,7.71%,TGFBR3;DOCK4;FZD2;ARHGAP29;SYNJ2;RAPGEF2;FZD1;PLEKHA2;SLC22A4
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.35557142319452684,-0.8612822133601045,0.6781326781326781,0.8923997452160003,1.0,4/12,20.67%,EIF4E;CYFIP2;EIF4E2;DCPS
prerank,ADP binding (GO:0043531),0.3367082116523924,0.8611489577828904,0.6374622356495468,0.8945979068087732,1.0,3/25,3.88%,PRKAG2;MYO18A;MYH10
prerank,cholesterol binding (GO:0015485),0.3079439857587637,0.8610160587679466,0.6680161943319838,0.8919637783307774,1.0,13/47,16.33%,ABCA1;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;GRAMD1A;VDAC1;NR1H3;OSBPL5;GRAMD1C;NPC1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3475946653448817,-0.8590095716595432,0.6504854368932039,0.8927227788368721,1.0,1/12,0.74%,SLC2A1
prerank,MAP kinase kinase activity (GO:0004708),0.3866875342593071,0.8580955043939343,0.6631393298059964,0.8944571733650137,1.0,3/15,12.98%,LRRK2;MAP2K1;MAP2K6
prerank,snRNA binding (GO:0017069),0.3066273044020147,0.8573537688611201,0.6595744680851063,0.8929423809400587,1.0,15/42,23.21%,RBMXL2;SNRNP70;RBM22;HEXIM2;RNPC3;LSM8;RBM41;CCNT2;LSM10;HNRNPU;CCNT1;HEXIM1;NCBP2;PRPF8;TOE1
prerank,phosphatidate phosphatase activity (GO:0008195),0.37880329267374413,0.8567815785326641,0.6258389261744967,0.8911387365275188,1.0,5/13,23.05%,PLPP3;PLPP5;LPIN3;LPIN2;PLPPR2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.3566543443216779,-0.8567522681371492,0.6396396396396397,0.8933391426151541,1.0,3/10,22.32%,ANKRD13A;USP15;FAAP20
prerank,thyroid hormone receptor binding (GO:0046966),0.33507181652395895,0.8562593876153706,0.657051282051282,0.8892252368171154,1.0,8/28,13.92%,BRD8;TACC1;TRIP12;MED16;NCOR1;NSD1;TRIP6;NCOA3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.26930399831058016,-0.8561513477066043,0.6871165644171779,0.8904093934395927,1.0,13/28,30.21%,EDC3;RPP14;POP4;MRPL44;RPP21;ELAC2;RNASEH1;NUDT16;EXO1;POP7;APEX1;FEN1;RPP40
prerank,miRNA binding (GO:0035198),0.3290834499897809,0.8548004123827422,0.6538461538461539,0.8890662612677088,1.0,10/30,24.63%,ZC3H7B;TUT7;HNRNPA1;TUT4;ZNF346;RC3H1;AGO4;RBM4;SOX2;AGO3
prerank,water transmembrane transporter activity (GO:0005372),0.3995893257572074,0.854319444216376,0.6376306620209059,0.8870278885403431,1.0,2/11,8.59%,PDPN;AQP6
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3556835030131355,0.8534220276773704,0.6298076923076923,0.885780782686152,1.0,8/21,18.86%,AKAP7;ARFGEF2;PRRC1;WASF1;AKAP8L;ARFGEF1;PJA2;PRKACA
prerank,myosin binding (GO:0017022),0.29488276496224863,0.8533032819999808,0.6746347941567065,0.8832149732940031,1.0,3/55,1.25%,KIRREL1;CALD1;GSN
prerank,carboxy-lyase activity (GO:0016831),-0.2835452969441301,-0.853073570985558,0.6714697406340058,0.8924537972072013,1.0,10/23,40.11%,ECHDC1;DDC;GAD1;BCKDHA;PPCDC;UXS1;MLYCD;AZIN1;PCK2;MVD
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3970428636668333,0.8524343198420301,0.6376306620209059,0.8819250743796766,1.0,3/11,26.39%,SLC22A4;SLC25A29;SLC25A47
prerank,endoribonuclease activity (GO:0004521),0.3215629906497746,0.8502834878618453,0.6656976744186046,0.8828771852245721,1.0,11/32,24.63%,SND1;ENDOU;PIWIL4;RNASEL;TSNAX;ENDOV;DICER1;NOB1;RCL1;LACTB2;AGO3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.34422654138381226,-0.8494139902718719,0.6453900709219859,0.8950126889721268,1.0,5/12,38.63%,DUSP7;DUSP8;DUSP3;DUSP5;DUSP2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3468119134662592,-0.8490176776306411,0.6727688787185355,0.8915739701560055,1.0,2/12,8.79%,SPPL3;BACE2
prerank,protein homodimerization activity (GO:0042803),0.23907046757533904,0.8400801884364648,0.8921370967741935,0.8975074737722005,1.0,97/589,15.96%,ENPP1;FBLN5;GHR;GDNF;SMAD3;CPQ;BCL2;NR2F2;CRYL1;FGFR1;TPM1;IL6R;BMPR1A;EPHX2;SLC30A8;IL17D;FGFR2;TPST1;PDGFRA;KIT;FOXP2;APOE;NPR3;IRAK2;CSF1;APPL2;DPYD;ACVR1;ZHX2;MAPK4;GSTM4;MIGA2;GSTM2;ADRA2C;TNNC1;ADRB3;LRRK2;PDXK;HOGA1;PML;KYNU;CEBPA;GUCY2D;ZBTB38;ALS2;IRAK3;MMUT;NAALADL1;STK4;MASP1;RBPMS;COMMD1;CAMK2B;CBY1;ARNT;MZF1;ACTN4;ZBTB4;ZBTB1;EXT1;S100A11;ABCB9;TIMM9;CARD9;KMT2A;SLC39A13;SMIM1;CEBPB;GALM;BHLHE41;ADRA2A;FBXO4;PANK1;TERF2;MAP3K13;CIP2A;CDA;ZNF318;GOLGA5;RIPK2;TSC2;TPM2;PSPH;ABCD2;SNX9;CRPPA;FLNA;NUDT16L1;DGAT2;GLIPR2;EXT2;CYP2R1;PEX11B;NLRC4;TMEM266;PRKRA;CASR
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3373550655754881,-0.8392355881987397,0.6790697674418604,0.9061652561360299,1.0,3/13,13.79%,PIP5K1B;PIK3C2B;PIK3CA
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.36756415074252574,0.8388750395830655,0.6479338842975206,0.8967345893101217,1.0,6/15,22.61%,SH3PXD2B;PLA2G4A;SAP30L;SESTD1;RUBCNL;LANCL2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2901726749380466,-0.8379836608914867,0.7150837988826816,0.9043134107795996,1.0,2/21,4.51%,GRIK2;P2RX7
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.37149283401836747,0.8344829289802902,0.672945205479452,0.9015360005515126,1.0,1/15,1.19%,PIK3R1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.35092380405290596,-0.8344005897560489,0.6605922551252847,0.9026428914418361,1.0,2/10,14.58%,DUSP7;DUSP8
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.35092380405290596,-0.8344005897560489,0.6605922551252847,0.9026428914418361,1.0,2/10,14.58%,DUSP7;DUSP8
prerank,peptide hormone receptor binding (GO:0051428),0.39607546816508526,0.8311909109297335,0.6655518394648829,0.9043758012205413,1.0,1/11,5.67%,VIP
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3729256503514949,0.8304321750776291,0.6804835924006909,0.9027738451688622,1.0,3/12,13.68%,CDK8;CCNK;CDK12
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.31219694675160753,0.8295613714234578,0.6897637795275591,0.9014377330205523,1.0,7/34,8.94%,MYO10;OGT;MYO1B;IQGAP2;ADAP2;ARHGAP9;COMMD1
prerank,nuclear receptor binding (GO:0016922),0.2605566243482844,0.8291589356994135,0.7559808612440191,0.899346867997846,1.0,20/111,14.19%,TCF7L2;SMAD3;NCOA2;BRD8;TACC1;MED14;TRIP12;MED16;NCOR1;STAT5B;ACTN4;NSD1;NCOR2;RNF6;TRIP6;WIPI1;NR4A1;TRIP4;NCOA3;TADA3
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.34046181157804584,-0.8280848717959035,0.6764705882352942,0.9094336291741187,1.0,9/12,51.42%,RRH;OPN1MW3;OPN1MW;OPN3;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,DNA replication origin binding (GO:0003688),-0.28353077459578047,-0.827110010008298,0.7412790697674418,0.907143877526014,1.0,11/23,36.23%,ORC4;MCM8;MCM3;DHX9;MCM5;ORC5;CDC6;GRWD1;POLA1;MCM7;KAT7
prerank,protein kinase inhibitor activity (GO:0004860),0.2978547116735151,0.8268705538177145,0.700960219478738,0.9004577355844853,1.0,9/42,15.54%,PARVA;ITPRIP;DNAJC3;SPRY2;TAOK3;DUSP19;IBTK;SPRED1;CDKN1C
prerank,endonuclease activity (GO:0004519),0.2928164579072294,0.8268701093452963,0.7248968363136176,0.897720781980885,1.0,17/49,26.21%,SND1;OGG1;ENDOU;REXO4;PIWIL4;RNASEL;MBD4;TSNAX;DICER1;NOB1;APLF;RCL1;LACTB2;AGO3;MRE11;N4BP2;ANG
prerank,G protein-coupled receptor activity (GO:0004930),0.24832138883629634,0.8265895354091375,0.825346112886049,0.8954952452262361,1.0,20/239,8.76%,ADRA1B;PDGFRL;ADGRV1;LGR4;PDGFRB;ADGRL1;NPR3;GPR63;LTB4R;ADRA2C;LHCGR;ADRB3;BDKRB2;MTNR1A;AGTR1;LPAR1;GRM2;DRD3;MAS1;MRGPRF
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3154654628005087,0.8241998416355861,0.7083946980854198,0.8966707180095836,1.0,6/30,11.00%,SLC30A8;SLC25A37;SLC30A2;SLC11A2;SLC30A10;SLC39A13
prerank,nuclear localization sequence binding (GO:0008139),-0.2967002828794886,-0.8144078086934172,0.7244094488188977,0.9262617617318338,1.0,4/18,10.31%,NUP153;NFKBIA;IPO5;CABP1
prerank,serine-type endopeptidase activity (GO:0004252),0.26723622110166745,0.8081365014297769,0.7768187422934648,0.9200378652630989,1.0,8/80,12.01%,MMP2;RHBDL3;CTSH;PRSS48;MASP1;APEH;CLPP;F2
prerank,GABA receptor binding (GO:0050811),-0.3362290677246822,-0.807434271247844,0.7223529411764706,0.9343131622433206,1.0,5/11,25.15%,PLCL2;TRAK2;GABARAP;JAKMIP1;AKAP5
prerank,ion channel inhibitor activity (GO:0008200),0.30393267880212327,0.80734826880367,0.7514792899408284,0.9185717485306213,1.0,2/35,4.26%,ITPR1;NEDD4
prerank,histone methyltransferase binding (GO:1990226),-0.32913336798192294,-0.8035891678804649,0.7114914425427873,0.9365936849689384,1.0,3/11,15.24%,LCORL;HSP90AB1;CBX1
prerank,antiporter activity (GO:0015297),-0.2891266667684246,-0.8034568643162268,0.7634408602150538,0.9326204894059478,1.0,9/20,29.42%,CLCN3;SLC35E4;SLC25A30;ATP1A3;SLC25A11;CLCN4;SLC35D1;SLC25A10;SLC25A14
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.26981845822254374,0.8031538353979725,0.7810126582278482,0.9226335843066507,1.0,10/75,11.00%,CRYL1;DHRS3;H6PD;MDH2;HSD3B2;MDH1B;ADH1A;DCXR;AKR1B10;KDSR
prerank,neuropeptide hormone activity (GO:0005184),0.321404414657668,0.8020120992060056,0.7167182662538699,0.9216423757310805,1.0,3/22,15.46%,VIP;NPFF;NPY
prerank,telomeric DNA binding (GO:0042162),-0.24665803034830103,-0.801707939122753,0.780952380952381,0.9314478938024037,1.0,18/32,42.12%,KDM1A;HNRNPD;CTC1;HNRNPA2B1;ZBTB48;SMG7;TEN1;HMBOX1;APEX1;PIF1;STN1;TERT;PURA;ACD;TERF2IP;UPF3A;TINF2;XRCC6
prerank,histone acetyltransferase activity (GO:0004402),-0.255269846907329,-0.7983830104086324,0.8056426332288401,0.9330013355918954,1.0,10/30,18.34%,TAF1;KAT2A;TAF10;TADA2A;USP22;KAT6A;EP300;NAA60;BRCA2;MCM3AP
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.30894280174539757,-0.7976169477334912,0.7543424317617866,0.9300983777444786,1.0,7/14,30.21%,RPP14;POP4;RPP21;ELAC2;TSEN34;POP7;RPP40
prerank,Tat protein binding (GO:0030957),-0.3405430099901611,-0.7948641072788307,0.7286012526096033,0.9304425585939414,1.0,4/10,26.63%,ACTB;NPM1;DLL1;SMARCA4
prerank,myosin II binding (GO:0045159),0.37365564491005787,0.791830364492962,0.6977152899824253,0.9350262606751815,1.0,3/10,13.46%,GSN;MYL4;LLGL1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3298916793750593,0.7901339225885399,0.7076461769115442,0.9347902103587823,1.0,7/20,19.12%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6
prerank,tRNA binding (GO:0000049),-0.23403616678110628,-0.7886122662526912,0.8166089965397924,0.9362997718573122,1.0,19/43,32.76%,TRMT10A;PSTK;PTCD1;YARS2;EEF1A1;KARS1;FARS2;AIMP1;AARS2;EIF2AK4;NSUN6;TRMT10C;CTU1;HSD17B10;TRMT10B;DALRD3;TERT;THG1L;DARS2
prerank,transferrin receptor binding (GO:1990459),-0.3331380512155251,-0.7869774630394144,0.7676537585421412,0.9348039131642383,1.0,4/10,29.71%,SNX1;CD81;CHUK;IKBKG
prerank,acetylation-dependent protein binding (GO:0140033),0.3239783788620903,0.786315288648531,0.7230273752012882,0.9349484874567487,1.0,5/20,10.96%,PSME4;PHIP;MLLT3;ATAD2B;KMT2A
prerank,lysine-acetylated histone binding (GO:0070577),0.3239783788620903,0.786315288648531,0.7230273752012882,0.9349484874567487,1.0,5/20,10.96%,PSME4;PHIP;MLLT3;ATAD2B;KMT2A
prerank,alpha-tubulin binding (GO:0043014),0.3001658263330529,0.785072786469427,0.7428139183055976,0.934183777490248,1.0,4/31,6.71%,DLEC1;EFHC1;INO80;BEX4
prerank,kinesin binding (GO:0019894),-0.25337134696290703,-0.7842024942024953,0.8106508875739645,0.9350712576470425,1.0,3/27,3.91%,ACTB;SPAG9;KIFAP3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.36713657842632935,0.7826460295630612,0.7194244604316546,0.9351793983568001,1.0,1/11,1.32%,SASH1
prerank,acetyltransferase activity (GO:0016407),0.3021445127365107,0.7812263216536695,0.7612612612612613,0.9346625237979832,1.0,11/31,24.67%,DBT;KAT2B;LCAT;SAT2;NAA50;NAA80;PAFAH2;SAT1;SMARCE1;NAT14;ESCO1
prerank,CARD domain binding (GO:0050700),-0.30774921399043126,-0.7773472048183623,0.7759433962264151,0.9413526444152996,1.0,4/14,15.64%,NOD1;CARD14;NOD2;CARD16
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.28995589035980157,0.7773284444436386,0.7681159420289855,0.9377007099898732,1.0,7/34,16.45%,SETD7;KMT5B;SETD4;KMT2E;SMYD3;SETDB1;EEF2KMT
prerank,3'-5' exonuclease activity (GO:0008408),-0.22567529279885126,-0.7724603554124,0.852233676975945,0.9445254552167055,1.0,12/45,20.62%,REV3L;CNOT6L;ANGEL2;RAD1;PNPT1;PNLDC1;TATDN1;DIS3L2;EXOSC5;CNOT7;CNOT8;USB1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.2543470299705314,-0.7699067565308766,0.8299120234604106,0.9444458922405369,1.0,12/24,37.72%,AK5;IP6K1;AK7;PMVK;PPIP5K1;ITPKB;AK3;ITPKC;NME2;IP6K3;NME4;PPIP5K2
prerank,SUMO binding (GO:0032183),0.351953227494433,0.7679087904731318,0.7593220338983051,0.9488173484995505,1.0,4/13,13.29%,PML;USPL1;SERBP1;CASP8AP2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.22410862165460785,0.7668603309129749,0.9107332624867163,0.9476737945417489,1.0,75/269,23.96%,TXNIP;SMAD3;BCL2;MOAP1;CDK5RAP3;RFFL;AXIN2;FAF2;SKI;DERL1;CUL4B;PML;VCL;RNF31;CUL5;DBT;SNCAIP;EGFR;ARRB1;NEK6;UBOX5;STAT2;LTBR;PRKN;ITCH;SMC6;CKB;IKBKE;SLC22A18;RAD18;YWHAE;ACVR1B;TRIP4;MUL1;DIO2;SYT11;SNX9;HSPA9;GLMN;UBE2D1;BAG5;HLTF;TMBIM6;AUP1;SPOP;LAPTM4B;SPART;MAP1LC3A;BECN1;RNF34;PRKACA;PSMD1;SUMO1;KDM4A;SMAD2;UCHL1;TRIB1;UBE2T;PSMA3;BAG6;PRDX6;AMBRA1;CBS;JKAMP;TSG101;RNF20;HSPA5;STAT1;HDAC6;ERLIN2;WFS1;UBXN7;BRCA1;ATXN3;CASC3
prerank,methylation-dependent protein binding (GO:0140034),0.264403153023452,0.7649483583015635,0.8192612137203166,0.9477586689991369,1.0,18/57,21.15%,ING3;ING5;PHF2;PHF1;L3MBTL1;KMT2E;L3MBTL2;KDM7A;JMJD7;WDR5;PHF8;CBX5;SPIN4;ATRX;KDM4A;RBBP5;CXXC1;KDM5A
prerank,neurexin family protein binding (GO:0042043),0.36556813163217833,0.7649019215810899,0.7164948453608248,0.9451110358975431,1.0,1/10,2.06%,SYTL5
prerank,retinoic acid receptor binding (GO:0042974),0.3319235164458557,0.7645033561252411,0.7520391517128875,0.9430417006400275,1.0,4/17,9.49%,RARG;TACC1;ACTN4;NSD1
prerank,CCR chemokine receptor binding (GO:0048020),0.29601578622132335,0.7634713078005637,0.7532846715328467,0.9419252030625411,1.0,4/28,16.92%,CCL19;CCL4;CXCL13;CX3CL1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2571330368796811,0.7634466645496538,0.8212927756653993,0.9392547238986095,1.0,10/69,14.90%,ASPG;PLA2G4A;DBT;LPGAT1;KAT2B;CERS6;CERS5;MOGAT3;CERS2;DGAT2
prerank,ribonuclease P RNA binding (GO:0033204),-0.32537258784195255,-0.7633520226679793,0.7517241379310344,0.9500361964557392,1.0,5/10,30.21%,RPP14;POP4;RPP21;POP7;RPP40
prerank,signal sequence binding (GO:0005048),0.28509075214021623,0.7592837444929901,0.7952871870397643,0.9424793766269356,1.0,7/35,18.27%,CEMIP;KPNA6;KDELR3;NUP214;KPNA2;KPNA1;KPNB1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.31633890547399385,0.7575983691841048,0.7748031496062993,0.9421729352272852,1.0,5/22,10.91%,OPTN;SPRTN;WDR81;ZBTB1;IKBKE
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.31145212248541065,-0.7559069466248137,0.7838479809976246,0.9569367530277036,1.0,2/11,5.66%,APEX2;RPS3
prerank,deubiquitinase activity (GO:0101005),-0.18971276979439572,-0.7550876787158061,0.9606741573033708,0.9540453810144953,1.0,26/88,26.60%,USP53;OTUD7B;MINDY2;USP29;MINDY1;OTUD7A;OTUD4;USP31;YOD1;OTULIN;USP14;TNFAIP3;USP22;USP15;USP4;UFD1;EIF3F;OTUB1;USP19;TANK;USP5;DESI2;USP7;OTUB2;USP1;UCHL5
prerank,nucleosomal DNA binding (GO:0031492),0.31361968186911565,0.7526436490492621,0.7682737169517885,0.946303937389012,1.0,6/21,17.39%,MBD2;SMARCC2;MTA2;SMARCD2;SMARCB1;HNRNPC
prerank,ribonuclease activity (GO:0004540),0.2598499124594024,0.7515790941797634,0.8378016085790885,0.9450940498670811,1.0,8/56,11.76%,SND1;ENDOU;RNASE12;EXOSC1;PIWIL4;RNASEL;RNASE7;EXOSC7
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.23651746837031884,-0.7509672355154984,0.8456591639871383,0.9555496907544355,1.0,2/29,1.35%,ACER3;ACER2
prerank,microtubule plus-end binding (GO:0051010),0.3102837510267733,0.7491529465957774,0.7944078947368421,0.9459097890327216,1.0,3/20,9.33%,STIM1;CLIP4;MAPRE2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.28046199800477944,0.7468766359051942,0.8016759776536313,0.9464890520978972,1.0,13/35,28.00%,BCDIN3D;QRSL1;TRMT13;TRMT9B;DTWD1;ALKBH1;FTO;DUS3L;TRMT12;TYW3;PTRH2;QTRT2;TRIT1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2954085543558633,0.7463450333427025,0.7881619937694704,0.9446382813431603,1.0,3/26,7.70%,B3GALT1;GBGT1;B3GALNT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.32479444282577297,-0.7449500151669947,0.7911832946635731,0.9599281196729923,1.0,4/10,22.06%,APOBEC1;GDA;ADARB2;DCTD
prerank,receptor antagonist activity (GO:0048019),0.3280823465889029,0.7445847928251365,0.7786885245901639,0.9444627155458674,1.0,4/17,22.01%,DKK3;IL18BP;FST;PXDN
prerank,vitamin D receptor binding (GO:0042809),-0.2949392603217367,-0.7442725029340778,0.833729216152019,0.9568862504934217,1.0,4/14,13.20%,MED1;MED4;SNW1;THRAP3
prerank,5'-3' exonuclease activity (GO:0008409),0.32923977030876517,0.7403126943227868,0.7654941373534339,0.947661650373318,1.0,6/14,24.87%,DCLRE1C;DXO;DCLRE1A;FAN1;XRN1;MRE11
prerank,NF-kappaB binding (GO:0051059),-0.24961393155330264,-0.7392156238272398,0.8228571428571428,0.9596100327907642,1.0,8/24,23.15%,FAF1;NFKBIA;EP300;NPM1;HDAC3;PSMA6;COMMD7;GSK3B
prerank,ubiquitin protein ligase binding (GO:0031625),0.21541344988489472,0.7341418446946697,0.9419354838709677,0.9534207362875989,1.0,70/254,23.96%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;AXIN2;FAF2;SKI;DERL1;CUL4B;PML;VCL;RNF31;CUL5;DBT;SNCAIP;EGFR;ARRB1;NEK6;UBOX5;LTBR;PRKN;SMC6;CKB;IKBKE;SLC22A18;RAD18;YWHAE;ACVR1B;MUL1;DIO2;SYT11;SNX9;HSPA9;GLMN;UBE2D1;BAG5;HLTF;TMBIM6;AUP1;SPOP;LAPTM4B;SPART;MAP1LC3A;BECN1;RNF34;PRKACA;PSMD1;SUMO1;KDM4A;SMAD2;UCHL1;TRIB1;UBE2T;PSMA3;BAG6;PRDX6;AMBRA1;CBS;JKAMP;TSG101;RNF20;HSPA5;HDAC6;ERLIN2;WFS1;UBXN7;BRCA1;ATXN3;CASC3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.26149062773712956,0.7319957726024963,0.8455172413793104,0.9537475148594414,1.0,21/49,25.50%,OPTN;SPRTN;EPS15;WDR81;ZBTB1;IKBKE;TNIP2;RAD18;DZIP3;TNIP1;PSMD4;UIMC1;ZFAND6;BRCC3;BAG6;ABRAXAS2;PRPF8;HDAC6;PARP10;ATRIP;RAD23B
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.22500561333505176,-0.7288620314999887,0.8896321070234113,0.9687931895671813,1.0,10/34,20.62%,CNOT6L;ANGEL2;PAN3;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;CNOT8;USB1
prerank,RNA polymerase II complex binding (GO:0000993),0.27253447170627976,0.7250392761174579,0.8269230769230769,0.960059420757924,1.0,11/32,21.71%,RECQL5;WDR43;PAF1;NCOA3;PCF11;CDC73;ELOF1;WAC;ELP4;HNRNPU;SCAF8
prerank,mRNA methyltransferase activity (GO:0008174),0.3310600586935951,0.7245534985216031,0.7713310580204779,0.9580544081992759,1.0,6/12,24.80%,NSUN2;METTL14;CMTR2;METTL3;METTL16;PCIF1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2829111998529246,0.7236715550237521,0.8203240058910162,0.9564192993424815,1.0,9/29,18.87%,PRKAG2;PKIA;SPRY2;KAT2B;HEXIM2;INCA1;SPRED1;CDKN2C;CDKN1B
prerank,GTP binding (GO:0005525),0.21834165248131102,0.7235981796436789,0.9375696767001115,0.9538809921380005,1.0,32/172,17.94%,RHOH;RHOD;RANBP17;RHOBTB1;RRAS2;RHOBTB3;MRAS;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RAP2A;RRAGD;RHOQ;TUBB2B;INSR;RND3;ARF4;TUBB2A;GNL2;ARF6;ARL5A;AGAP2;RAB32;RHOG;RHOU;GNAI1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.2523839767800057,-0.7217992959474694,0.8528610354223434,0.9734671241101575,1.0,13/21,51.49%,GRM5;GRM1;GRIA1;CHRNB1;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1;DRD1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2784541503637954,-0.7189460081468966,0.8584686774941995,0.9727812779145706,1.0,9/14,51.27%,CAPNS1;CAPN6;CAPN3;CAPN11;CAPN12;CAPN2;CAPN8;CAPNS2;CAPN9
prerank,O-acyltransferase activity (GO:0008374),-0.2259931864235663,-0.717292470276625,0.9142011834319527,0.9705298424288443,1.0,6/30,16.38%,MBOAT1;LPCAT1;PLA2G4C;MBOAT7;LPCAT3;LPCAT2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.29529778656751543,0.716887584537834,0.8190327613104524,0.9594443998721773,1.0,1/24,1.32%,GLUL
prerank,lysine N-methyltransferase activity (GO:0016278),0.2979229890991528,0.7128992982151331,0.8226837060702875,0.9618159303901394,1.0,3/20,16.45%,SETD7;SETD4;EEF2KMT
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2842960564341552,0.7126668028794528,0.8208,0.9595350997089435,1.0,11/24,22.61%,PLA2G4A;OSBPL8;PLEKHA8;ARFIP2;GOLPH3L;OSBPL5;GSDMD;GOLPH3;SESTD1;RUBCNL;LANCL2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.32631560928881026,0.7124621108891942,0.8084745762711865,0.9571510816949672,1.0,4/14,16.41%,AIFM1;NOX4;CYB5R4;NOX3
prerank,mRNA 5'-UTR binding (GO:0048027),0.28655997255415966,0.7108177909458885,0.8320251177394035,0.9565869686165281,1.0,7/24,16.67%,MYH10;IGF2BP2;DDX3X;LARP1;UTP23;SYNCRIP;IGF2BP1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.24546585283649186,-0.7096697318114104,0.8770491803278688,0.9750420009206558,1.0,6/23,18.27%,PLEKHA5;HIP1R;KIF16B;WDR45B;WIPI2;CLVS2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.26091193387073014,-0.7088545942192251,0.8641025641025641,0.9719285574676805,1.0,4/16,17.79%,CD38;RPS3;MACROD2;SMUG1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2640698866544433,0.7044420730147528,0.8739495798319328,0.9618455865162481,1.0,3/38,6.25%,PIK3R1;FRS2;LRRK2
prerank,ATPase regulator activity (GO:0060590),0.2596409009607765,0.7040142910606352,0.860632183908046,0.9597891724946906,1.0,7/38,16.12%,DNAJC1;ATP1B2;KATNB1;TOR1AIP1;BAG5;FNIP1;TOR1AIP2
prerank,RNA binding (GO:0003723),0.19893809311784483,0.703591659508073,1.0,0.9577875632810092,1.0,236/1321,18.88%,POLR2D;CELF2;SAMD4A;RBMS1;BICC1;ROCK2;RBMS3;LRP1;C1D;DCN;TENT5A;A1CF;RBFOX1;CSDC2;RRBP1;SON;ADK;RBMXL2;MACF1;FNDC3B;RBFOX2;HNRNPLL;RFTN1;SND1;SPATS2L;MYO18A;MYH10;CDC42EP4;IGF2BP2;POLR1G;CAST;ZC3H7B;ENDOU;GOLGB1;TNS1;MDH2;NUDT7;OAS2;DYNC1H1;MAP3K20;SIDT1;SNRNP70;TNRC6B;ZFP36L1;NPM3;THOC2;ERI3;SERPINH1;ACO1;RPUSD4;BUD23;SF1;DDX17;SNTB2;CPEB3;PNN;DDX60;NPM2;NUP42;TOP3B;DNTTIP2;ALDH18A1;RPP25L;REXO4;DXO;EXOSC1;HELZ;TUT7;SAFB2;CHD2;RBMS2;ZNF106;ERAL1;TNRC6A;RBM22;NONO;NSUN2;RBPMS;IBA57;METTL14;HNRNPR;ASCC3;FLYWCH2;HNRNPA1;RAVER2;ACTN4;APEH;GFM1;DDX39A;DIMT1;FTSJ3;DDX19A;PRRC2B;HEXIM2;EIF4A2;ADAT1;RNASEL;PARN;PPHLN1;ERI1;EIF3A;WDR33;BYSL;RAE1;DDX31;TFAM;DDX3X;RPUSD2;POLRMT;MANF;TRIP6;NUP98;EIF5B;SUGP2;DDX23;EIF2S2;PPP1R10;STXBP1;RCAN3;SUGP1;EXOSC7;SERBP1;RBM19;DDX50;YWHAE;NMD3;MAGOHB;GANAB;TUT4;MTREX;LARP1;WDR43;SLC16A3;DDX10;USO1;HMGN5;UTP23;TEFM;TRMT9B;STAU1;USP10;FASN;ESF1;NOL3;ALDH6A1;IFIT2;RBM34;HELZ2;RC3H2;TIAL1;P4HB;MARK2;TEP1;SNRPD2;RBM39;TCERG1;HSPA9;AKAP8L;SRP72;NELFE;GTF2E2;FLNA;RBM4B;NUDT16L1;PRRC2C;SRSF5;NSUN5;GPKOW;PCF11;FUBP3;RPP30;RBM6;DNAJC21;GNL2;HLTF;SYNCRIP;CLK3;DDX52;DZIP3;RBM5;TBL2;MRPL23;PRKRA;RRP7A;HUWE1;PSPC1;RPP38;EPPK1;MRPL40;TRMT2A;EIF3I;KTN1;ELP5;COA6;TRUB2;LSM8;IGF2BP1;ZBP1;TENT4B;DCP1A;KPNA2;CKAP4;ALKBH1;LONP1;PATL1;HNRNPC;SF3B1;SF3B2;ZNF346;SRRM2;PRPF6;DHX58;TSNAX;NGDN;DARS1;DDX4;RRP9;KHDC4;ENDOV;NAF1;LSM10;DDX1;PSMD4;KPNB1;DICER1;SAP18;SRSF10;PPIE;R3HDM2;FIP1L1;METTL3;EIF3C;PRRC2A;TPR;CPSF2;RC3H1
prerank,MHC class I protein binding (GO:0042288),0.31555091029390403,0.7020037211017441,0.82793867120954,0.9570094746524482,1.0,4/13,20.81%,DERL1;ABCB9;TAPBP;TAP1
prerank,voltage-gated ion channel activity (GO:0005244),-0.26828817275129124,-0.6974857973594348,0.8413461538461539,0.9806834162549717,1.0,5/14,23.05%,KCND2;CACNA1H;ANO6;HCN1;HVCN1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2781632241648466,-0.6961810423218419,0.8379746835443038,0.9780620030106538,1.0,6/12,27.96%,DHRS4;CBR1;NDUFS7;CBR4;NQO1;CRYZL1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.23365186033068183,-0.6952396505480949,0.8849315068493151,0.9751222628772707,1.0,5/25,10.97%,ARAP3;HIP1R;PLEKHA1;KIF16B;PLEK
prerank,RNA polymerase binding (GO:0070063),0.2949064919852302,0.6929818895529936,0.8470209339774557,0.9647824465833994,1.0,7/18,23.49%,NEDD4;TCERG1;CCNT2;CCNT1;PKN2;SCAF8;BRCA1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3134723225762878,0.690601390955766,0.8159203980099502,0.9649453348974912,1.0,5/13,20.91%,DNASE1L1;ENDOV;DICER1;ZGRF1;FAN1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.21333243386616577,-0.68560740532331,0.9161490683229814,0.9812111302726052,1.0,10/33,20.62%,CNOT6L;ANGEL2;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;DCP2;CNOT8;USB1
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.24981187509478847,-0.6840619187660796,0.8795518207282913,0.9788894129910743,1.0,4/17,16.27%,AK5;CLP1;NOL9;AK7
prerank,gamma-tubulin binding (GO:0043015),-0.23446647106286062,-0.6824506675147156,0.9124668435013262,0.9764822656082297,1.0,6/21,18.70%,DIXDC1;PAK1;GIT1;CDK5RAP2;BRCA2;RAB11FIP5
prerank,death receptor binding (GO:0005123),0.3035803322928882,0.6750043065324783,0.8656716417910447,0.9790905512027469,1.0,8/15,26.79%,NTF3;CASP8AP2;BDNF;FEM1B;MADD;MYD88;FADD;RIPK1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.31918900257359883,0.67479025209746,0.8365217391304348,0.9767139614892808,1.0,11/11,68.10%,CHRNB2;CHRNA7;CHRNA4;CHRNA9;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2831837236840211,0.6704440281639293,0.8652037617554859,0.9784717494168453,1.0,4/20,16.72%,USP47;OTULINL;USP9X;COPS2
prerank,CXCR chemokine receptor binding (GO:0045236),0.31073992974163805,0.6642701008981502,0.8402777777777778,0.9820179484118803,1.0,2/11,13.89%,ITCH;CXCL13
prerank,neuropeptide receptor binding (GO:0071855),-0.2606225126434815,-0.6639154184912766,0.8854166666666666,0.9891042485576331,1.0,2/14,18.44%,SHANK1;PPY
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2729918776791404,-0.6635035206117254,0.8870967741935484,0.9856071786422722,1.0,5/12,20.79%,CCDC88A;VEGFA;VEGFC;DAB2IP;VEGFD
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.27295997546442713,-0.6603323552072712,0.863080684596577,0.984439110398841,1.0,6/11,46.13%,HCN1;HCN4;AQP1;CNGA2;CNGA4;CNGA3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.22409080586898641,0.6588356652646421,0.9473023839397742,0.9846050102743374,1.0,6/73,8.59%,LGR4;NPR3;LTB4R;LHCGR;BDKRB2;MAS1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.30291571185647154,0.6527626971831383,0.8756855575868373,0.9876012479360099,1.0,4/11,19.18%,NAA50;NAA40;NAA20;NAA80
prerank,nuclear import signal receptor activity (GO:0061608),0.28464190301526376,0.6526016675447054,0.85,0.9851718785641962,1.0,4/15,18.27%,KPNA6;KPNA2;KPNA1;KPNB1
prerank,protein phosphatase activator activity (GO:0072542),-0.25642539185141405,-0.6504985550611256,0.8811881188118812,0.9888927298067576,1.0,3/13,11.06%,PPP2R5A;CALM1;CALM3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2563739017775513,0.6483481602873011,0.8914373088685015,0.9864689587786978,1.0,7/28,21.55%,PRKAA2;LRRK2;MAP2K1;MAP2K6;AKT1;PRKACA;AURKA
prerank,methylated histone binding (GO:0035064),0.22218178519182258,0.6476731526719098,0.9461942257217848,0.9844675082277765,1.0,18/62,21.15%,ING3;ING5;PHF2;PHF1;L3MBTL1;KMT2E;L3MBTL2;KDM7A;JMJD7;WDR5;PHF8;CBX5;SPIN4;ATRX;KDM4A;RBBP5;CXXC1;KDM5A
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2381595204446712,0.6417602502150277,0.9148311306901615,0.9868595980473788,1.0,12/38,22.61%,SH3PXD2B;PLA2G4A;SNX12;WIPI1;SNX21;DENND1A;PARD3;ATG2B;SESTD1;WDR45;RUBCNL;LANCL2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.26275629824529245,0.639140188218061,0.8998410174880763,0.986571680267377,1.0,4/20,14.90%,AGPAT3;LPGAT1;MOGAT3;DGAT2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.21886499685957633,0.6338652121396028,0.9566360052562418,0.9884737182370735,1.0,16/54,24.02%,ASPG;ASPA;SIRT2;NGLY1;HDAC8;HDAC4;VNN1;SUDS3;AGA;DARS1;SIRT5;MIER3;HDAC5;HDAC6;ACER1;HDAC1
prerank,palmitoyltransferase activity (GO:0016409),0.24939891696287297,0.6295708280564969,0.9153046062407132,0.9895100963338689,1.0,1/28,1.32%,GLUL
prerank,translation initiation factor activity (GO:0003743),0.23572308705661948,0.6267200596131295,0.9295977011494253,0.9892571412035781,1.0,9/36,18.64%,EIF4A2;EIF3A;EIF2B4;EIF5B;EIF2S2;EIF4E3;EIF2B3;EIF3I;EIF3C
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.25960180066754635,-0.6230629278925753,0.9209876543209876,1.0,1.0,7/11,29.88%,NUDT4;DCP2;NUDT11;DCPS;NUDT16;NUDT10;NUDT1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.23333027137596737,0.6188401083183982,0.9270833333333334,0.9925576621532581,1.0,12/33,22.05%,RECQL5;WDR43;PAF1;NCOA3;PCF11;CDC73;ELOF1;WAC;ELP4;HNRNPU;SCAF8;MAF1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.27276604859902803,0.613907747640468,0.9056291390728477,0.993568747803398,1.0,1/15,5.15%,PLA2G4A
prerank,kinase activity (GO:0016301),0.19499933678880316,0.6132288219306558,0.9828009828009828,0.991513797623153,1.0,22/109,19.37%,LYN;EPHA4;MVK;LRRK2;PDXK;SPHK2;MAP4K4;FN3KRP;CKB;CHKB;PI4KA;PANK1;CERK;AKT1;GK;CDC7;ITPKA;TAOK1;FN3K;COASY;NMRK1;PAPSS2
prerank,phosphatase activator activity (GO:0019211),0.27459722337166365,0.6087830006993401,0.9109243697478991,0.9921148568803118,1.0,3/14,12.35%,FRS2;BMP2;PPP2R5D
prerank,histone methyltransferase activity (GO:0042054),0.23186197098071804,0.6085276151167858,0.9228486646884273,0.9897501609527468,1.0,5/32,13.80%,SETD7;KMT5B;KMT2E;SMYD3;SETDB1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19981516033749971,0.6031225702504369,0.9851116625310173,0.9907993590369639,1.0,13/83,13.16%,USP11;USP47;USP20;USP35;USP24;USP48;USP30;USP9X;USP38;USP9Y;MINDY3;USP32;USP10
prerank,exoribonuclease activity (GO:0004532),0.28145464427834194,0.6028304747729882,0.9139414802065404,0.9885321533368242,1.0,5/12,27.54%,EXOSC1;EXOSC7;EXOSC2;EXOSC8;EXOSC9
prerank,single-stranded DNA helicase activity (GO:0017116),-0.21103818640060867,-0.6024806320868127,0.9645569620253165,1.0,1.0,9/19,29.21%,RAD51;DHX9;POLQ;WRNIP1;HELB;MCM5;DSCC1;CHTF18;PIF1
prerank,telomerase RNA binding (GO:0070034),0.24595125092086215,0.601837940305061,0.9270664505672609,0.9866478769985266,1.0,7/22,23.23%,PARN;TEP1;TENT4B;HNRNPC;NAF1;HNRNPU;XRN1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.21362934906920147,-0.6017045361274698,0.9510309278350515,1.0,1.0,8/20,29.65%,RPS3;ZRANB3;EXO1;EXOG;APEX1;ENDOG;FEN1;ERCC5
prerank,omega peptidase activity (GO:0008242),0.19452552653438174,0.5935201267503923,0.9866504854368932,0.9891816559727533,1.0,14/89,13.16%,USP11;USP47;USP20;USP35;USP24;USP48;APEH;USP30;USP9X;USP38;USP9Y;MINDY3;USP32;USP10
prerank,ribosome binding (GO:0043022),0.20972266980463092,0.5928311299332154,0.9728997289972899,0.9871350797044046,1.0,11/46,21.89%,CPEB1;CPEB3;ERI1;EIF6;SERBP1;SRP72;EIF3C;CCDC47;SEC61A1;BAG6;CPEB4
prerank,aspartic-type peptidase activity (GO:0070001),-0.24876573797171342,-0.5883174068045017,0.9514348785871964,1.0,1.0,2/10,23.74%,BACE2;CTSE
prerank,glucose transmembrane transporter activity (GO:0005355),0.2525018876368308,0.58604733646245,0.9165302782324058,0.9888089018606783,1.0,4/17,18.17%,SLC2A10;SLC5A3;SLC2A4;SLC2A8
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.28036433794242716,0.5827907678640888,0.9283216783216783,0.9881725788817678,1.0,4/10,24.19%,PML;IDE;FAN1;ANKRD13D
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.20345263386957918,-0.5825251398081522,0.9710526315789474,1.0,1.0,10/22,38.63%,MTMR2;DUSP7;DUSP8;DUSP23;CDKN3;DUSP3;SBF1;PPM1F;DUSP5;DUSP2
prerank,damaged DNA binding (GO:0003684),0.21223507142206674,0.5815758627227176,0.9752407152682255,0.986355343507247,1.0,6/44,11.94%,OGG1;CUL4B;DCLRE1C;SMC6;DCLRE1A;RAD18
prerank,DNA secondary structure binding (GO:0000217),-0.18485390000487506,-0.5812268123235578,0.9839743589743589,1.0,1.0,9/31,25.47%,MEF2C;YY1;RAD51C;HMGB2;HMGA2;MSH2;RAD51AP1;GEN1;LIN54
prerank,aminopeptidase activity (GO:0004177),-0.19465525732398803,-0.5759546035631169,0.9787234042553191,1.0,1.0,9/26,26.67%,XPNPEP3;MMP15;RNPEPL1;METAP2;BLMH;MMP16;TRHDE;LNPEP;NPEPPS
prerank,four-way junction DNA binding (GO:0000400),0.24550852370321047,0.575177008182748,0.9298531810766721,0.9874011504543724,1.0,7/17,26.35%,RAD51B;RAD51D;XRCC2;MSH6;HMGB3;ABL1;HMGB1
prerank,ribonuclease P activity (GO:0004526),-0.24079602024261723,-0.5744335651185899,0.9530516431924883,1.0,1.0,5/11,30.21%,RPP14;POP4;RPP21;POP7;RPP40
prerank,phospholipase inhibitor activity (GO:0004859),0.27366763574925607,0.5671391627054326,0.9126559714795008,0.9889861050992358,1.0,5/10,34.31%,ANXA5;ANXA2;ANXA4;ANXA9;ANGPTL3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.22289007270520922,-0.5656117575088934,0.9642857142857143,1.0,1.0,6/13,35.56%,TRMT10A;TRMT1L;TRMT10C;TRMT10B;FTSJ1;TARBP1
prerank,MHC protein binding (GO:0042287),-0.19959319885353521,-0.5640111246806571,0.9517426273458445,0.9996814739329094,1.0,4/20,17.15%,ATP5F1A;TUBB4B;CD81;LAG3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.1776293765192713,-0.5594328392042524,0.9824561403508771,0.9977598403461909,1.0,8/28,30.16%,TMBIM1;TRAF5;TRAF1;DAB2IP;TRAF2;BABAM2;TRAF6;BID
prerank,cAMP response element binding (GO:0035497),-0.23759341427491382,-0.5436164010423848,0.9681093394077449,0.9996585315980278,1.0,6/10,32.96%,CREB1;JUN;HMGA2;ATF2;NR4A3;E4F1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2562378388579735,0.5421844202398453,0.9306759098786829,0.9975369725406865,1.0,3/11,17.82%,FBXO11;PRMT9;CARM1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.24799286827735978,0.5267471325177175,0.9402730375426621,1.0,1.0,2/11,12.19%,HNRNPA1;TERF2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.23291276317369108,0.5252781858275776,0.9515859766277128,0.9989707121766593,1.0,3/14,13.81%,MTMR3;MTMR7;PTEN
prerank,carbohydrate kinase activity (GO:0019200),-0.221394020492016,-0.5237259009832992,0.9616252821670429,1.0,1.0,1/11,5.96%,HK2
prerank,deoxyribonuclease activity (GO:0004536),-0.2026131831374252,-0.5235098749477384,0.9755501222493888,0.9979212285362548,1.0,5/14,29.65%,RPS3;ZRANB3;DNASE1L2;APEX1;ERCC5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.228509794486902,0.5198771534168772,0.9747474747474747,0.9982472382951314,1.0,4/17,22.36%,DPYD;DECR1;DECR2;SRD5A3
prerank,DNA polymerase binding (GO:0070182),0.21691808921213593,0.5095243948113467,0.9771615008156607,0.9988128438574979,1.0,9/18,30.99%,FANCI;RTEL1;CDK2AP1;LONP1;NABP2;HMGB1;SMG6;HSP90AA1;PCNA
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.2266769977786925,0.5086784334986842,0.9752475247524752,0.9966695870717278,1.0,2/14,12.11%,AK8;NME6
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2432858455015219,0.5075894074608719,0.967741935483871,0.9945961860177865,1.0,2/10,11.86%,DCLRE1C;DCLRE1A
prerank,snoRNA binding (GO:0030515),0.19244870931986893,0.5044310984772307,0.9868035190615836,0.993123705289674,1.0,9/30,27.08%,NUDT7;BYSL;NUDT16L1;RRP9;BMS1;NUDT5;NOP14;HEATR1;TBL3
prerank,N-acyltransferase activity (GO:0016410),-0.155634158601777,-0.5007893358694546,1.0,0.9992887942995441,1.0,4/32,11.42%,NMT2;TGM2;PLAAT3;SIRT1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.18754453354385642,-0.5006102877704511,0.9856801909307876,0.9956232589884697,1.0,6/15,30.86%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PIK3CD;PI4K2B
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.21606763688442968,-0.499964101770507,0.9746543778801844,0.9920805819884798,1.0,6/10,39.84%,NCF2;NOX1;NCF1;NCF4;DUOX1;CYBA
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2306592038434092,0.49030224754588836,0.9621621621621622,0.9943032043276486,1.0,3/10,19.18%,NAA50;NAA20;NAA80
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2051548104796707,0.4803436676134774,0.9869281045751634,0.9940976576539357,1.0,1/18,5.40%,HSD3B2
prerank,U6 snRNA binding (GO:0017070),0.2095059941974532,0.4618770927664129,0.9774305555555556,0.995133939042846,1.0,4/14,22.90%,RBM22;LSM8;PRPF8;METTL16
prerank,Toll-like receptor binding (GO:0035325),0.21218039803487393,0.4499526848666273,0.9844559585492227,0.9945988842817208,1.0,3/11,21.79%,TLR6;TIRAP;MYD88
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.16311577104127772,-0.43010101997158523,1.0,0.9973201294329707,1.0,9/15,45.77%,P2RX7;P2RY14;PTAFR;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,SUMO transferase activity (GO:0019789),0.17520720529916967,0.4022168800591793,0.9882747068676717,0.9971699239308541,1.0,3/16,19.90%,MUL1;HDAC4;NSMCE2
